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Summary 
The Epidemiology of Cognitive Function in a Community Based Population. The EPIC-Norfolk Study 
PhD dissertation by Shabina A. Hayat 
Although age is the strongest known risk factor, not all people who reach old age develop dementia 
before they die. Recommendations on potentially modifiable risk factors for the prevention of 
dementia are based on evidence that is, at best, moderate in strength. There are major calls to 
strengthen the evidence on potentially modifiable risk factors of dementia.  
The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) is a prospective 
population study of 25 639 men and women aged 40–79 years first recruited in 1993-1997, who 
attended a health examination. Subsequent follow-ups have involved self-report of health and lifestyle 
and further health examinations. Cognitive measures (7 tests assessing a range of domains) were 
introduced as part of a third health examination between 2006 and 2011 (including data from a pilot 
phase 2004–2006) and are available on 8585 individuals. Almost complete follow-up for disease 
outcomes, including dementia and mortality, has been established via linkage to health records.  
Education was strongly associated with cognitive function for all abilities tested. Cross-sectional and 
prospective analyses showed those who were physically inactive during work, were less likely to have 
poor cognition (bottom tenth percentile of a composite cognition score); Odds Ratio (OR) = 0.68 (95% 
Confidence Interval or CI 0.54, 0.86 P=0.001). In contrast, inactivity during leisure time was associated 
with increased risk of poor performance in the cross-sectional analyses, although this association was 
not observed in the prospective analyses. Poor cognition was independently associated with higher 
risk of all-cause mortality and predictive of incident dementia.  Associations were observed for the 
composite score (global cognition) as well as specific cognitive abilities. Poor cognition in four or more 
tests was associated with ten-fold increased risk of developing dementia compared with those who 
did not perform poorly in any test OR=10.82 (95% CI 6.85, 17.10 P<0.001). Addition of each cognitive 
measure strengthened prediction models of dementia further, Area under the curve (AUC) = 0.85 (95% 
CI 0.82, 0.87 P<0.001), with the single test for episodic memory having the strongest influence. 
Routinely collected health records are increasingly encouraged and used for epidemiological research 
for dementia outcome ascertainment. The linkage of the cohort to diverse routine records enabled 
comparison of these data sources.  I provide evidence for the need of a more consensus-based 
approach to the methods of data collection, coding and interpretation of health data across all sources 
examined (hospital inpatient, mortality and mental health services datasets).  
iii 
In summary, the findings from this dissertation suggest the relationships between lifestyle factors, 
poor cognition and dementia are complex. For stronger evidence, future studies need to account for 
characteristics of the sample population and for the test used to measure cognition. Furthermore, 
there is a need for a more nuanced approach to the way the exposure of interest as well as dementia 
outcomes are measured and to adequately address the issue of potential confounding.  
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Chapter 1: Introduction 
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1.1 Summary 
In this Chapter, I present the current state of knowledge of the epidemiology of the broad spectrum 
of cognitive ageing including cognitive impairment and dementia in an ageing population. This chapter 
is a critical evaluation of the recent literature of the established risk factors of cognition across a 
continuum of cognitive function. The purpose is to identify the gaps in the understanding and 
interpretation of previous research that will be addressed by this thesis. The main aims and objectives 
of the thesis are also presented at the end of this chapter. 
For this (Appendix 1) and subsequent chapters, an electronic search was performed using Pub Med to 
try to find evidence on age related differences in cognitive function and on the broader subject of 
cognitive ageing. Although a systematic review was not conducted for this thesis, the search on existing 
evidence for each chapter was comprehensive to examine what is known on the subject area and 
identify what is not known, unclear or limitations from previous studies. Where available, reviews on 
cognition and each exposure or outcome were examined. Manual searches involving the scanning of 
reference lists of articles to identify further articles were also carried out. Searches were focused on 
older adults.  
1.2 Background 
There are nearly 12 million people in the UK who are aged 65 or over and this number continues to 
rise. It is expected that, in 50 years, there will be an additional 8.6 million people aged 65 years and 
over – that is roughly equivalent to the population of London. [1] The increasing number of older 
individuals in the population is leading to a projected increase in numbers with chronic disease and 
disability, conditions strongly associated with ageing. Cognitive impairment and dementia are 
particular concerns and have a major impact on the quality of life and independence of an individual. 
Cognitive impairment and dementia are age-related conditions that have huge implications, both, as 
a human and an economic cost to society. [2]  Though decline in cognitive function is associated with 
ageing and memory complaints in the elderly are common, cognitive impairment and dementia are 
not an inevitable part of ageing. [3] There is a wide range of cognitive capability seen within the older 
population [4] and cognitive impairment itself is a broad term. Cognitive impairment relates to 
impairment in one or multiple cognitive domains based on objectively measured performance. 
Dementia is a syndrome characterised by impairment in these domains, sufficiently severe to interfere 
with daily functioning. This thesis deals with cognitive function and impairment across a range of 
abilities. 
3 
1.2.1 Dementia: a global health challenge 
Dementia is said to be the leading cause of dependence and disability worldwide [5] and described as 
the greatest challenge of our time. [6] Approximately 47 million people are currently living with 
dementia, costing £26.3 billion in UK alone, [7] with numbers of individuals with dementia and costs 
set to rise as life expectancy increases. [5] The value of preventing or delaying dementia onset is far 
greater than that of early detection or treatment to prevent further decline. [8]   
In December 2013, Canada, France, Germany, Italy, Japan, Russia, the United Kingdom and the United 
States (the G8 nations) established the World Dementia Council (WDC), consisting of experts from 
across disciplines to provide global advocacy and leadership on key dementia challenges. [9] This is 
one of the many initiatives across the world to improve lives of those living with dementia. There is 
growing evidence that the prevalence of dementia is declining in high-income countries, [10] providing 
some hope of the possibility in preventing or delaying dementia. [11] Research has focused primarily 
on the impaired states, after the condition has developed, with less focus on prevention.  
However, the body of research in prevention is growing. [11] There is emerging evidence that public 
health interventions might, if implemented effectively, contribute to delaying the onset and reducing 
the future number of people who have cognitive impairment and dementia. Postponing dementia 
onset by only one year could reduce dementia cases globally by nine million in 2050. [12]  A number 
of reports including those from the National Academies of Sciences, Engineering, and Medicine and 
the Lancet Commission on Dementia Prevention, Intervention and Care, [6,11,13] have been published 
on the available evidence for recommendations on future public health strategies on how to best 
manage or prevent cognitive decline, impairment and dementia. With no treatment available for the 
commonly expressed dementia syndromes, there is an increasing interest in the potential role of 
modifiable factors in preventing or delaying the onset of dementia.  
1.3 Cognitive assessment 
There are many assessment tools available for assessing cognition, [14–18] for both study and 
diagnostic purposes. Tests have been developed to assess different abilities and across different 
settings, and their utility vary across populations they are used in. [19] Performance on tests is 
influenced by demographic factors, such as age, gender and education level. [20] Further limitations 
for assessing cognition described in the literature include low levels of accuracy for detecting mild 
impairment. [21–23] Many studies have been limited either by small cognitive batteries assessing few 
cognitive domains or using tools such as the widely used Mini-Mental State Examination [24] (MMSE) 
which is known to be less sensitive to milder levels of cognitive dysfunction. [14,25] This heterogeneity 
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makes comparisons across studies difficult. [26] It is necessary to evaluate the utility of tests and to 
identify tests that are sensitive to early changes in cognition as well as able to capture the complexities 
of real-world tasks. [26]
Current policies do not support screening for future dementia among apparently healthy individuals. 
This is due to the lack of certainty of the clinical outcome and effective interventions, with potential 
for more harm than good.[6]  However, neuropsychological testing has been shown to be a useful 
addition to prediction models of dementia in prospective cohort studies. [27,28] These dementia risk 
models are all currently within the research settings only. The purpose of such models is to classify 
individuals into different risk categories and in particular, identify those with high risk. [27] Further 
evidence and evaluating risk in different populations has been called for. [29] The predictive accuracy 
of such models have been reported as acceptable among different cohorts, [27] some better at ruling 
out those at lower risk than identifying the higher risk individuals. [30] 
1.4 Cognitive ageing is a continuum 
Cognitive ageing describes change in cognitive function as people age. However, cognitive ageing is 
complex and it is still unclear why there is such heterogeneity in the cognitive performance observed 
in the older population. [31] It is necessary to consider the continuum of cognitive ageing including the 
dementia syndromes rather than the distinct disease states. This decline is a result of a combination 
of lifestyle, biological, genetic and environmental factors, which puts some individuals on the course 
of cognitive impairment and possible dementia and others on a course of healthy cognitive ageing.[32]  
There is a wide spectrum of cognitive ability from ‘normal’ to severe dementia. [33–35] The need to 
understand the mechanisms of cognitive ageing and the factors contributing to differences observed 
in individuals is not a new debate. [36,37]  Figure 1.1 Is a diagrammatic representation of decline across 
this spectrum. 
In addition to the difficulty in separating the pathological from the non-pathological, [36] there is also 
complexity and inconsistency by which cognitive domains are assessed. There is a plethora of tests 
used in research to measure cognition, making it difficult to compare across studies. Each of these 
tests measure a slightly different aspect of cognition, with varying cut-off thresholds, and many tests 
not validated in the populations for which they are intended to be used. [16]  Furthermore, older adults 
are likely to have a range of co-morbidities, sensory losses, or to be taking medication that may impair 
cognition that may impact their cognitive performance, making it even more difficult to define 
cognitive ageing.  
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Differences in age-related decline form a continuum and not discrete groups of diseased states. 
Cognitive decline in absolute terms is difficult to determine. This is because decline has to be in relation 
to a prior level of function, which in most cases, particularly in research studies examining cognition, 
is not available.  Also, similar levels of brain pathology can present very different levels of performance, 
[33,37] including individuals showing no apparent decline, yet presenting with considerable pathology 
in their brains [37] (discussed further below under ‘Subtypes of dementia’). 
Although the progression of dementia is on a continuum, in practicality, the stages of dementia have 
to be clinically defined and categories have been introduced such as mild cognitive impairment, which 
align somewhere between normal cognitive ageing and dementia.  The earliest clinical stages are 
characterised by noticeable memory lapses, but do not affect the individual’s ability to carry out 
activities of daily living. [38] Individuals need more assistance in their daily life as the dementia 
progresses to the more moderate and severe stages which may involve further memory loss, 
confusion, possible personality and behavioural changes and eventually death. [39] 
Figure 1.1: The disease spectrum from ‘normal’ cognition to severe dementia (Alzheimer’s Disease). 
(Source: Gale et al., Journal of Medicine 2018) [40] 
1.4.1 Normal cognitive ageing 
Increasing age is associated with lower performance on cognitive tasks. The effect of age on general 
cognitive function has been shown to be apparent from the age of 45 years onwards. [41] 
Understanding the wider implications of age related decline and not just in terms of impairment is 
extremely important, because this wider ranging decline impacts the majority of older individuals.[26] 
It is necessary to have insight to the variability observed in this group of individuals usually categorised 
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as ‘normal’. Normal ageing is not a precise term, as it does not accurately reflect the range of variation 
observed in older individuals. One generally used definition of ‘normal’ is the absence of disease; [42] 
which is not appropriate to use in older individuals who are likely to have a number of co-morbid 
conditions, impairments and disabilities.  
It is therefore more fitting to refer to what is ‘typical function’, which would include comorbidities, and 
some decline with increasing age, but not to the extent that significantly influences cognitive function. 
However, even this definition, which relies on a notion of what is construed to be average for a 
particular age group, is not particularly useful as this varies substantially in different populations. 
[43,44] There is a huge amount of inter-individual and intra-individual variability amongst older adults. 
That is, not only are there differences in ability across age-groups, but the trajectory of decline vary 
across the different cognitive functions. [45] Some aspects of cognition decline, whilst others may 
remain stable or improve at different time points.  In general, older individuals do not perform as well 
as those younger, however, there is huge variability, amongst older individuals, with some cognitively 
performing as well, or even out-performing their younger counterparts.[26]  Various studies have 
examined this heterogeneity in older people, but many are restricted in the domains they assessed or 
the characteristics and age range of their sample population. 
1.4.2 Mild Cognitive Impairment 
Mild Cognitive Impairment (MCI) is described as the transitional stage between normal ageing and 
early dementia in the literature, recognised as a separate clinical condition. [46] Individuals with MCI 
are said to have cognitive impairment but not sufficiently severe to constitute dementia. The scope of 
MCI has changed from its earlier version of focus on memory impairment only, [47] broadening to 
include impairment in other cognitive domains. [48] MCI has attracted particular interest, because 
although this cognitive impairment is not severe enough to meet the clinical criteria of dementia, an 
individual with MCI has been reported to have an increased risk of dementia. [49] This suggests that 
many individuals with MCI are actually in a pre-dementia phase of the disease. [50]  However, using 
MCI as a milder form of cognitive impairment and pre-dementia to try to identify early mechanisms 
that trigger dementia has been complicated. This is because not all MCI converts to dementia, [49,51] 
making it a very unstable and heterogeneous state. [52] Other reasons for inconsistencies across 
studies reporting on MCI are similar to those reported above, that is variation in the characteristics of 
the population assessed, inconsistency in the operational criteria for MCI, insufficient of follow-up 
time, and the nature of the assessment tools. Further more robust studies are needed to examine early 
stages of decline. [53] 
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1.4.3 Subtypes of dementia 
Dementia is an umbrella term and is best described as a syndrome than a specific disease. It describes 
the symptoms that occur when the brain is affected by certain diseases or conditions. Dementia can 
result from a number of distinct diseases and disorders with different aetiologies and 
pathophysiologies that cause damage to the brain. Even within the same disease, there is considerable 
heterogeneity in terms of symptoms and disease trajectories. [54] Primary dementias include 
Alzheimer’s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB), frontotemporal 
dementia (FTD),where decline in cognitive abilities is mostly due to an underlying neurodegenerative 
process and not a direct result of a specific aetiology. [55] Secondary dementias are those caused by, 
or closely related to an underlying disease such or condition, such as infection with the Human 
Immunodeficiency Virus, Parkinson’s disease (PD) head injury, stroke, thyroid disorders or vitamin B12 
deficiency.  Table 1.1 is an overview of the more commonly reported characteristics of the main 
dementia subtypes, although  it is important to highlight, most dementia, is predominantly associated 
with mixed pathologies. [56] 
Individuals will exhibit different symptoms, depending on the type and stage of their particular 
dementia and which part of the brain is affected by the disease process. These symptoms will change 
with time as the diseases progress to involve different areas of the brain. Different types of dementia 
tend to target particular parts of the brain, as presented in Figure 1.2, though clinical symptoms do 
not strictly reflect a specific aetiology, [54] and the figure’s pathological and clinical presentations 
should be interpreted with caution.  Ageing is associated with many chronic diseases, some that affect 
the brain and influence cognition. People with dementia and MCI present with mixed 
neuropathologies, [57] and these comorbid pathologies are said to account for as many if not more 
dementia than AD. Furthermore, neuropathologies of the common causes of dementia [AD, VaD and 
DLB) have been reported to be present in the brains of older persons without dementia. [58] This 
complexity is a combination of mixed dementia pathologies and the influence of cognitive or neural 
reserve. [57] 
Treating dementia as a single entity at a population level is considered to be appropriate for policy 
development and also many risk factors are shared, particularly for AD and VaD.  Using this approach 
of a broader classification also improves external validity. [59]  Many studies involve individuals who 
are already identified clinically in cognitive decline, with fewer studies involving the healthy and 
cognitively unimpaired. Understanding cognition in older people, not only in terms of impairment, but 
across the spectrum, including that of high cognitive function is important.  
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Table 1.1: Overview of the Clinical Characteristics of the main dementia subtypes 
Dementia subtype Clinical Symptoms [60] 
Alzheimer’s disease (AD) 
Short-term memory impairment in early stage; other domains may 
also be affected (e.g. problem solving, finding words, making 
decisions). Insidious onset and slow progressive decline. 
Vascular dementia (VaD) 
Usually correlated with cerebrovascular disease (stroke, lacunar 
infarcts) and atherosclerotic comorbidities (diabetes, hypertension, 
coronary heart disease) 
• Mild memory impairment in early stage 
• Impaired judgement
• Possible gait difficulties and falls (depending on the extent of the
stroke)
• Sudden or gradual onset
Mixed dementia 
 The abnormal protein deposits associated with Alzheimer's disease 
coexist with blood vessel problems linked to vascular dementia. Also 
seen are AD related changes in the brain along with Lewy bodies. 
Individuals with mixed dementia may have brain changes linked to all 
three AD, VaD and DLB. 
Dementia with Lewy bodies 
(DLB) 
Confusion, Poor executive function and visual hallucinations in early 
stage; deficits on tests designed to examine visual perception. Motor 
alterations (as in PD) are absent in DLB. Fluctuating cognition 
associated with parkinsonism. 
Frontotemporal dementia 
(FTD) 
More prominent personality changes (disinhibition) and behavioural 
disturbances (apathy, aggression, agitation with less memory 
impairment in early stage). 
Parkinson’s dementia (PD) 
Up to 80% of patients with Parkinson's disease progress to dementia. 
Motor alteration including tremor, rigidity, bradykinesia and changes 
in gait. Dementia similar to that of LBD or AD. 
Other dementias 
Dementia can be the result of varied and different pathophysiologic 
processes affecting the brain, with slight variation in clinical 
presentations depending on the underlying cause. 

















































































































1.5 Cognitive Reserve 
The concept of cognitive reserve has been proposed to account for the discrepancy between the 
degree of brain damage or pathology and its clinical manifestations. [62]  It is now known that about 
a third of older persons without dementia or MCI meet pathologic criteria for AD, suggesting that many 
people are able to maintain excellent cognition despite the accumulation of brain pathology. [57]  
What allows some people to be more resilient to cognitive impairment than others is unclear, but it is 
understood that cognitive reserve may be mediated in many different ways. [63] It is also considered 
to account for social and leisure engagement as well as for cognitive functioning. [64] Cognitive reserve 
is a hypothetical construct, and therefore cannot be measured directly. Proxy indicators of cognitive 
reserve include educational attainment, occupational achievement, and intelligence. Education is 
probably the most widely used indicator of cognitive reserve. [65] However, other factors that are 
closely related to education such as social economic status (SES), occupation and childhood education 
and parental SES as well as lifestyle exposures have been associated with reserve. [66,67]   Clearer 
understanding of cognitive reserve and its relationship with different factors is important, if we are to 
develop interventions to slow cognitive ageing or reduce the risk of dementia.  
1.6 Characterisation of cognitive abilities 
Cognitive ability covers a number of domains, which together form the basis of cognitive function. As 
yet, there does not appear to be an agreement on the classification of the cognitive domains or which 
abilities are most important in testing cognitive decline and importantly, which predict future adverse 
health outcomes.  The leading theoretical model for conceptualising cognitive abilities splits cognition 
in to two categories, ‘fluid’ and ‘crystallised’ abilities. [68]  Fluid abilities include abilities such as recall, 
learning, problem solving, encoding and recognition and crystallised ability is regarded as knowledge 
gained over time (such as vocabulary and general knowledge). In general,  fluid mental abilities have 
been shown to decline with age, occurring from as early as middle age, [37] whilst crystallised abilities 
remain fairly stable well into later life. [69–71] Mental function can be assessed in terms of both global 
and domain specific function. [69] It is stating the obvious that cognitive abilities are central to carrying 
out everyday activities, living independently and for general health and wellbeing, but understanding 
the components and determinants may help us better understand how best to maintain abilities in 
later life. 
Distinguishing between cognitive abilities is important because they play different roles and are 
influenced by age to varying degrees. However, measuring these abilities is complicated because they 




of another, or different abilities work in conjunction to execute a given function.  There is lack of 
agreement between a particular tests and its assumed cognitive domain. [72] Figure 1.3 shows some 
of the abilities mentioned in the literature and, as mentioned previously, considered to be important 
in assessing cognitive performance.  Individuals can have impairment in one cognitive domain but 
perform well in another or a number of cognitive deficits can occur concurrently. There is increasing 
evidence of substantial variability in cognitive abilities within individuals, [73] but the role of this 
variability within different domains is not clearly understood. [74]  Where studies have examined 
cognitive abilities in more detail, studies are restricted such as just including women [74] or those of 
older age groups. [21,72,74,75] 
Dementia is characterised by severe deficits mainly within the fluid cognitive abilities, which worsen 
and affect more domains as the disease progresses. [76] Dementia for most, has a long prodromal 
period, whereby individuals who go onto develop dementia, exhibit cognitive deficits many years 
before any symptoms or receiving a clinical diagnosis. [77]  Variability across tasks may also indicate 
neurological dysfunction. [73] Greater variability across different cognitive domains has been 
associated with poorer performance and dementia, [78] and has been said to be a good predictor of 
cognitive impairment over and above the mean level of performance in cognitive tasks. [79] 
Furthermore, there is also evidence of more pervasive cognitive deficits across domains in earlier 
stages of decline, and not just memory alone. [80–82]  
Studies have reported on different cognitive tests to assess cognitive deficits related to dementia. [83]  
Although current  policy does  not support screening [6]  neuropsychological assessment is central to 
the diagnosis of dementia and identifying individuals who may be in a prodromal phase dementia.  
Studies have varied considerably in terms of the cognitive domain assessed, length of follow-up, or the 
characteristics of the population, all making it difficult to compare the predictive accuracy of these 
tests. [27]  
Not everyone with MCI or mild cognitive dysfunction, is in the preclinical phase of the disease, but 
there has been increasing perception of a need to identify tools that can separate accurately those 
who will remain stable from those who will progress to dementia. While several studies have reported 
the ability of cognitive tests to predict the onset of dementia in the short term, few have studied this 
phenomenon for a period of more than 10 years. [84] Further risk assessment across different 
populations using existing and new assessment tools is recommended to get further insight to the 
validity of neuropsychological tests. [27] Characterising assessment tools across different cognitive 
abilities and examining how these tools are influenced by the population characteristics is important. 




predicting dementia.  Most studies have examined these models in later life, with very few able to 
examine mid-life predictors.  
Figure 1.3: Some cognitive abilities used in assessing cognitive function 
  
1.7 Definitions and Classification Systems 
There are two main diagnostic classification systems that are used for the clinical diagnosis of 
dementia. The World Health Organisation’s (WHO) International Classification of Diseases and Related 
Health Problems 10th Revision (ICD-10) and the American Psychiatric Association's Diagnostic and 
Statistical Manual of Mental Disorders, currently as the fifth edition (DSM 5). [59] In addition to these 
two classification systems, there are other recognised systems that have been specifically developed 
for diagnosis of Alzheimer’s and vascular dementia respectively.  These are: National Institute of 
Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders 
Association (NINCDS/ADRDA) and the Neuroepidemiology Branch of the National Institute of 
Neurological Disorders and Stroke–Association Internationale pour la Recherche et l'Enseignement en 
Neurosciences (NINDS–AIREN). In 2011, the National Institute on Aging (NIA) and the Alzheimer’s 
Association (AA) convened to update the NINCDS-ADRDA criteria for AD and all cause dementia [85] 
to include the asymptomatic, minimally symptomatic, and dementia phases of AD, [86] as well as 
incorporating the available information from clinical, imaging, and laboratory assessments. [85] 
Although there is considerable compatibility between the systems, there is no clear formally agreed 
definition and because the criteria are set based on clinical judgement, there can be variability in 
classifying an individual depending on the system used. The classification system used by hospital 
codes in the UK is the WHO’s ICD-10, which will be discussed in this thesis. Further details of the other 




1.8 Dementia ascertainment using medical record Linkage in UK. 
To examine associations of dementia with risk factors robustly and accurately, studies need to involve 
a representative sample followed up long term. One high quality study is the Medical Research Council 
Cognitive Function and Ageing Study (CFAS).[87,88] A particular strength of CFAS is the use of a study 
algorithmic approach to diagnose dementia, which gives consistency across area and time. [88] 
However not all population studies are able to use this approach. Furthermore, one of the main known 
limitations of longitudinal studies is attrition and loss to active follow-up, in particular of those who 
are sick, frailer and older. Therefore, medical records are an important resource for dementia 
ascertainment allowing a more complete follow up of individuals in a cohort, reducing risk of bias.  
In the UK, the National Health Service (NHS) allows hospital usage free at the point of delivery for all 
UK residents and so will hold medical records on the whole population. This presents an ideal 
opportunity for well-characterised cohort studies to strengthen their ability to investigate the role of 
risk factors for different health outcomes, including dementia, through record linkage. Administrative 
health databases in the UK contain clinical data coded using the ICD-10 classification system.  Routinely 
collected NHS databases in England include Hospital Episode Statistics, (HES) and mortality data that 
can be linked using their unique NHS number and date of birth via NHS Digital.  The linked hospital 
records contain coded diagnostic information for all inpatient and day-case admissions. [89]  
Dementia diagnoses are also held in national mental healthcare data, which are held in separate 
datasets from HES and mortality data. These different datasets are described in further detail in 
Chapter 7. However, these databases are primarily for administrative purposes, and research purposes 
are secondary use of these data. It is therefore important to examine these databases carefully to get 
a better understanding of the underlying nature of these data to allow accurate case ascertainment.  
Not all individuals with dementia may have a hospital admission with a diagnosis of dementia.  
Nevertheless, while the sensitivity of hospital records to identify dementia cases is uncertain, as long 
as appropriate codes are used, the specificity of routinely collected healthcare data to identify disease 
cases is very high.[90] 
In general practice, clinical information is recorded using a ‘Read Code’ system developed by Royal 
College of General Practitioners (RCGP) representatives from England, Northern Ireland, Scotland and 
Wales and is maintained and updated by NHS Digital. This coding system is different yet again to the 
others listed above, but can, largely, be mapped to ICD or DSM codes, this is then mapped to the 
nearest read code equivalent when transferred to GP records. Linking to GP records is not always 
possible as described in detail later (Chapter 8). Most studies therefore use HES or mortality data. 




Rates of dementia will vary depending on the definition of dementia used, which varies across coding 
and disease classification In addition to this inconsistency across systems, changes in policy and 
practice has raised concerns over the accuracy and completeness of dementia recording in health care 
records, [91,92] which differ not only at general practice level but geographically across the UK. [93,94] 
Although there have been two large scaled cohort studies comparing dementia ascertainment across 
data sources, these studies have their limitations, including that they have fewer dementia cases due 
to the age profile of the cohort. [91,95] Medical records are a major source of case ascertainment for 
epidemiological studies examining relationship of different risk and protective factors of dementia. 
[91,96]  Scrutiny of these methods across different populations and geographical areas is necessary in 
order to understand the strengths and weaknesses of using routinely collected records in research.  
1.9 Assessing cognitive performance in older populations 
A diagnosis of dementia is made only after a comprehensive assessment, [97] and will depend on the 
classification system used. Therefore, the criteria for defining impairment can vary and be inconsistent. 
Cognitive impairment ranges from mild to severe. Dementia is typically diagnosed when the 
impairment in cognitive function has become severe enough to compromise the functions of every-
day life, and this of course will vary from one individual to the next. There may be a decline in the 
ability to judge, think, plan and organise, or a significant change in behaviour in terms of emotional 
responsibility, irritability, or loss of social skills.  
A diagnostic assessment for cognitive impairment involves a number of steps. This includes history 
taking, cognitive assessment, physical and laboratory examination and a review of medication, all 
factors that may have an adverse effect on cognition. [16,19]. The Mini Mental State Examination 
(MMSE) is probably the most frequently used test for diagnostic purposes [18], however, more 
recently a number of alternatives are being used by practitioners such as the 6-item Cognitive 
Impairment Test (6-CIT), Addenbrooke’s Cognitive Examination (ACE, or the revised version ACE-R) and 
the General Practitioner Assessment of Cognition (GPCOG) to name a few. Table 1.2 shows the main 
domains assessed, the maximum possible score and the cut-off indicating impairment for each test. 
Even in clinical practice, there are no commonly agreed cut-offs and the recommendation is that the 
cut-points should be adjusted to account for factors, such as age and education [25] or the setting in 
which the test is administered. [98] There has been much debate over the issue of screening for 
dementia [16,99] and one of the reasons for arguing against screening, other than the lack of available 
treatment and cause of anxiety to an individual are the concerns over the validity and utility of the 




Table 1.2. Common assessment tools used in clinical practice 




6-CIT Orientation, attention and memory 28 8 /28 or 10/28 for severe impairment* 
 
MMSE Global measure of cognition (memory 
attention, registration, language 
visuospatial, praxis, verbal fluency 
executive function 
30 24/30 or 23/30 for severe impairment 
27/30 for higher educated individuals 
ACE-R Attention/orientation, memory, 
verbal fluency, language and visuospatial 
abilities 
100 88/100 or 82/100 in hospital or clinic 
setting 
GPCOG GPCOG-Patient Component: Cognitive 
assessment of orientation, memory and 
visuospatial abilities  
Informant component: Assessment of 
functional abilities in activities of daily life 
9 (Patient) 
8 (Informant) 
4/9 on GPCOG-Patient Cog and 3/8 on 
GPCOG-Informant  
* Higher score reflects poorer performance 
In terms of research settings, the number of tests is too vast to list. It is broadly accepted that cognitive 
abilities can be measured in both general and specific terms, and different assessment tools have been 
used across studies reporting both on domain specific and global cognition. Most studies report on 
global cognition, with much fewer reporting domain specific results. Even those testing different 
domains, report either using composite scores or z- scores. As yet, there does not appear to be an 
agreement on the classification of the cognitive domains and there is still a lack of consensus on which 
abilities are the most important in testing cognitive decline. [69] Using common metrics such as z-
scores may facilitate comparison of scores across different measures; however, these standards have 
their limitations. Using a composite score results in loss of information on the separate abilities and z-
scores assume a normal distribution and are usually standardised by age. However in terms of 
maintaining cognition, generally of greater interest, is the absolute level of function regardless of age. 
Numerous dementia risk models have been developed, and currently are confined within research 
settings only. The purpose of such models is to classify individuals into different risk categories and in 
particular, identify those with high risk. [27] Further evidence and evaluating risk in different 
populations has been called for. [29] Neuropsychological measures are key measures included in 
prediction models of dementia in addition to age. [27,28] Greater variability and impairment across 
different cognitive domains has also been associated with poorer performance and dementia. [78]  
Despite a great deal of research and debate, it remains   unclear as to whether we should consider any 
impairment in absolute terms or relative to age and education. Furthermore, cut-points predicting 
disease or impact on function and what level requires action will be different for different individuals 
and across different populations. Socioeconomic and demographic variation among populations can 




suggesting poor performance or even impairment in a given population could be typical scores in a 
poorly educated but unimpaired community sample. [44] This problem has been addressed in studies 
by deriving cut-off scores from the population itself, [101] defining performance at a predetermined 
percentile of the population sample as "impaired". Therefore, cognitive ageing is not easily defined by 
a clear thresholds on cognitive tests, as many factors such as, occupation, education, as well as health, 
may influence test performance and norms. [26] There is a need to question what is important to 
measure when assessing cognitive function.  
1.10 Cognitive Epidemiology 
Understanding how cognitive function is associated with disease and health outcomes, as well as 
identifying potentially modifiable environmental determinants of cognitive health in mid to later life is 
important and may help inform clinical and public health interventions. [102] Studying determinants 
and risk factors of cognitive impairment and dementia is paramount to gain insight into the 
mechanisms relating to cognitive impairment and dementia. By influencing these factors, it is hoped 
that the course of the disease can be modified. [103] In this section, I briefly discuss the main factors 
investigated in cognitive epidemiology research.  
1.10.1 Risk factors for cognitive impairment 
Dementia is a multifactorial disorder, resulting from a lifetime exposure of protective and risk factors. 
As reducing risk of dementia as well as promoting good cognitive health in older people are both 
important in terms of public health, then having in-depth knowledge of these different factors, and 
how they may reduce or increase an individual’s risk of developing dementia is necessary. By studying 
these risk factors in a meaningful way, we can have a better understanding of the mechanisms leading 
to dementia as well as shedding light on whether these factors could differentially influence or 





1.10.1.1 Non-modifiable factors 
Age itself is the strongest risk factor for cognitive impairment and dementia [36] which of course is not 
modifiable. [59] Also non-modifiable are genetic risk factors, of which the most established risk factor, 
particularly for AD is the apoliprotein E (ApoE) gene. [54] ApoE presents in three allelic forms (e2, e3, 
and e4), of which the e4 allele is a recognised risk factor faster cognitive decline [104] and 
dementia.[54]  
Women have been reported as having higher dementia rates, however, this difference has generally 
been accounted for as women have longer life expectancy than men. As age is the greatest risk factor 
for dementia, the lifetime risk of dementia is greater for women, but the exact differences in risk 
factors remain unclear and might vary across populations. [105] Studies generally adjust for sex, but 
few have actually examined sex differences in risk factors for dementia. Some factors have been 
reported to confer greater risk for men, such as hyperlipidemia and myocardial infarction with 
depression for women. The distribution and prevalence of major risk factors between the sexes and 
age groups vary, and further work is needed to identify how these risk factors differ in men and 
women. [106]  
1.10.1.2 Modifiable factors 
The concept of prevention being better than cure, [6]  in the absence of any substantial progress on 
the latter, [6] underpins the growing interest in the role of modifiable risk factors for cognitive 
impairment and dementia, a number of which have been reported. Socioeconomic factors have been 
examined in detail, and shown to be strong correlates of cognition, with associations persisting 
throughout life. [107] Education has been identified as the strongest and most consistent protective 
factor for dementia, [108] and as mentioned previously, is commonly used as a proxy measure for 
cognitive reserve. [65,109] Studies have also suggested that dietary, such as adherence to a 
Mediterranean diet, and lifestyle factors such as physical activity are associated with cognitive 
function, [110] although for both the evidence is considered to be incomplete. Physical inactivity 
(independent of physical activity), has been found to be risk factor for major health conditions, [111] 
including cognitive impairment. [112], but the neuroprotective effect of physical activity has not been 
consistently shown. [113]  
Many modifiable risk factors for dementia are mostly related to cardiovascular disease (CVD) risk 
factors (diabetes, hypertension and obesity). Managing the known risk factors for CVD such as, 
diabetes, hypertension, mid-life obesity, physical inactivity and smoking to reduce dementia risk, are 




[115] although longer prospective investigations present a more mixed picture. [116] It is unclear if 
depression is a risk factor, a feature of the preclinical phase of dementia, or an associated comorbidity 
with a common cause. It is quite possibly a combination of all three. Other factors that are not so well 
established, but have been proposed as to influence dementia risk include body fat distribution, 
especially abdominal fatness (central obesity), as reflected by waist circumference or waist-to-hip ratio 
(WHR) [117] and poor lung function. [118] Management of hearing loss and social isolation have also 
been included in the list.  
1.10.2 Cognitive performance as predictors of mortality 
Poor cognitive performance has been reported to predict increased mortality risk. [39,119,120] A 
number of hypotheses have been presented. [121] One hypothesis is that higher education and social 
class are both related to better health and to improved cognition and so all three are associated with 
better health and lower mortality.  The second hypothesis suggests cognitive function has an indirect 
effect on mortality, mediated through social and behavioural lifestyle differences, such as healthy 
eating, stopping smoking and exercise, which in turn affect mortality. A third hypothesis is that 
cognitive ability may be a proxy indicator of deficient brain development that is correlated with later 
adulthood illness or as a marker for general bodily integrity. [122] 
The relationship between cognition and mortality is complex despite being consistently reported. [123]  
Better cognitive ability is said to be an indicator of a well-functioning body influenced by genetic as 
well as early and later life biological and environmental factors. This includes the integrity of the brain 
and the efficiency of information processing, which has been suggested to be more strongly related to 
mortality than other cognitive abilities.[124,125]  Even though many cohort studies have shown robust 
associations between cognition and mortality, there still remains ambiguity on understanding this 
relationship and as yet no pathway or mechanism has been postulated. Variation in methodologies 
has resulted in inconsistencies across studies and there are no clear explanations of the mechanisms 
involved.  The question of whether poor cognitive function is merely a marker for general decline or 
plays a causative role in death remains unanswered. Further clarity on this complex relationship is 
needed. Studies examining association of milder cognitive dysfunction and mortality have been 
inconsistent. [39,119]  
1.10.3 Cognitive performance as predictors of dementia 
Neuropsychological testing provides information on the nature and extent of cognitive deficits There 




not just memory alone. It is important to be able to identify how impairment across a range of different 
cognitive abilities are related to health outcomes, particularly death and dementia.  
1.11 Gaps identified in the literature 
Despite the huge efforts and investment in research in cognitive ageing and dementia, there is still a 
further need to strengthen the evidence on potentially modifiable risk factors of cognitive impairment 
and dementia. Many protective and risk factors cluster together, making it hard at times to interpret 
the data. The variability observed in the literature can be explained, in part by health status, education, 
socioeconomic factors and genetics, but is also likely to be due to heterogeneity in methodologies 
across studies. The review of the literature has identified a number of gaps that have not been 
adequately addressed in the previous literature and will shape the specific aims and objectives of this 
thesis.  
Although many studies have shown cognitive function to be hugely variable in older people, many 
studies are restricted in the domains they assessed, reporting mainly on global cognition, or limiting 
to memory. It is necessary to examine a wide range of abilities. Studies have also been limited in the 
age range of the study population involving only older individuals, [87,88] or with population sample 
recruited from clinical settings, [123] who may have other co-morbidities. There are studies that are 
restricted in terms of including either only men, [126,127]. Women [95] or limited in the socio-
economic range. [126,128] All these limitations have the potential to not only introduce bias and 
confounding, or reduce generalisability of the findings, but also make it difficult to compare across 
studies. It is extremely important to disentangle confounding caused by methodological variation.  
Smaller studies are unable to account for a wide range of covariates, limiting the ability to detect the 
associations and control for potential confounders. [129] Given the complexity, any associations and 
the selection of covariates need careful consideration. Failure for adequate adjustment for covariates 
leads to residual confounding. Furthermore, lack of detailed examination of both the way exposure 
and outcome variables are measured can also mask the true nature of relationships. It is important to 
use a nuanced approached where possible to examine these factors, adjusting for a range of co-
variates without losing power to tease out the true relationship, which may be some of the reasons as 
to why previous studies have been inconsistent in their findings.  
In terms of modifiable factors, education and physical activity are of particular interest, as they both 
could either exert direct effects on brain structure, improving vascularisation and contributing to 
building cognitive reserve.  For physical activity, there is already the mantra, what is good for the heart, 




longer follow-up suggest that a lower risk of dementia in physically active people may be attributable 
to reverse causation. [113]  Educated people typically have lower risk of cardiovascular disease and 
engage in healthier behaviours; therefore education is important not only as a determinant, but also 
as a confounder in many of these studies.  It is important to gain further insight into this complex 
relationship of different domains of physical activity in a long prospective cohort across a wider socio-
economic range.  
A number of studies have shown the relationship between cognition and mortality, [121,130–133] for 
both global and domain specific measures. [121,131]  However, the evidence for association at milder 
levels is mixed. [119,134,135]  It would be of interest to explore whether this relationship extends 
beyond to include poor performance, even before any evidence of impairment, which would impact 
more individuals in an ageing population.  For studies examining cognitive measures predicting 
dementia, there are limitations in terms of the range of cognitive tests and short follow-up time. 
Examining these in individuals free of cognitive impairment or dementia at the time of cognitive testing 
and across a wider age range merits further investigation.  
Finally, the use of health records as a measure of dementia outcomes in medical research and for policy 
tracking has become an increasingly important resource for dementia ascertainment. Whilst the 
availability of data provides opportunities for powerful and efficient research, these data sources are 
prone to inconsistency, misclassification and influenced by change in dementia practice and policy.  
Researchers should be aware of the strengths and limitations of the secondary use of health records 
used within their studies and report on the influence of these factors on the accuracy of their findings. 
1.12 Overview of setting: The EPIC-Norfolk Study  
The European Prospective Investigation into Cancer (EPIC) is a 10-country collaborative study in which 
EPIC-Norfolk is one of the UK centres, designed to investigate the aetiology of major chronic diseases. 
[136]  EPIC-Norfolk recruited and examined 25 639 men and women resident in East Anglia (aged 40–
79 years), between 1993 and 1997 at baseline. The EPIC collaboration was set up to examine the 
dietary determinants of cancer, but the remit in the EPIC-Norfolk cohort was broadened from the 
outset to include determinants of other health conditions and chronic diseases disability and death in 
middle and later life. [137] Recruitment was via general practices in the city of Norwich and the 
surrounding small towns and rural areas; detailed methods have been published.  [137,138]  As 
virtually all residents in the UK are registered with a general practitioner through the National Health 




Cognitive assessment was introduces as part of the third health examination (3HC) between 2006 and 
2011, with a brief pilot phase between 2004 and 2006. [138]  Epidemiological studies, such as EPIC-
Norfolk provide data to define impairment based on function of normal ranges within healthy 
populations. Recruitment for EPIC-Norfolk was via general practices, and participants were included 
only from those practices that agreed to participate. Of the 77,630 individuals invited to take part in 
the study, 30,445 (39%) responded and 25,639 (33%) attended the baseline examination. For the third 
health examination, 18,380 from the original cohort were invited, of which 8,623 (47%) took part. 
Although the study team tried to maximise participation by facilitating travel, and accommodating 
participants through flexible clinic hours, this would have been limited due to funding and practical 
reasons.  
For a study to be representative of a population, there needs to be a high participation rate from the 
whole population, or a random subset of the population.  Those who did not take part would be more 
likely to be older, frailer and cognitively impaired.  While the original participants in the EPIC-Norfolk 
study were largely comparable in characteristics to the those in the Health Survey for England, those 
returning for the third health examination were survivors and more likely to be healthy and have the 
capacity to participate so without obvious dementia.  Though the EPIC-Norfolk participants are likely 
to represent a healthier subset of the older UK population, there was still good representation from 
men and women, across a wide age range, education and social class and cognitive ability. These 
limitations are addressed in individual chapters of this thesis. 
1.13 Potential to study the epidemiology of cognitive function in EPIC-Norfolk 
The likely selection of healthier individuals participating in EPIC-Norfolk make it difficult to generalise 
from the findings to estimate and quantify the prevalence of the cognitive impairment and the burden 
of dementia in the UK.  However, examining and understanding associations of risk factors with 
cognitive function and dementia within in this cohort can potentially shed light on underlying 
aetiological mechanisms which may inform future policies.  There will of course be some limitations 
and biases introduced in the analyses presented in this thesis. However, these will be highlighted in 
the specific chapters, including where possible, the bias introduced by non-participation. The impact 
of missing data, specific to individual analyses is addressed in each chapter separately.  
1.14 Aims and objectives 
This thesis attempts to address some of these specific gaps as highlighted in the literature review, using 
a cohort, with no overt cognitive impairment at the time of testing, providing further insight to the 




the question of what is important to measure when assessing cognitive function and to gain 
understanding of the utility of these tests in predicting outcomes such as mortality and dementia.  By 
characterising the assessment tools, which has been limited in the literature, and knowing how best 
to measure cognition across the spectrum, we can gain a better understanding of cognitive function 
and impairment.   
The overall aim of this thesis was to obtain an understanding of factors associated with cognitive 
function in later life and to address the knowledge gaps with the aim to add to the emerging body of 
evidence of prevention and delay of cognitive impairment and dementia. 
The well-characterised nature of the EPIC-Norfolk cohort, and long follow-up allows for a more detailed 
approach to examine potential confounders, that other studies may not have addressed adequately. 
This study is well-placed, not only to identify factors associated with poor cognition but also factors 
associated with maintaining abilities in older age. EPIC-Norfolk is an excellent platform to investigate 
cognitive function across a broad spectrum of abilities in men and women, across levels of education, 





The specific objectives of this thesis are: 
1. To describe the rationale and methods for introducing cognitive measures in the EPIC-
Norfolk Study, giving outline of study design, and key findings (Chapter 2). 
2. To present descriptive statistics and distributions of cognitive performance across a range of 
cognitive domains in this cohort of men and women in mid to later life.  To operationalise 
cognitive dysfunction across different cognitive abilities in individuals who are clinically 
cognitively unimpaired (Chapter 3). 
3. To examine associations of socio-demographic variables and cognition and provide further 
insight as to how cognitive assessment tool relate specifically to age, sex, social class and 
education (Chapter 4). 
4. To examine the relationship (both cross-sectional and prospective) between physical 
inactivity during work and leisure time and cognitive performance (Chapter 5). 
5. To explore the reported increased risk of mortality associated with cognitive dysfunction and 
dementia, by examining whether relationship can be observed at lesser levels of poor 
cognition, and whether this varies across cognitive domains (Chapter 6).  
6. To examine the recording of dementia diagnosis in routinely collected health records, the 
impact of incomplete or inaccurate recording, and how variation across sources may 
influence analysis and interpretation of associations (Chapter 7). 
7. To examine the utility of the cognitive tests used in EPIC-Norfolk to predict dementia and 
also examine whether the extent of impairment across different cognitive tasks enhances the 
predictive power over and above the level of individual cognitive test performance alone 
(Chapter 8). 
1.15. Study Design 
The study design is summarised in Figure 1.4, presenting the selection of the study population, size of 
the analytical sample, primary exposures and outcomes of interest and methodology for each of the 





























































































































The work presented in this Chapter has been published: 
Hayat, S. A., Luben, R., Keevil, V. et al., (2014). Cohort Profile: A prospective cohort study of objective physical and cognitive 
capability and visual health in an ageing population of men and women in Norfolk (EPIC-Norfolk 3). International Journal of 






This chapter will expand on information presented in the previous chapter on the background, 
rationale and methods used to measure cognitive function in the EPIC-Norfolk cohort as well as the 
other covariates used in the analyses. This chapter also provides details on the characteristics of the 
participants and the level of attrition within the study caused by various reasons (i.e. death or poor 
health), that may be considered a potential bias in the analyses carried out in subsequent chapters of 
this thesis.  
2.2 Introduction  
Substantial data already exist on dementia and cognitive impairment, mainly in the older population 
using a wide range of instruments, each with merits and limitations assessing different aspects or 
stages of cognition. There is a need for assessment in a wider age range from mid to later life that will 
allow accurate measure of a broad range of ability and domains, with an optimal balance between 
sensitivity and specificity in the settings in which these tools are applied. EPIC-Norfolk has had a 
particular focus on characterizing exposures in terms of modifiable lifestyle factors. One of the key 
priorities of this study has been to develop, improve and gain further insight into exposure 
measurement and to characterise participants extensively in terms of their lifestyle, physiological, 
metabolic and genetic profiles. The specific aim of this chapter is to describe in detail, the assessment 
tools used to measure cognitive function, the selection of covariates, descriptions of the main 
exposure and outcome measures and the characteristics of the participants selected in order to 
address the proposed research question in this thesis.  
2.3 Ethical Permission and Research Approvals 
Ethical approval for EPIC-Norfolk core study (Baseline) was provided by the Norwich District Health 
Authority ethics committee (Rec Ref: 98NC01). EPIC-Norfolk 3HC, the baseline for cognitive measures, 
was approved by the Norfolk Local Research Ethics Committee (05/Q0101/191) and East Norfolk and 
Waveney NHS Research Governance Committee (2005EC07L). Participants gave signed informed 
consent at both baseline and then subsequently at the 3HC to cover new measures that were not 
present in previous health examinations. This study was conducted in compliance with the principles 
expressed in the Declaration of Helsinki and the Research Governance Framework for Health and Social 
Care.  
Section 251 (S.251) of the NHS Act 2006 allows the common law duty of confidentiality to be set aside 
in specific circumstances where anonymised information is not sufficient and where patient consent 
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is not practicable. EPIC-Norfolk S.251 approval to allow access to medical records and complete follow 
up of participants. In more recent phases, explicit signed consent to link to medical records has been 
given by participants attending health examinations. 
Section 251 Application number 059: 
https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/confidentiality-
advisory-group-registers/ 
2.4 Settings and population 
The European Prospective Investigation into Cancer and Nutrition (EPIC) project is an international 
collaboration across ten European countries (France, Germany, Greece, Italy, The Netherlands, Spain, 
United Kingdom, Sweden, Denmark and Norway). This well-established cohort was initiated in 1989–
1990, recruited of 519 978 participants (366 521 women and 153 457 men), mainly aged 35–70 years 
at baseline. [136,139] EPIC was originally designed to investigate the role of nutrition in cancer 
aetiology, but the study has grown to include other medical conditions such as cardiovascular disease, 
diabetes and Parkinson’s. [140] 
The work in this thesis is based on the data collected in EPIC-Norfolk, one of the two centres from the 
United Kingdom of this ten-country collaboration. Although EPIC-Norfolk started as a diet and cancer 
study, its remit was widened from inception to include investigation of major determinants of chronic 
disease, disability and death in middle and later life and lifestyle exposures other than just diet. [137] 
The study location comprises of the city of Norwich and its surrounding small towns and rural areas 
(Figure 2.1). This area was chosen on the basis of low level of outward migration and the practical 
advantage of being served by one major district general hospital at the time, which would facilitate 
end-point ascertainment through linkage to hospital-based records.  
2.4.1 Recruitment of participants to the study  
In total 77 630 men and women then aged 40–79 years were invited to take part EPIC-Norfolk at 
baseline between 1993 and 1997 through registers in thirty-five general practices in Norfolk. The 
standard protocols of the health examination have been published. [137] Specific details of the 




Figure 2.1: A map of Norfolk representing the distribution of participants soon in 2000 and in 2014, 
showing little change in migration over the course of the study. 
 
2.4.2 Baseline Health Examination 
At the baseline health examination, trained nurses took anthropometric measurements on individuals 
who were wearing light clothing and no shoes. Height was measured to the nearest millimeter using a 
free-standing stadiometer, and weight was measured to the nearest 0.1kilogram (using digital scales, 
Tanita). Body mass index (BMI) was calculated as weight in kilograms divided by the square of height 
in meters. A D-loop non-stretch fiberglass tape was used for the circumference measures. Waist 
circumference was measured at the smallest circumference between the ribs and the iliac crest to the 
nearest 0.1 cm while the participant was standing with the abdomen relaxed, at the end of a normal 
expiration. Waist circumference was defined as the minimum circumference at the natural waistline 
between the lower rib margin and the iliac crest. Hip circumference was defined as the maximum 
circumference between iliac crest and the crotch. Waist:hip ratio (WHR) was calculated as hip 
circumference/waist circumference. 
Lung function was measured by forced expiratory volume in one second (FEV1) using an electronic 
handheld turbine spirometer (Micro Medical Ltd, Rochester, United Kingdom), with the higher of two 
consecutive expirations recorded after a practice blow. Calibration was performed regularly on a 
weekly basis to ensure the accuracy and precision of both equipment and personnel. Although 
measures of both FEV1 and forced vital capacity (FVC) were taken, only FEV1 is reported here. Blood 
pressure was measured by using an Accutorr non-invasive oscillometric blood pressure monitor 
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(Datascope Medical, Huntingdon, United Kingdom) after the participant had been seated for 5 min. 
The mean of two systolic readings was used in the analyses. 
Nurses also took non-fasting blood samples in plain and citrate bottles. Serum concentrations of total 
cholesterol, were measured on fresh samples with the RA 1000 (Bayer Diagnostics, Basingstoke). 
Plasma vitamin C levels were measured from blood drawn into citrate bottles. The blood was stored 
overnight in a dark box in a refrigerator at 4–7°C and then spun at 2,100g for 15 min at 4°C. Plasma 
was stabilized in a standardized volume of metaphosphoric acid and then stored at 270°C. The plasma 
vitamin C level was estimated using a fluorometric assay within 1 week of sampling (12). The coefficient 
of variation was 5.6% at the lower end of the range (mean 33.2 µmol/l) and 4.6% at the upper end of 
the range (mean 102.3 µmol/l). 
2.4.2.1 Health and Lifestyle Questionnaire 
A health and lifestyle questionnaire (HLQ) was posted to the participants for self-completion, which 
they either returned by free-post or returned at the health examination. The health and lifestyle 
questionnaire has a common format across the EPIC cohorts. Sociodemographic, health and lifestyle 
data were collected from the HLQ.  
2.4.2.2 Covariates from questionnaire 
Marital status was categorised as ‘married’ or ‘single’ (combining single, separated, divorced and 
widowed categories). Education (the highest level attained) was categorised into three groups (i) No 
qualification (not completing school up to the age of 16), (ii) Completion of school up to the age of 16 
or up to the age of 18 and finally (iii) those obtaining an education to graduate level (those who 
obtained a degree or equivalent) or above. 
Social class, for men was coded using current occupation except if participants reported as being 
unemployed in which case their partner’s social class was used. Last employment was used for men 
who were retired. Unemployed men without partners were unclassified. Social class in women was 
based on their partner’s social class except when the partner’s social class was unclassified or missing, 
or they had no partner in which case social class was based on their own occupation. An unemployed 
woman without a partner was coded as unclassified. Social class was classified according to the 
Registrar General’s occupation-based classification scheme into five main categories. [141]. Social class 
I consists of professionals, class II includes managerial and technical occupations, class III is subdivided 
into non-manual and manual skilled workers (III non-manual and III manual), class IV consists of partly 
skilled workers, and class V comprises unskilled manual workers.  
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Smoking history was derived from yes/no responses to the questions “Have you ever smoked as much 
as one cigarette a day for as long as a year?” and “Do you smoke cigarettes now?” Alcohol consumption 
was derived from the question “How many alcoholic drinks do you have each week?” with four 
separate categories of drinks. Total alcohol consumption was estimated as the total units of drinks 
consumed in a week. For these analyses, a moderate drinker was defined as someone who drank one 
or more units a week (that is, not a non-drinker) but not more than 14 units a week. Participants were 
categorised by smoking status as current, former, and never smokers, and alcohol consumption was 
computed as units per week. 
Total (habitual) physical activity was assessed using two questions (Appendix 2). The first referred to 
usual occupational physical activity (over a period of one year), classified into four categories: 
sedentary or inactive, standing, physical work and heavy manual work. The second question was on 
the amount of time spent in hours per week in both winter and summer, on cycling and other physical 
exercise from which the average time spent daily in leisure-time activity per day was calculated.  A 
simple four-category physical activity index was derived based on the level of activity from 
occupational and leisure components (Appendix 3). The questionnaire was validated as a measure of 
physical activity energy expenditure against individually calibrated heart rate monitoring. [142]  The 
physical activity index has previously reported to predict total mortality, cardiovascular disease 
incidence [143] and stroke. [144] 
Medical history was ascertained with the question “Has a doctor ever told you that you have any of 
the following?” followed by a list of conditions that included heart attack, stroke, diabetes, depression 
requiring treatment, pulmonary disease, asthma and cancer. Hearing problems were ascertained from 
yes/no response to the question “Do you have any problems with your hearing?”  
2.4.3 Recruitment to the Third Health Examination phase (3HC)  
Invitations to the third health examination (3HC) phase of EPIC-Norfolk (also called EPIC-Norfolk 3) 
included a follow-up health and lifestyle questionnaire (HLQ, follow IV). Participants were asked to 
send their response on ‘Participation Form’ indicating their preference of timings and returning their 
completed HLQ in a freepost envelope. Those not attending could also give a reason for their refusal. 
Every endeavour was made to facilitate participation, including providing transport for the less abled 
participants wanting to attend the health examination. The order of GP practices approached for EPIC-
Norfolk 3HC was based on geographical location and distance from the clinic in the Regional Centre 
(Norwich). Practices were approached two at a time, one at close proximity to the clinic (city practice) 
and one further afield (rural area). Funding constraints led to the exclusion of 4 of the original 35 GP 
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practices from follow up. As a result of not including these practices, 1906 eligible participants were 
not approached for EPIC-Norfolk 3HC. Recruitment to EPIC-Norfolk 3HC is summarised in Figure 2.2.  
2.4.4 EPIC-Norfolk 3HC Pilot Study 
EPIC-Norfolk 3HC was piloted using one of the collaborating GP practices for over 18 months between 
2004–2006. This pilot demonstrated willingness of participants to travel a significant distance (15 miles 
in this case) to take part.  The pilot indicated the feasibility of including new measures as well as 
measures collected in previous examinations and estimate of response rate from the cohort. The 
results of the pilot were used to make modifications to the protocol where necessary, to allow some 
of the tests more suitable to an epidemiological setting.  
2.4.5 Follow-up 
There have been five health check phases since the start of the study. A diagrammatic representation 
of the timeline is given in Figure 2.3 of the different phases over the past 25 years of the study and the 
level of participation at each stage. The inclusion criteria for invitation to each health examination is 
to include all participants (funding permitting) who consented at baseline, after excluding those who 
had died or previously requested no further approaches. Record linkage to participant data at NHS-
Digital, the national provider of data on health (mainly from National Health Service) and social care in 
England, ensured participant contact information was up to date. In addition to health examinations, 
participants have also been invited to complete health and lifestyle questionnaires (HLQ), food 
frequency questionnaires, seven-day food diaries, health and life experiences (HLEQ) and physical 
activity questionnaires at regular intervals in between health examinations. Other than the HLQ from 
baseline (1HC) and third health examination phase (3HC), questionnaires and health examination 
measures from the other time-points have not been used in this thesis. This is highlighted in Figure 2.3 





Figure 2.2: A flow chart of participant recruitment for EPIC-Norfolk 3HC.  
 
Modified from Hayat et al., IJE (2014) 
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Participants have been passively followed up for mortality and other health end-points through 
medical record linkage. Further details of the specific data used for each analysis are provided in the 
relevant chapters. A description of record linkage and the different data sources used for dementia 
diagnosis is given below with further details in Chapter 8. Cognitive measures were introduced to EPIC 
at the third health examination phase (3HC) between 2006-2011 with a brief pilot phase between 
2004–2006. All cognitive measures used in this thesis are from this time point. Repeat measures of 
cognition were taken at the 5th health examination (2016-2018), although these measures were not 
available at the time of writing this dissertation.  
2.4.6 EPIC-Norfolk -Third Health Examination  
The three main areas of investigation for the third health examination phase EPIC-Norfolk (3HC), also 
called EPIC-Norfolk 3, [138] were visual health, cognition and physical capability.  Other aspects of 
ageing that were included were skin ageing and physical activity.  Measures from the previous health 
examinations were also repeated. These included anthropometry (height, weight, waist 
circumference, hip circumference), blood pressure, heel-bone ultrasound, impedance/body fat 
percentage, ankle brachial pressure, lung function and blood sampling. The 3HC lasted between 150-
180 minutes, with the cognition component lasting approximately 40 minutes depending on the ability 
of the participant. Detailed guidelines for scoring (as summarised in Appendix 4) were also provided.  
The cognition battery was conducted approximately half through the appointment. This was so that 
sufficient time had elapsed for the nurse administering the test to establish a rapport with the 
participant, but not too long into the appointment where the participant may have become anxious or 
tired, which could then have a possible effect on their performance. 
Though EPIC-Norfolk 3HC ran over 7 years (including the pilot), the administration of the health 
examination remained unchanged with staff tightly following a standardised protocol for test 
administration and scoring, adhering to a script for some for a standard verbal response ensuring 
consistency and accuracy minimizing variation, differences in interpretation and reducing subjectivity. 
The protocol also included guidance on how to encourage participants without giving feedback. The 
EPIC-Norfolk 3HC protocol and cohort profile have been published. [138] Full lists of the measurements 





















































































Box 2.1: Self-report data collected from questionnaires at EPIC-Norfolk 3HC 
Health and Lifestyle Questionnaire (Follow-Up IV) 
Socio-demographic  
Employment status 
Self-rated Health and diagnosis (including vision and hearing) 
Social networks and support, Leisure activities and Hobbies  
Activities of daily living 
Falls 
Medication  
Smoking and alcohol (*Alcohol intake measure of unit per week was calculated from number of drinks 
consumed per day over 7 days which was different from baseline which was calculated from total number 
of drinks consumed over 7 days). 
*Self-perceived wealth and economic status 
 
Health and Life Experiences Questionnaire (HLEQ) 
Psychosocial Measures 
*Widespread Pain using the Manchester Coding System 
Social life 
Loneliness  
Anxiety and depression  
Mood status  
Health  
Daily activities, lifetime events,  
Childhood experiences personal beliefs 
 
Physical Activity Questionnaire (EPAQ2) and perception of local environment 
*Self- report on physical activity behaviours in three domains: activity at home, work and recreation. Also, 
using Geographical Information Systems (GIS) with Neighbourhood Environment Walkability Scale, (NEWS) 
to observe how environmental factors play a role in determining behaviour 
*Skin Ageing 
*Self- report on exposure to UV sunlight (lifetime and previous year) 
*Skin reaction to sunlight exposure 
*Tanning (including attitude towards UV exposure) 
*Use of sun protection/skin care 
*Natural hair colour (at age 20 and current) 
 
Dietary Data 
 7Day Food Diary and FFQ  
 




Box 2.2: New and repeat objective measures applied at the third health examination (3HC) 
Venous Blood 
Sample 
Biomarkers included full blood count (platelets, total white blood count, neutrophils, 
basophils, eosinophils, monocytes, lymphocytes, total red blood cell count); Mean 
corpuscular volume - MCV Hematocrit (HCT) haemoglobin (Hb); glycated haemoglobin 
(HbA1C); Lipid profile (Total cholesterol, HDL LDL Triglyceride); vitamin C; creatinine; 
albumin; and C-reactive protein.  




Standing height (Stadiometer, Chasmores, UK), weight, waist and hip circumference. 
Impedance /body 
fat 
Body fat percentage measured using TANITA TBF-300 MA Body Composition Analyser 
(Tanita UK, Ltd., Yiewsley, UK). 
Physiological 
Function 
Brachial pressure and heart rate measured with Accutorr PlusTM automatic 
sphygmomanometer blood pressure monitor (Datascope Medical, Huntingdon, United 
Kingdom). Also measured was *Ankle Brachial Pressures using the mini Dopplex D990 
Doppler Pen with Ultrasonic Doppler flow detector (Huntleigh Healthcare, UK) and 




Attenuation of broadband ultrasound(dB/MHz) and speed of sound (m/s) were 
measured twice on each foot with CUBA clinical instrument (McCue Ultrasonics, 
Winchester). 
*Skin Ageing Digital Images of skin on face and hands. 
*Cognitive 
Assessment 
Retrospective and prospective memory, attention and calculation, registration, new 




Gait speed, balance, chair stands, one leg stand (for participants under age 70), grip 




Physical Activity using a commercial accelerometer, the GT1M (Actigraph, Florida, USA). 
*Eye Examination Visual acuity (VA) using the LogMAR visual acuity chart 1 (Precision Vision, LaSalle, IL, 
USA), intraocular pressure (IOP) using an AT555 Non-Contact Tonometer (Reichert, New 
York, USA) and later using the Ocular Response Analyzer (ORA, Reichert, New York, USA), 
axial length and anterior chamber depth using IOLMaster, (Carl Zeiss Meditech Ltd, 
Welwyn Garden City, UK), retinal nerve fibre layer thickness (GDx VCC, Zeiss, Dublin, CA, 
USA. Threshold visual field analysis was done with the Humphrey field analyser (Carl 
Zeiss Meditech Ltd, Welwyn Garden City, UK), optic nerve head topography determined 
using the HRT II (Heidelberg Retina Tomograph, Heidelberg Engineering, Heidelberg, 
Germany), Colour fundus photography of optic disc and macula using a Topcon non-
mydriatic retinal camera TRC-NW6S non-mydriatic retinal camera and IMAGEnet 
Telemedicine System (Topcon Corporation, Tokyo, Japan) with a 10 megapixel Nikon D80 
camera (Nikon Corporation, Tokyo, Japan). 
Medication Confirmation of medication by nurse using repeat prescription slips. 
Source: Hayat et al. (2014)
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2.4.7 Objective Cognitive Measures in EPIC-Norfolk 3HC 
The Cognition battery used in EPIC-Norfolk consisted of seven tests assessing both global function and 
specific cognitive abilities. These tests were chosen on the basis that they are validated tests, assessing 
a range of cognitive domains and had been shown to be sensitive to the early changes of decline, and 
associated with function and health outcomes.  The cognitive tests used in EPIC-Norfolk are described 
below. It is important to highlight that whilst the score of each test purports to assess the performance 
of a single ‘main’ ability, the score reflects a range of other abilities that are being utilised.  Each test 
assesses more than the one single ability (as shown in Fig 2.4) and to execute a task successfully, 
abilities work in conjunction not independently of each other. In this thesis, I have used the main ability 
of each test, however for the visual sensitivity test (VST), there were two separate outcome measures 
that were available later in the thesis. Chapters 3 and 4 only include one measure from this test, 
whereas the remaining chapters include both, giving a total of 8 different abilities assessed. 
Short Form Extended Mental State Exam (SF-EMSE) 
The Extended Mental State Exam (EMSE) [22] extends the widely used Mini Mental State Exam 
(MMSE), [145] a test known for its limitations, [14,25] in particular in higher functioning individuals. 
[22].  The original EMSE consists of 47 items from the Cambridge Mental Disorders of the Elderly 
Examination (CAMDEX) interview schedule [146,147] as well as items recommended in the report from 
the MRC Alzheimer’s Disease Workshop held in 1987. [148]. EPIC-Norfolk used a modified shorter 
version of this test consisting of 11 selected items assessing functioning at the higher end of the ability 
range.  Using items from the SF-EMSE, a full-scale MMSE score could also be ascertained by assuming 
an almost perfect performance on the excluded items in a highly functioning population. [149] The ‘full 
derived’ MMSE score allows the comparison of the other components of the battery using the SF-
MMSE scores as a validated and recognised standard. 
Attention and Visual Search (Letter Cancellation) 
The letter cancellation task [150] assesses attention, mental processing and speed. The task involved 
a visual search of a set of random letters printed in a grid like format consisting of 26 rows and 30 
columns with the aim of crossing out as many of the 72 possible target letters (P and W) within one 
minute.  There are two outcome measures in this task, the first is for speed which is total numbers of 
letters searched in the allocated time and the second is the accuracy score (the outcome measure that 
was used in this thesis), which is number of correctly identified target letters minus all potential target 
letters missed up to the point scanned by participant. 
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Hopkins Verbal Learning Test (HVLT) 
The HVLT [151] is a short reliable test of verbal recall and recognition. [152–154] The test consists of a 
12-item word list, from three semantic categories, (‘precious stones’, ‘human shelter’ and ‘animals 
with four legs’). Participants were presented with the word list on a computer screen and asked to 
memorise the words. The computer program was timed with an interval of 1 second between each 
word presentation. At the end of the presentation the participant was asked to recall as many of the 
words as they could. The list was shown a further two times. Correctly recalled words were recorded.  
A score for each trial and the total recall score (maximum of 36) was noted.  Any incorrect words 
mentioned were also documented, and although not used in here, are available for future analysis. 
Here, the total HVLT score was used as the outcome measure. 
Cambridge Neuropsychological Test Automated Battery: Paired Associates Learning (CANTAB-PAL). 
The Paired Associates Learning test (CANTAB-PAL), tests episodic memory and new learning and has 
shown to be a sensitive tool as a determinant of memory deficit in the early stages of dementia. [155–
158] Participants were presented with six white boxes (and then eight at the final stage) on a touch 
screen, opening sequentially to display 1,2,3,6 and then 8 abstract visual patterns. Immediately after 
the final test pattern was displayed, one of the patterns was displayed in the middle of the screen and 
the participant was required to touch the box where that pattern was located on the screen. The task 
consisted of eight stages and up to ten presentations after which the task terminated. There are a 
number of outcome measures in CANTAB-PAL, all which have to be analysed with reference to the PAL 
stages completed measure.  The outcome measure used here was the ‘first trial memory score’ (FTMS), 
the number of patterns correctly associated to their locations in the first attempt summed across the 
stages completed. Details on the other outcome measures and the justification to use FTMS is given in 
the scoring criteria in Appendix 4. 
Visual Sensitivity Test (Reaction Time) 
The Visual Sensitivity Test (VST) [159] assesses disturbance of the magnocellular pathway and consists 
of two parts: In the first part, a triangle appears at random on the screen and the participant had to 
press the space bar on the computer as soon as the triangle was seen. In the second part, the screen 
is full of constantly moving dots, from which a triangle forms at a random point on the screen. The test 
required the participant to press the space bar when the triangle became apparent, with the triangle 
gradually becoming more obvious with time, and so increasing the probability of detection over time. 
The VST gave 70 measures per participant, with the final reading value (used in analyses) being the 
average of these measures.  The majority of analyses in this these uses both stages of the test as 
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separate outcome measure of reaction time (in milliseconds), VST-Simple and VST-Complex reaction 
times respectively. Timings were recorded and stored automatically under the participant’s unique 
study number.  
The National Adult Reading Test (NART) 
The National Adult Reading Test (NART) [160] shown to correlate with pre-morbid intelligence and 
general cognitive ability [161,162]. The NART uses the assumption that the level of reading ability is 
closely related to general intellectual level and is a more objective measure of pre-morbid ability than 
using demographic variables such as years of education and socio-economic status. [162]  The NART is 
widely accepted and commonly used though it is known to have limitations, particularly in the less 
educated. [163] As the words in the NART do not follow the standard (British) grapheme-phoneme 
rules, the test requires the participant to recognise the word in its written form, as decoding the word 
would result in an incorrect pronunciation. The NART thus gives an implicit measure of the individual’s 
knowledge of the English vocabulary. This test provides a measure of reading ability or prior crystallised 
intelligence, when assessing level of cognition for an individual both in absolute terms and relative to 
others within their age range. 
Participant were presented with 50 irregular words of varying difficulty on a computer screen.  Here, 
the short NART protocol [164] was used from which a full NART score was derived using an algorithm 
based on the performance on the first half of the test (Appendix 4). Only those individuals scoring 
between 21-25 on the first half of the test, proceeded to the full NART of 50 words. The outcome was 
an error score, so a higher score indicated lower performance. There have been some reservations 
regarding the practical utility of the short NART, but its accuracy, at the time of the 3HC was shown to 
be almost equivalent to the full-length NART. [165]  
Prospective Memory 
This is a test for the memory for future intentions, previously suggested to be sensitive to early stages 
of cognitive decline. [166,167] Participants were asked to remember to carry out an explicit instruction 
at a specified point later in the appointment.  This was to seal and initial an envelope when it was 
handed back to the participant after completing a previous task. Responses were scored on whether 
both, one or none of the actions were completed when the envelope was handed to them. For the 
purpose of the analysis here, participants were defined as being ‘successful’ if they carried out at least 
one correct action without having to be prompted.
 
 













































































































































































































































































































































































































































































































































































































































































































































































2.4.8 EPIC-Cognition battery scores and data cleaning  
The scoring (and where necessary, details on the criteria) applied to each item on the components of 
EPIC- Cognition battery are given in Appendix 4.  
2.4.9 Ascertainment of endpoints  
Almost complete follow-up for disease outcomes in EPIC-Norfolk has been established via linkage to 
routinely collected National Health Service (NHS) databases in England (Hospital Episode Statistics, 
HES) and mortality data for all participants using their unique NHS number and date of birth. The linked 
hospital records contain coded diagnostic information for all inpatient and day-case admissions. [89] 
To maximise dementia ascertainment, EPIC-Norfolk also obtained national mental healthcare data 
from three separate mental health data releases covering different time periods. These were Mental 
Health Minimum Data Set (MHMDS), Mental Health and Learning Disabilities Data Set (MHLDDS) and 
the Mental Health Services Data Set (MHSDS), which contain record-level data about individuals in 
contact with mental health services including memory clinics.  
The MHMDS, MHLDDS and MHSDS incorporates mental health data (including dementia), over the 
follow-up periods, 2009-2014, 2015-2016 and 2017-2018 respectively. Each subsequent release was 
wider in scope than the previous version. These datasets contained mainly service-level breakdowns 
that were not applicable here with little additional diagnostic information. The latest release, MHSDS 
was the widest and most complex dataset which contained substantially more diagnostic information. 
Limited GP data have also been used in this thesis. Further details of record linkage and the datasets 
are given Chapter 7.  
2.5 Analyses  
Measuring performance against the distribution of cognitive scores within a population to define 
abnormality, particularly where the data are not normally distributed has been described previously, 
[44,168] and to derive cut-off scores for community studies from the population under investigation 
to be a reasonable methodology to adopt. [169] The data for most of the tests in EPIC-Norfolk, were 
not normally distributed and the prevalence of dementia and cognitive impairment using accepted 
standard diagnostic criteria is low in the cohort. [170] It was therefore necessary to establish 
operational criteria for cognitive dysfunction specific to this population. [170]  Due to the distribution 
and non-linear response observed in all the analyses in this thesis, associations were examined using 
approximate percentile cut-offs rather than the continuous cognitive score. Details on how 
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participants were defined into categories of performance are given in the separate chapters.  For most 
analyses in this thesis, poor performance on any test was defined  as obtaining a score less than a cut-
off point corresponding to the 10th percentile of the population distribution in each of the cognitive 
tests individually. For prospective memory, where participants either succeeded or failed the task, 
those failing were assigned to the poor performance group and those succeeding, to the standard 
level.  Associations with cognitive function, mortality and dementia were examined using different 
methodologies as described in the separate chapters.  
To address the limitation of multiple testing, a composite score (EPIC-COGComp) was also created for 
some of the analyses. EPIC-COGComp represents general cognition and a wider range of cognitive 
domains underlying all the cognitive functions assessed. A categorical variable was created for EPIC-
COGComp score as with the individual tests. Details of how associations were assessed are given in the 
individual chapters and in Appendix 5.  
2.5.1 Missing data and extreme outliers 
If a cognitive test was abandoned or the participant refused to continue, the participant was scored 
on what had been completed and the data included in the analysis.  Reasons for refusal were recorded 
to differentiate those participants who refused or failed to complete as a result of a technical fault or 
ran out of time, from those who refused because they expressed anxiety or difficulty with the task.  
Those who refused prior to starting a test or those who said no to a test component were assigned as 
missing data.  Any participant identification number that could not be accurately assigned to a known 
individual was also removed from the final analysis as were any implausible values.  Specific details on 
missing data are given in the separate chapters. 
2.5.2 Reporting on results 
Participants scoring low on any of the cognition tests were not referred for further assessment, nor 
were results reported to their GP. This was indicated on the participant information sheet (PIS) sent to 
the participant in the invitation pack. Clinically relevant results from other parts of the health 
examination such as for raised blood pressure, lipid profile and the eye examination were referred to 




2.6 Participant Characteristics and Attrition 
Of the 77 630 approached to take part in EPIC-Norfolk, 30 445 consented and completed a health 
questionnaire, of which 42% of all women agreed to take part as compared to 36% of all men. It is 
difficult to compare characteristics between responders and non-responders as limited data are 
available on non-responders, other than non-responders were more likely to be men and younger. All 
ages were well represented for both men and women in the EPIC-Norfolk cohort including those who 
were 70 years or older. The cohort was 99.7% White Caucasian, with fewer smokers than the general 
UK population. [137]  The cohort was similar to the national population samples studied in the Health 
Survey of England, in terms of anthropometry, serum lipids and blood pressure. Of those who 
consented, 25 639 (84%) attended a health examination at baseline (1HC). These participants were 
within the age range 40–79 years. 
Table 2.1: Age and sex distribution of responders and non-responders at baseline (1993–1997). 
  Responders  Non responders  
Age-Band (Years) 
39.0 %  
(N=30, 445) 
61.0 %         
(N=47, 185) 
   
Men  48.7% (37, 825) 36.2 (13 700) 63.8 (24 125) 
≤ 44 4.3 (587) 6.5 (1572) 
45-49 16.7 (2287) 21.0 (5061) 
50-54 15.9 (2178) 18.2 (4385) 
55-59 15.2 (2075) 15.1 (3649) 
60-64 15.6 (2142) 13.1 (3165) 
65-69 15.4 (2112) 11.8 (2848) 
≥ 70  16.9 (2319) 14.3 (3445) 
   
Women 51.3% (39, 805) 42.1 (16 745) 57.9 (23 060) 
≤ 44 4.6 (778) 6.2 (1422) 
45-49 18.4 (3084) 18.7 (4304) 
50-54 16.1 (2699) 16.1 (3717) 
55-59 15.1 (2523) 13.8 (3189) 
60-64 14.8 (2482)  13.0 (3009) 
65-69 14.9 (2492)  13.4 (3080) 





To examine attrition in the cohort, the baseline characteristics of those who attended both the 1HC 
and EPIC-Norfolk 3HC were then compared with the 17, 789 participants who attended the 1HC only 
(Table 2.2). The proportions of men and women were similar, with women comprising 55.3% of the 
group attending both baseline and follow-up health examinations and 54.5% of those attending the 
baseline health examination only (P=0.2). Those who returned to take part in EPIC-Norfolk 3HC were, 
at the time of the first health examination, more likely to be younger, taller and have lower weight, 
lower blood pressure and lower cholesterol concentrations. They were also more likely to be educated 
to at least to O-level standard or equivalent (i.e. leaving school with exams at 16 years of age), to have 
a higher socioeconomic status, to have never smoked and to have been more physically active. 
Responders to EPIC-Norfolk 3HC were also more likely to drink more alcohol at baseline than those 
who did not respond.  
Table 2.2 shows that the patterns seen in the baseline characteristics were the same in both men and 
women. Although, as might be expected, those attending EPIC-Norfolk 3HC were healthier and of 
higher education and socioeconomic status at baseline compared with those not attending, the cohort 
still represents a diverse population with a wide socio- economic distribution and range of lifestyle 
factors of interest, such as physical activity and obesity. Those invited for the 3HC (N=18 382) but did 
not attend, were also compared to those who actually attended to give further insight to the 
characteristics of those used in the various analyses in this thesis. Those who were invited and did not 
attend, were more likely to be older, with higher self-reported heart attack, stroke and diabetes 
prevalence. Non-attenders were also more likely to have no qualifications and be in the lower socio-




Table 2.2: Baseline characteristics of participants in EPIC-Norfolk.  Participants who attended health 
examinations in both the first and third phases of EPIC-Norfolk (3HC + 1HC) are compared to those 
who were examined in the first phase only (Baseline, 1HC). 
 Men Women 
Variable 3HC+ 1HC 1HC only P-value                  3HC + 1HC 1HC only P-value                  
 (N=3615) (N=7992)  (N=4495) (N=9537)  
Mean (SD)a       
Age (years) 56.6 (7.9) 61.0 (9.5) <0.001 55.2 (7.8) 60.7 (9.5) <0.001 
Height (cm) 174.9 (6.5) 173.6 (6.7) <0.001 162.1 (6.0) 160.4 (6.3) <0.001 
Body Mass Index 
(kg/m2) 
26.1 (3.0) 26.7 (3.4) <0.001 25.5 (4.1) 26.6 (4.4) <0.001 
Systolic Blood Pressure 
(mmHg) 
134.2(16.3) 138.9 (18.1) <0.001 129.4 (17.1) 136.0 (19.4) <0.001 
Total Cholesterol 
(mmol/L) 
6.0 (1.1) 6.1 (1.1) 
 
0.01 6.1 (1.1) 6.4 (1.2) <0.001 
Frequency, % (N)b       
Education       
No qualification 22.0 (795) 34.3 (2739) <0.001 29.5 (1327) 48.2 (4593) <0.001 
Any Qualifications 78.0 (2819) 65.7 (5245) <0.001 70.5 (3167) 51.8 (4936) <0.001 
Social Class 
(% Non-manual) 
65.0 (2333) 55.4 (4324) <0.001 67.5 (3001) 58.5 (5393) <0.001 
Smoking        
Current 8.7 (313) 13.8 (1092) 
<0.001 
8.8 (392) 12.6 (1187) 
<0.001 Ex-smoker 49.7 (1792) 56.7 (4492) 30.3 (1354) 33.2 (3123) 
Never 41.6 (1498) 29.5 (2339) 61.0 (2729) 54.2 (5108) 
Physical Activity        
Inactive 23.1 (834) 34.4 (2752) 
<0.001 
20.3 (914) 35.3 (3363) 
<0.001 
Mod. Inactive 26.1 (945) 24.0 (1913) 33.2 (1493) 31.5 (3000) 
Mod. active 25.0 (905) 22.0 (1755) 26.0 (1168) 20.4 (1948) 
Active 25.8 (931) 19.7 (1571) 20.5 (920) 12.9 (1226) 
Median (IQR)c       
Alcohol Intake 
(Units/ week) 
7.0 (2.5, 14.5) 6.0 (2.0, 14.0) <0.001 2.5 (1.0, 7.5) 2.0 (0.5, 6.0) <0.001 
Note: Groups were compared using unpaired student’s t-testa, chi squareb and Mann Whitneyc tests as appropriate.     
Abbreviations: 1HC: First Health examination; 3HC: Third Health examination; Mod, moderately; SD= Standard Deviation; 
IQR= Inter-Quartile Range; kg: kilogram; cm: centimetres; mmHg: millimetres of mercury; mmol/L: millimoles/Litre; %: 




Table 2.3: Characteristics of individuals with a cognitive test measure compared to those who either 
did not attend or had no cognitive test measure. 
 Total Invited (N=18, 382)  
 





Characteristics at Baseline    
Mean (SD)    
Age 55.7 (7.8) 58.9 (9.3) <0.001 
    
Frequencies, % (N)    
% men 44.7 (3841) 42.0 (4117) <0.001 
Level of education    
No Qualification 26.2 (2251) 45.1 (4414) 
<0.001 O or A level 56.1 (4521) 46.2 (4521) 
Graduate Level or above 17.6 (1513) 8.7 (856) 
Social Class    
Professional 8.8 (748) 4.9 (468) 
<0.001 
Managerial 41.1 (3498) 30.1 (2867) 
Skilled Non-Manual 16.0 (1364) 17.1 (1635) 
Skilled Manual 20.6 (1748) 26.8 (2555) 
Semi-Skilled 11.2 (950) 16.3 (1550) 
Non-Skilled 2.3 (197) 4.8 (459) 
    
Alcohol (Units/week)    
0 8.9 (763) 15.5 (2263) 
<0.001 ≤ 14 Units 75.2 (6426) 71.6 (6912) 
> 14 Units 15.8 (1353) 12.8 (1239) 
Smoking Status    
Never 52.2 (4463) 45.0 (4365) 
<0.001 Former 38.9 (3329) 41.0 (3971) 
Current 8.9 (760) 14.0 (1361) 
Co-morbidities    
Heart attack 1.5 (128) 2.6 (251) <0.001 
Stroke 0.6 (50) 1.0 (99) 0.001 
Cancer 4.4 (374) 4.4 (426) 1.00 
Diabetes 1.0 (85) 2.2 (218) <0.001 
Depression 14.6 (1250) 14.3 (1398) 0.6 
    







2.7 EPIC-Norfolk Study overview 
There are over 25 years of longitudinal data on this well-characterised cohort of men and women from 
Norfolk, first seen at baseline between 1993–97 when they were aged 40–79 years.  The remit of EPIC-
Norfolk has broadened over the years to include other aspects of ageing including cognition and 
dementia. A major strength of the EPIC-Norfolk study is the availability of longitudinal exposure and 
health outcome data from baseline to the present. This cohort provides the opportunity to examine 
the trajectory of functioning in the general population and in particular the determinants of high as 
well as poor performance.  
From the 1HC onwards, emphasis has always been placed on using validated instruments and objective 
biomarkers to measure exposures including diet and physical activity. This has been extended to 
include cognitive measures that were introduced to EPIC-Norfolk as part of the third health 
examination phase. Reviewing the utility of the various cognitive tests for use in an epidemiological 
setting is part of this thesis and will be discussed further in Chapter 3.  
Most large cohort studies have to rely on linkage with death records to obtain mortality by cause, and 
on self- reported questionnaires for non-fatal health outcomes which are limited by response rates 
and subjective recall. The EPIC-Norfolk cohort has been followed up by medical record linkage since 
1999, first by linking to local hospital and disease registers, and more recently via NHS-Digital. This 
allows complete case ascertainment which would otherwise not be possible.  
The main limitations of the study are those that concern all cohort studies, in particular healthy 
volunteer bias and attrition. As one would expect, individuals would be less likely to participate in 
either the baseline or subsequent follow-up examinations if they were seriously ill, disabled or had 
major cognitive or visual impairment. In EPIC-Norfolk third health examination, there was likely to be 
selective truncation of individuals from the cohort at the lower end of the distribution of functional 
performance and some loss of frailer members of the cohort, but there remains a large range of 
performance and health to examine determinants of healthy ageing. Furthermore, the availability of 
baseline characteristics and mortality, and follow-up of the original cohort, enable characterisation of 
both those who have and those who have not participated in follow-up examinations. The 
characteristics of those included in the analyses and those who are not, are examined in each chapter.  
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This chapter details the distribution of cognitive function in different cognitive domains by age and sex 
and compare the utility of a number of assessment tests in EPIC-Norfolk. A total of 8623 participants 
attended the third health examination  with cognitive test measures available on 8585 individuals. The 
cognitive test battery comprised of seven validated tests including: a shortened version of the 
Extended Mental State Exam (SF-EMSE); letter cancellation task; Hopkins Verbal Learning Test (HVLT); 
Cambridge Neuropsychological Test Automated Battery Paired Associates Learning Test (CANTAB-
PAL); Visual Sensitivity Test (VST); Shortened version of the National Adult Reading Test (Short-NART) 
and a task to test for prospective memory. Descriptive data are presented for this cohort of men and 
women in mid to later life. 
There were no overt reports of cognitive impairment in EPIC-Norfolk  participants at time of cognitive 
testing. Increasing age was generally associated with declining mean cognitive function with the 
exception of Short-NART, where there did not seem to be any strong association with age. Although 
the test scores generally decline across age groups (with the widest variation seen in the oldest age 
group), there was a range of capability from poor to high performance in each age band, with some 
participants from the oldest age group outperforming their younger counterparts. Some sex 
differences were also observed. These variations may provide insights into the determinants of 




3.2 Introduction  
A broad range of cognitive capability is observed in the older population [171] as well as substantial 
inter-individual heterogeneity in rates of decline. [71] The range encompasses high cognitive 
functioning even in the very old, [75] mild cognitive impairment (MCI), through to dementia at the 
other end of the spectrum.  Substantial data already exist on dementia and cognitive impairment, 
mainly in the older population, from using a wide range of instruments, each with merits and 
limitations that assess different aspects or stages of cognition. Episodic memory deficits have been 
shown in a number of studies to be associated with the strongest and most persistent risk of cognitive 
decline [129,172] and are the most common and earliest complaints in MCI. [173] However deficits in 
other cognitive domains can also occur, some early on, including attention, executive functioning, 
prospective memory, semantic memory, verbal ability, visuospatial skills, attention and processing 
speed.[174–176]  
There is a need for assessments to cover a broad range of ability and domains, have an optimal balance 
between sensitivity and specificity with high positive predictive value in the settings in which they are 
applied. Population-specific normative values for cognition are necessary. This not only allows for 
comparison of cognitive performance of those presenting in a clinical setting, [177] but may assist  to 
identify early indicators of decline. However, before we are able to advise guidelines and policies on 
health, we need to gain better insight into the ageing process in the general population and the range 
of functions in both domain specific and global cognition.  
The primary aim of this chapter is to present data from a general population of men and women 
without overt cognitive impairment using a comprehensive cognitive test battery assessing a range of 
function including memory (retrospective and prospective), executive function, attention, calculation, 
registration, language, praxis, abstract thinking, processing and new learning. The secondary aim is to 
explore the comparability of the different tests and their use in a community setting.   
3.3 Methods 
3.3.1. Participants and measurements  
Participant recruitment and an overview of the EPIC-Norfolk methods have been described earlier in 
Chapter 2. This includes a detailed description of the cognition battery. Specific methods for the work 





Smoking status, mental activities, employment status and hobbies were obtained from responses from 
the health questionnaire completed near the time of 3HC.  Participants were asked to report on type 
and frequency of mental activities with the question ‘Please indicate when you take part in any of the 
following activities’ followed by the following options: (1) Listening to radio; (2) Reading newspaper; 
(3) Reading magazines; (4) Reading books; (5) Playing games such as cards, chess; (6) Crosswords and 
(7) Puzzles. A mental activity score was calculated by assigning 1 point for an individual who reported 
doing a particular activity once a year or less up to 5 points if they did the activity every day. In total 
there were seven activities (listening to the radio, reading the newspaper, reading magazines, reading 
books, playing games such as cards or chess, crosswords and puzzles). The minimum score possible 
was 7 and the maximum was 35. Those with missing data were excluded from the analysis. 
Education level was obtained from baseline questionnaire and dichotomised:  The first category was 
leaving school with no formal qualification (less than O level or equivalent, or leaving school before 
the age of 16). The second category consisted of those leaving school with at least some qualification. 
This group combined those attaining O-level or equivalent (completing school to the age of 16), A-level 
or equivalent (completing schooling to the age of 18 years) and those obtaining a degree or equivalent.   
3.4 Analysis 
The outcome measures of six of the test components were continuous. The prospective memory 
variable measure was dichotomised into ‘successful’ and ‘unsuccessful’.  The descriptive data (using 
the original untransformed scores of the continuous variables) are presented as medians and inter-
quartile ranges as the cognitive scores in majority of the tests were not normally distributed. For the 
SF-EMSE Items, letter cancellation (Accuracy Score), HVLT, and CANTAB-PAL (FTMS), a higher score 
indicated better performance. For the outcome measure for VST (reaction time) and NART (Short 
NART-Error Score), a higher score indicated poorer performance.  Cross sectional data are presented 
by age and sex and by age, sex and MMSE Category. For further insight, a graphical representation of 
the scores using a range of percentiles (1st, 10th, 25th, 50th, 75th, 90th and 99th) by age group and sex are 
also given.  Statistical analysis for this chapter was performed using SPSS version 21.0 (IBM Corp., 





Of the 8623 participants attending the 3HC, 45% (n=3861) were men and 55% (n=4762) were women. 
Cognitive data were available on 8585 individuals. Over 90% of those with cognitive data completing 
or attempting six or all the tests in the battery. The CANTAB-PAL and VST had slightly lower completion 
rate (at 86.5% and 83% respectively), partly due to a technical computer failure, resulting in loss of 
data on 150 participants. Table 3.1 summarises the cognitive domains covered by each of the tests 
used in this study and the number of participants completing each test component.  
Men and women were equally likely to complete the tests, with 6011 (69.7%) participants attempting 
all the components of cognitive battery and only 850 participants (less than 10%) of those taking part 
attempting or completing five components or fewer.  Those completing all the components were 
slightly younger (mean age 68.8 compared to 70.9 years in men and 67.4 compared to 69.8 years in 
women), and were more likely to be either in paid employment or actively taking part in regular social 
networks when compared those who did not complete all the tests. More men had left school with 
qualifications than women (77.8% compared to 70.3%), although more women participated in regular 
social activities (68.5% for women compared to 59.5% for men). Women also reported more mental 
stimulating activities in their leisure time (with mean mental activity score of 23.2 in women as 
compared to 21.1 for men). 
Distributions for cognitive function (by each test component and stratified by sex) are presented in 
Figure 3.1.  The SF-EMSE distribution had a negative skew but did not have the same strong ceiling 
effect as the SF-MMSE scores in this cohort (distribution not shown), with 2298 (27%) of participants 
scoring the maximum SF- MMSE score of 29 as compared to only 2.4% (n=200) scoring the maximum 
EMSE score of 37. The data for letter cancellation (PW Accuracy) and HVLT Total Score were both 
approximately normal distributed, as was the distribution for FTMS (other than a peak at score 0, which 
suggests that a high proportion of participants were unable to achieve a correct response 
immediately). The data for reaction time of the VST were highly positively skewed (as a result of a few 
extreme, but genuine slow responders).  
For the short NART, there was a peak at the error score of 24, followed by alternating peaks and 
troughs in data giving a ‘comb-like’ distribution. This pattern in the distribution is as a result of the 
short NART algorithm (as described Appendix 4). The peaks in the distribution can be attributed to 
those assigned an error score by the algorithm, artificially inflating the scores at these points. The 
greatest peak (and the starting point of this comb effect of the data) was seen to occur at the cut-off 
point of score of 20 (giving a full NART error of 24), which was the point where participants with this 
score or lower, did not continue with the second half of the test.  
 
55 
Figure 3.1: Distribution of scores (of continuous cognition variables) in men and women in EPIC-Norfolk  
SF-EMSE score negatively skewed  
PW-Accuracy score normally distributed 
 HVLT score normally distributed 
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Figure 3.1: Continued 
 
 FTMS: Normal distribution.  Peak at 0 
represents participants unable to achieve 
a correct response immediately.  
VST: Positively skewed distribution.  
Genuine slow responders. 
Short NART:  ‘comb effect’ due to algorithm. 





























































































































   
   
   
   
   
   
   
   
   
   
   
   
   














































































































































































































































































































































































































































































































































































































































































































































































































































































































































    
The median scores of each of the test components were plotted with age in men and women as shown 
in Figure 3.2 (3.2a–3.2g). The data presented here are cross-sectional, showing the association of 
scores with age group. Figure 3.2 showing median scores declining with age. The proportion of 
participants successfully completing the prospective memory task lowers with increased age group. In 
the case of the VST (Figure 3.2f), the median reaction time increases with age group.  The short NART 
error score showed an increase with age initially, remains steady then a slight reduction in the oldest 
group (Figure 3.2g). In almost all tests, women generally performed better than men. 
The data were further characterised by calculating percentile scores plotted by age group. Figure 3.3 
shows lower scores with increasing age. For higher percentiles, scores remain reasonably stable across 
age groups, but the spread and variation in scores becoming greater across each age group, with the 
lowest percentile having markedly lower performance. The variation in scores was least for the SF-
EMSE compared to the other tests in the battery. For reaction time and short NART error score, the 
99th percentile indicated the poorest performers. The short NART error score exhibited widest 




    
Figure 3.2: Cognitive performance with age in men and women in the EPIC-Norfolk 3HC cohort.   
Scores (median values) as shown in Figures 3.2a-3.2d are test scores where higher scores correspond to better 
performance and scores in Figures 3.2 f and 3.2g are reaction time and error score respectively, where a higher 
score indicates poorer performance. Figure 3.2e is shown as a percentage of participants successfully 




    
Figure 3.3: Cross-sectional percentile levels of scores by age group in EPIC-Norfolk men and women  
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Figure 3.3 Continued 
A graphical presentation of percentile scores plotted against age-group (cross-sectional) showing performance 
from the highest to the lowest percentile scores in the six tests with continuous scores.  
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The measures from each test component were compared to the MMSE, which is widely used in both 
research and clinical settings, despite its limitations. [178] The accepted cut off score of less than or 
equal to 23 as indicating presence of cognitive impairment has evolved from research findings,[25] 
although higher cut-offs have been used. [18,179] In this high functioning cohort, there were very few 
individuals with a score of ≤23; therefore the cut off used here for poorest performance was based on 
the 10th percentile score of 24. A modified form of the MMSE (SF-MMSE) was used, with its derived 
full MMSE score [149] creating three categories based on the distribution of SF-MMSE scores in the 
study population. The first category was defined as ≤ 24), the third category was defined at the highest 
SF-MMSE scores (28–29) and the middle category was created using the remaining scores of 25–27. 
Tables 3.2 and 3.3 shows the distribution of all the tests in cognitive battery across the three SF-MMSE 
categories in men and women respectively. The general pattern for all the test components were 
similar with the scores of the continuous test variables improving across SF-MMSE categories. For the 
prospective memory test, the proportion of participants successfully completing the task also 
increased across the three SF-MMSE categories.  Again, scores in women were slightly higher than 
men. There was still a range of performance seen across all three SF-MMSE categories.   
The top performing 2298 participants who performed perfectly on the SF-MMSE (achieving a 
maximum possible score of 29), also included participants who were amongst the poor performers 
(with scores in the bottom 10th percentile) for the other components. These findings were still valid for 
the top 25% and for the top 10% of the SF-EMSE performers (Table 3.4), although the numbers were 
increasingly lower than those seen with the top SF-MMSE scores. 
Spearman’s rank correlation coefficients were calculated (Table 3.5) to investigate the strength of 
relationship between each of the tests used in EPIC-Norfolk cognitive battery. The correlations were 
moderate to weak for most tests with HVLT having stronger associations with the other tests, such as 
with SF-EMSE (r=0.49) followed by FTMS (r=0.38) and short NART (r=-0.38). This inverse association 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   


















































































   
   
   
   
   
   
   
   
   
   
   
   














































































   
   
   
   
   
   
   
   
   
   
   
   
















































































   
   
   
   
   
   
   
   
   
   
   
   






























































































   
   
   
   
   
   
   
   
   
   
   
   



























































































































































































































































    
Table 3.5: Spearman’s correlation coefficient between the test components of the EPIC-Norfolk 
Cognition Battery 
  SF-EMSE 
PW 
Accuracy  HVLT  FTMS 
Prospective 
memory VST 
PW-Accuracy  0.33 
    
  
HVLT  0.49 0.33 
   
  
FTMS 0.34 0.26 0.38 
  
  
Prospective memory 0.26 0.19 0.23 0.21 
 
  
VST -0.16 -0.17 -0.17 -0.17 -0.09   
NART -0.38 -0.21 -0.34 -0.21 -0.13 0.06 
To illustrate the relationship of the tests further, the distribution of the scores were plotted as contour 
plots (Figure 3.4).  The contours represent strength of correlation between scores of the tests. There 
seemed to be some undefined spread for each test, however there was a systematic pattern seen in 
all the plots, with some of the test pairs showing a better relationship than others. The general 
direction of the plot and the peak of overlap of scores seem to appear in areas where one would 






    
Figure 3.4: Contour plots to show relationship of data from EPIC-Norfolk cognition battery 
 
 
Legend: The contours represent the strength of the relationship between the scores (continuous) of 
the test components. The first plot in each row shows the outcome measure variable of each 
individual test plotted against itself depicting the perfect positively linear association. Subsequent 
plots showing the relationship with one of the other tests. Some test pairs showing a better 
relationship than others. The peak (white area) representing the region with greatest density of 






    
3.6 Discussion 
In this chapter, cross-sectional findings are presented on cognitive function profiles across a range of 
domains using previously validated instruments in men and women in EPIC-Norfolk 3HC (age 48-92 
years). Despite the EPIC-Norfolk cognitive battery being relatively long, it was well tolerated by this 
general study population. Individuals can have impairment in one cognitive domain but perform well 
in another or a number of cognitive deficits can occur concurrently. There is increasing evidence of 
substantial variability in cognitive abilities within individuals. Hilborn et al., (2009) termed this 
variability in performance across different tasks within an individual as ‘dispersion’. It is important to 
gain a better understanding of the dispersion displayed by healthy individuals in order to allow 
accurate clinical judgment on unhealthy or abnormal dispersion. [73]  
Previous studies have shown that a variety of cognitive deficits are associated with preclinical stages 
of different types of dementias and that decline can occur in a number of cognitive domains, even 
before any of the clinical criteria of early stages of cognitive decline are met. [21,180] These findings 
are consistent with previous studies that have shown variability and dispersion across different 
cognitive domains in older people. [73,181]  Further investigation is necessary to confirm whether the 
differences observed across the domains provide any meaningful indicators of cognitive performance 
over time. 
The frequency distribution and data from the pilot (where the full NART was used for 300 participants) 
indicate that the short NART equation does not hold in this cohort.  The aim of the short- NART was to 
lessen participant load and anxiety, however in an assessment such as the one in this study; 
participants were as likely to be anxious for any of the other components.  The pilot data show that 
participants who obtained a score of 20 (n=82) for the first half of NART obtained a mean score of 7.9 
(SD=3.7) for the second half, which is better than the algorithm prediction.  
As with previous studies [182,183] age was also found to be inversely associated with the complete 
range of cognitive function being tested with the exception of NART, where there did not seem to be 
any strong association between the short NART score and age. This confirms previous findings that 
NART is a good measure of pre-morbidity [161,162] and that age has little or no effect on NART 
performance in the absence of early dementia. [184]  
Differences in abilities across gender and age categories were observed. These may have arisen 
because of age and sex differences in education status.  Although education was not investigated in 
detail here, the sample includes individuals leaving school with and without qualifications in all age 
groups analysed. There was also a finding seen in EPIC-Norfolk that has not been noted in other studies, 
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where women perform better than men across all the test components in all age groups, and even 
though more men than women reported leaving school with some qualification, this suggests that 
educational status might not explain these sex differences seen. Women gave reports of more social 
and mentally stimulating activities in their spare time, both linked to better cognitive performance at 
older age. [185]  
Percentile scores from this cross-sectional data (Figure 3.3) show that the greatest decline in all test 
components is seen in poor performers across all the age groups. This graphical presentation can be 
used to compare scores or estimate age and sex adjusted scores across the different domains 
investigated here. Individuals scoring below the 25th percentile could be considered as cognitively 
impaired for that domain and require further investigation.  
The MMSE’s lack of ability to assess individual domains and its poor sensitivity to mild cognitive 
impairments are frequently cited limitations. [25] This is because most healthy individuals can 
successfully answer most of the test items.  Even though more demanding tests are available, 
[14,15,22] the MMSE still remains the most widely used and cited test of global cognition. The 
psychometric qualities and utility of the other tests used in the battery were compared with the SF-
MMSE to provide a baseline for future studies as a comparator with other studies. The MMSE, being a 
global measure of cognition contains items that test the same domains of memory function as the 
other components of cognitive battery. As expected, a positive direction with increased SF-MMSE 
score category was observed across all tests, however, there was still a range of scores (capability) 
within each of the SF-MMSE categories.  
On further investigation of participants obtaining the maximum score of 29 on the SF-MMSE, we found 
in the range of 6-8% of men and 2-5% of women also scored in the bottom 10th percentile of the other 
tests (Table 3.4). On examining those individuals who obtained the top 25% and further in the top 10% 
SF-EMSE scores, there were still participants in poorest performers (10th percentile) of the other tests, 
although the figures were reduced. Those scoring in the bottom 10th percentile tended to be older 
than those with scores above the 10th percentile for all the tests apart from the Short NART. The 
number of participants scoring the maximum possible score of 37 on the SF-EMSE was small (n=200). 
No individuals scored in the bottom 10th percentile of the other tests other than one person who 
scored in the lowest 10th percentile for the NART.  We show that obtaining a perfect score on the 
MMSE does not indicate absence of impairment, thus confirming previous findings for the need to 
supplement the MMSE in cognitive testing, [25] particularly in a normal to high functioning population. 
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The limited reliability and validity of the MMSE in a general population has been attributed to the 
restricted range of MMSE. The EMSE has been shown to be sensitive across a range of performance, 
to avoid the ceiling effect and that (even in its short form as it has been used here), the EMSE provides 
extended coverage of cognitive domains (extending on attention, memory, processing and executive 
function).  
Spearman’s rank correlation (Table 3.5) show correlations are moderate to weak for most tests with 
HVLT having the strongest associations with other test components especially with FTMS and NART. 
This is not surprising, as HVLT, FTMS and NART assess similar cognitive sub domains of memory and 
language, however the moderate degree of correlation is somewhat counterintuitive, as we would 
expect this to be higher.  The contour plots (Figure 3.4) depict the spread of scores (and area of 
overlap) indicating that with some association, there is also some non-systematic scatter of scores 
suggesting that these tests may be assessing different aspects of cognitive function. 
As part of the work carried out by myself and colleagues at EPIC-Norfolk, we addressed some practical 
and methodological issues with regards to minimising variability and subjectivity that can be 
introduced at any part of administration, scoring or cleaning of the data. Detailed description of the 
methods are given in the publication [170] and how we standardised protocols for use in an 
epidemiological setting to ensure accuracy and consistency. Having these methods standardised and 
documented is also extremely important to allow comparability and potential harmonisation of data 
with other studies. The other advantage of this study over previous studies is that it has been 
conducted in a large well characterised cohort of men and women with good representation from a 
very wide age range, which has been a limiting factor in some previous studies. [126,186]  
There is likely to be some loss of the more cognitively impaired, the oldest and frailest participants, 
there remains a wide range of performance and health across the whole age span of interest (from 
mid–life to over 90 years) represented in EPIC-Norfolk 3HC. The other limitation is that this is a cross-
sectional study and so although age differences and between person effects can be observed, within 
person differences or age related changes cannot, as  longitudinal data are required. Finally, and very 
importantly, in this particular investigation, the potential effects of education were not taken into 
account. Education is a known strong predictor of cognitive function [187–189] and on the rates of 
decline. [190] The purpose of this chapter was to present the descriptive data on this cohort. The 




    
Everyday activities in the real world are complex, requiring independence, planning, organisation, 
sequencing and judgement and have been shown to be a significant predictor of functional status. 
[191] Therefore, assessing cognitive function in a range of domains such as executive functions, 
planning, flexibility, abstract thinking, semantic memory as well as episodic memory is vital.  The EPIC-
Norfolk Cognition battery is a comprehensive battery of accurate and well-tolerated tests that provide 
evidence of cognitive function in a number of cognitive domains that have previously been reported 
to be involved in much earlier stages of decline. Though there is reduction in performance across age, 
there is also a great deal of heterogeneity in older individuals. In the subsequent chapters, I provide 
further insight to this variability individuals across the cognitive domain assessed. Careful 
consideration should be given to the purpose for using a particular test (including whether the aim is 
to obtain global or domain specific measure, time availability and target population) when selecting 
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4.1 Summary 
Cognition covers a range of abilities, such as memory, response time, language and different tests 
cover specific or generic aspects, however differences between the measures may be observed within 
the same individuals. In this Chapter, the association of sociodemographic factors, age, sex and 
education were examined for the different cognitive domains covered by the seven cognitive tests 
used in EPIC-Norfolk 3HC. Cognitive measures were available on 8584 men and women for these 
analyses.  
Though age, sex, education and social class were all independently associated with cognitive 
performance in multivariable analysis, the magnitude of these associations differed across the 
different cognitive tests.  Increasing age was associated with increased risk of a poor performance 
score in all of the tests, except for the National Adult Reading Test (NART), an assessment of crystallized 
intelligence. Compared to women, men were more likely to have had poor performance for verbal 
episodic memory, Odds Ratio, OR = 1.99 (95% Confidence Interval, 95% CI 1.72, 2.31), attention 
OR=1.62, (95% CI 1.39, 1.88) and prospective memory OR=1.46, (95% CI 1.29, 1.64); however, no sex 
difference was observed for global cognition, OR= 1.07 (95% CI 0.93, 1.24).  The association with 
education was strongest for NART, and weakest for processing speed. The varying relationships seen 
across different tests may help explain discrepancies in results reported in the current literature and 
provides insights into influences on cognitive performance in later life.  
4.2 Introduction  
Cognitive ability covers a range of domains, which together form the basis of cognitive function. These 
domains include recall, learning, understanding, encoding and recognition, most of which require prior 
knowledge and experience. Measuring cognitive abilities is not straightforward because they are not 
clearly distinct from one another. One ability may have an impact on the performance of another, or 
different abilities work in conjunction to execute a function, thus making selection of cognitive tests 
and the interpretation of results difficult.  
There is a growing interest in the heterogeneity of cognitive performance observed in the ageing 
population (1) and what might constitute ‘normal cognitive ageing’. Certain abilities such as memory, 
spatial ability and processing speed have been observed to decline more readily than others such as 
comprehension and vocabulary which tend to remain stable for longer [69,71]. Some suggest that 
decline in mental speed contributes to the decline seen in other abilities [43,192]. Studies have also 
indicated that decline occurs at global and at domain specific level [21,81,174,193] and so both should 
be tested.  
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The difficulties and limitations associated with assessment of cognitive function as a result of the 
variability in cognitive testing and methodologies restricting cross study comparisons are well known 
[16,19]. Although a plethora of cognitive assessment tools exist, test performances vary depending on 
the populations in which they are being used [19]. Low levels of accuracy for detecting mild 
impairment, demographic biases and a lack of an agreed battery of tests appropriate for use in 
different situations, all add to the complexities [16].  
There does not appear to be an agreement on the classification of the cognitive domains and there is 
a lack of consensus on which abilities are most important in testing cognitive decline [69]. The aim of 
this analysis was to gain further insight into how performance on a range of widely used cognitive 
assessment tools may relate to the socio-demographic factors, age, sex, social class and education. 
4.3 Methods 
4.3.1. Participants and measurements  
An overview of the EPIC-Norfolk 3HC methods has been described in Chapter 2.  Specific methods for 
the work presented in this chapter are given here.   
4.3.2 Covariates 
The covariates used in this analysis are as follows. Education based on the highest qualification 
attained and social class were taken from baseline questionnaire. These variables have been described 
in Chapter 2. Age (at the time of cognitive testing) was categorised into 5 year age bands. Information 
on marital status was obtained from the health questionnaire completed near the time of the health 
examination. Very few participants reported being separated (less than one percent), so this category 
was combined with the divorced group giving four categories; married, single, widowed and divorced 
or separated.  
4.4 Analysis 
Poor performance was defined as described in Chapter 2, using a cut-off corresponding to the 10th 
percentile of the population distribution in each of the cognitive tests individually. It was not possible 
to define a cut-point with 10% of the population distribution for the prospective memory task as 19% 
of the population failed the task and therefore this was used as the lower cut-point.  Participants were 
then classified into two groups based on the cut-off for each of the tests.  
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Associations of age, sex, marital status, education and social class with the different cognitive tests 
were assessed using multivariable logistic regression modelling. Marital status, education and social 
class were grouped as follows: Marital status into Married and Single (combining, Single, separated, 
divorced and widowed categories); Social Class into Non manual (combining classes I, II and III non-
manual) and manual classes (combining manual classes III manual, IV and V); Education was re-
categorized into three groups ; No qualification (less than obtaining an O level or equivalent or not 
completing school up to the age of 16), Completion of school up to the age of 16 or up to the age of 
18 (by combining the two categories of attaining ‘O’ level or equivalent and ‘A’ level or equivalent) and 
finally those obtaining education to graduate level (those with a degree or equivalent) or above.  
 Obtaining a score less than a cut-off point corresponding to the 10th percentile of the population 
distribution (or failing the prospective memory task) was first examined by univariate analysis, using 
the chi-square test to observe differences between the groups for each socio- demographic variable. 
The associations between each variable and being in the poor performance group were assessed using 
logistic regression analysis adjusting for co-variates; age (per 5 years), sex (women being the reference 
group), marital status (being married as the reference group), educational level (no qualification being 
the reference group for the three level education variable, and with qualifications being the reference 
group for the dichotomised education variable) and social class (non-manual, as the reference group) 
where social class was examined using both the “conventional” method using a woman’s partner’s 
occupation, as well as personal measures according to a woman’s own occupation.  
Data were further examined stratified into two age groups at age 65 years (those under age 65 and 
those 65 years and older). Age was also included in a model as a continuous variable and the 
unstandardised (Beta) coefficient were examined to compare differences in terms of chronological 
years of age for education level (comparing those with no qualifications with those completing school 
to the age of 16 or 18 and secondly, those with no qualifications with those educated to graduate 
level).  
To examine difference in poor cognitive performance for age depending on education level, a further 
model was run, which included the interaction term age group (< 65 and those ≥65 years) x education 
(entered as the dichotomized variable, no qualification compared to those with any qualification). 
Tests showing a significant interaction between age group and education (no qualification compared 
to those with any qualification), were then stratified to examine the magnitude of differences in 
associations for these two age groups. Although intelligence and education are said to be correlated, 
[194] it was not assumed that the test for crystallised intelligence, NART, was measuring the same 
exposure. As a secondary analysis, associations were examined by further adjusting for the NART Error 
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Score. All P values reported are 2-sided. Statistical analyses for this chapter were performed using SPSS 
version 21.0 (IBM Corp., Armonk, NY, USA). 
Missing data in cognitive tests  
To explore the effect of missing data, a sensitivity analysis was carried out only in individuals with 
complete data on all seven cognitive tests and the specified covariates (n = 5727).  
4.5 Results 
Of the 8623 participants attending the third examination, cognitive data were available on 8585 men 
and women. At the time of writing this chapter, the data were available on 8584 individuals and seven 
cognition measures rather than eight, which are presented in the results here. Table 4.1 presents 
descriptive data showing the characteristics of the men and women in the EPIC-Norfolk cohort 3 for 
these 8584 individuals and Figure 4.1 shows the distribution of the EPIC-Norfolk participants with poor 
cognitive performance across the seven cognitive tests.  Subsequent chapters refer to 8585 individuals 
and eight cognitive measures (reason for this discrepancy is explained in Chapter 2).  This is a higher 
functioning cohort, with over 50% of participants not in the poor performing group for any test. Less 
than 10% of the cohort had a poor performance score in three or more tests. Tables 4. 2a-c present 
the distribution of poor cognitive performance by socio-demographic variable (age, sex, marital status, 
education and social class) in each of the tests. Tables 4.3 and 4.4 show associations adjusted for age 
only and the covariates age, sex, education and social class respectively.  
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Figure 4.1: Distribution of participants in the poor performance group across the seven cognitive 





    
Table 4.1: Characteristics of the 8584 individuals with available cognitive measures participating in 
EPIC-Norfolk (2006–2011), including pilot data (2004–2006). 
  Men Women 
  (N=3840) (N=4744) 
     
Mean Age (SD) 69.4 (8.1) 68.1 (8.0) 
Frequency % (N)     
Age Band (Years)     
<60  10.3 (397) 14.0 (665) 
60–64  22.7 (871) 26.4 (1252) 
65–69  20.9 (802) 20.8 (985) 
70–74  19.8 (760) 17.4 (825) 
75–-790  15.4 (591) 12.9 (613) 
≥ 80 years 10.9 (419) 8.5 (404) 
Marital status     
Single 3.1 (116) 4.0 (184) 
Married 86.6 (3244) 71.5 (3314) 
Widowed 6.2 (234) 16.3 (754) 
Separated or Divorced 4.0 (152) 8.3 (386) 
Education     
Degree Level  20.1 (772) 15.6 (741) 
A level and equivalent 48.0 (1844) 41.1 (1951) 
O Level and equivalent 9.8 (377) 13.6 (647) 
No Qualifications 22.0 (846) 29.6 (1404) 
Social Class     
Professional 9.5 (364) 8.2 (384) 
Managerial 42.7 (1628) 39.8 (1869) 
Skilled Non Manual 12.2 (466) 19.1 (898) 
Skilled Manual 22.7 (865) 18.8 (883) 
Semi-Skilled Manual 11.0 (418) 11.3 (532) 
Non-skilled 1.9 (72) 2.7 (125) 
Mean Cognitive Test Score (SD)     
SF-EMSE 32.5 (3.2) 32.7 (3.0) 
HVLT 23.9 (5.5) 26.1 (5.4) 
FTMS 15.2 (4.6) 15.6 (4.5) 
PW-Accuracy 11.6 (6.1) 13.1 (6.0) 
VST, Reaction Time (ms) 2282.5 (430.6) 2229.9 (455.4) 
Short NART Error Score 17.9 (10.3) 16.6 (9.5) 
Frequency % (N) 
Prospective Memory (Successful)  
77.7 (2912) 84.1 (3915) 
Abbreviations: A Level, Advanced Level; CANTAB-PAL, Cambridge Neuropsychological Test Automated Battery Paired 
Associates Learning Test; FTMS, First Trial Memory Score; HVLT, Hopkins Verbal Learning Test; ms. milliseconds; NART, 
National Adult Reading Test; N, Number; O Level, Ordinary Level; SF-EMSE; Shortened version (Short form) of the Extended 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   








































































































































































































































































































































































   
   
   
   
   






   
   
   
   
   
   







   
   
   
   
   







   
   
   
   
   







   
   
   
   
   







   
   
   
   
   






   
   
   
   
   































































































































































































































































































































































































   
   
   
   
   







   
   
   
   
   
   







   
   
   
   
   







   
   
   
   
   







   
   
   
   
   







   
   
   
   
   







   
   
   
   
   





















































































































































































































































































































































































































































































































































































































































































































   
   
   
   







   
   







   
   
   







   
   
   
   







   
   
   







   
   















































































































































































































































































































































































































































































































































































































   
   
   







   
   







   
   
   







   
   
   
   







   
   
   







   





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.4 indicates that increasing age was associated with being in the poor performance group for 
all tests, except the NART error score (intelligence) for which there was no significant trend with age 
in the multivariable model, Odds Ratio (OR)= 0.96 (95% Confidence Interval (CI) 0.91, 1.01 P=0.09). The 
strongest association was observed for HVLT OR = 1.68 (95% CI 1.60, 1.77) P<0.001)) followed by FTMS 
OR = 1.50 (95% CI 1.42, 1.58 P<0.001), both testing for episodic memory. The OR observed for the tests 
for the other domains were more comparable to each other. 
Stratifying data by age group (<65 and ≥65 years of age) 
When the data were stratified into the two age groups (<65 years and ≥65 years), the most striking 
difference in association between the age groups was observed for the VST for both age and sex, where 
for the under 65 group, there was no association between age and poor performance, OR= 0.9 (95% 
CI 0.75, 1.15 P=0.5) or for sex, OR= 0.99 (95% CI 0.71, 1.37 P=0.9), but statistically significant 
associations observed in the 65+ years age group for age, OR= 1.52 (95% CI 1.40, 1.66 P<0.001) and 
sex OR= 1.23 (95% CI 1.01, 1.50 P=0.04). The results for the stratified analyses are shown in Table 4.5.  
Sex 
There were noticeable differences in the odds ratios for gender across the different tests.  Men were 
more likely to be in the poor performance group for HVLT, PW-Accuracy, the prospective memory task 
and NART. Weaker, but not statistically significant associations were observed for FTMS and VST. There 
were no differences observed between men and women for SF-EMSE.  
Marital status 
Marital status was significantly associated with cognitive performance for FTMS and PW-Accuracy, 
with poor performance more likely in single than married individuals. The other tests showed no 
evidence of associations with marital status. 
Education  
More education was strongly associated with decreased poor performance across all the tests. 
However, the strength of association varied from one test to another, with NART being most strongly 
associated, particularly at graduate level.  
Education was examined as a dichotomized variable (so that the ORs for education were directly 
comparable with the other covariates). This time comparing no qualification with any qualification 




observed were; SF-EMSE OR=2.22 (95% CI 1.92, 2.56P<0.001); HVLT OR=1.89 (95% CI 1.62, 2.20 
P<0.001); FTMS OR=1.63 (95% CI 1.38, 1.93 P<0.001); Prospective memory OR=1.42 (95% CI 1.24, 
1.62P<0.001); PW-Accuracy OR=1.45 (95% CI 1.23, 1.70 P<0.001); VST OR=1.37 (95% CI 1.14, 1.65 
P=0.001) and NART 4.31 (95% CI 3.66, 5.08 P<0.001). Again, any qualification compared to no 
qualification having the strongest association for the NART. 
Using the unstandardized regression coefficients (from the model adjusting for covariates in table 3), 
we observed that the likelihood of being in the poor performance group for those with an education 
up to ‘O’ or ‘A’ level compared to having no qualification was equivalent to being just over 5 years 
younger for HVLT, FTMS, PW-Accuracy, prospective memory task, and VST.  Comparing those at 
graduate level to no qualification, the risk was equivalent to being almost 10 years younger for most 
of the tests and 13 years younger for the HVLT.  For the SF-EMSE, those with O/A level qualifications 
compared to those with no qualifications was equivalent to being 9.9 years younger and those 
educated to graduate level was equivalent to 19.6 years younger. 
There was significant interaction between education (no qualification compared to those with any 
qualification) for HVLT (p=0.01) and FTMS (p=0.01) but not for SF-EMSE, PW-Accuracy, prospective 
memory, VST or NART.  On stratifying the data for both HVLT and FTMS (complete data not shown), 
the associations were stronger with education for the under 65 age group for HVLT,  OR= 3.42 (95% CI 
2.35, 4.99 P<0.001) than for the ≥65 year age group OR= 1.94 (95% CI 1.65, 2.28 P<0.001); and for 
FTMS, the under 65 age group OR= 2.50 (95% CI 1.73, 3.62 P<0.001) and ≥65 year age group OR= 1.66 
(95% CI 1.39, 1.99 P<0.001). This can be seen in the associations observed for education in the age 
group stratified data (Table 4.5), particularly for education to O/A level (completing education to 16 or 
18 years) for HVLT and FTMS. Associations were considerably stronger for the <65 years age group as 
compared to the ≥65 years for both these tests.  The association with education did not differ greatly 










































































   






















































































   
   
   
   






























   
   
   
   












   












   
   
   
   

























































































   
   
   








   
   








   
   
   








   
   
   








   
   








   
   
   








   
   
   




















































































































































































































































































































































































































































































































































































































































































































































































































































   




























































   
   








   
  








   
  








   
   








   
   
   












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Social Class  
Manual social class was independently associated with poor performance for all the tests apart from 
VST. On repeating the model but using individuals’ own social class or occupation rather than the 
‘conventional’ method, the associations observed were slightly stronger, however, there were no 
qualitative differences observed in the relationship. The data for both measures of social class are 
shown in Table 4.6. 
Adjustment for NART 
When the models were additionally adjusted for the NART error score as a secondary analysis (Table 
4.7), the odds were attenuated, but a higher likelihood of poor performance per 5 year increase in age 
was still observed for all remaining tests. The relationship observed for SF-EMSE reversed, with men 
27% less likely to be in the poor performance group than women OR=0.83, (95% CI 0.71, 0.97) P=0.02. 
Little change seen was observed in the associations for any of the tests for marital status.  
Associations with education at both ‘O’ or ‘A’ level and at graduate level were attenuated but still 
observed for SF-EMSE and FTMS after adjusting for NART. Graduate level education remained inversely 
associated with for poor cognitive performance. Associations were no longer significant for education 
and PW-Accuracy or the prospective memory task, For HVLT, associations with education were 
observed at graduate level but not at ‘O’ and ‘A’ level. For VST, associations were only observed for 
those completing school to ‘O’ and ‘A’ level but did not remain at graduate level. For social class, 
additionally adjusting for NART substantially attenuated associations, with just SF-EMSE still 
statistically significant association.  
Missing data in cognitive tests 
The results from the sensitivity analysis carried out only on individuals with complete data on all tests 

















































































































































































































































































































































   
   
   





   
   
   





   
   
   





   
   
   





   
   
   





   
   
   





   
   
   








































































































































































   
   
   





   
   
   





   
   
   





   
   
   





   
   
   





   
   
   





   
   
   

































































































































































































































































































































































































































































































































































































































































































































































































   



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   








   


































































































































































































































































































































































































This chapter presents the results of the association of age, sex, education, social class and (as a 
secondary analysis), crystallized intelligence on different cognitive abilities using a range of assessment 
tools in a healthy population of older men and women. We observed that the relationship of 
sociodemographic factors with cognitive function does depend on the assessment tool used.  
Older age was found to be associated with poor performance in all of the cognitive tests (abilities), 
except with the NART score (crystallized intelligence), confirming in this larger study that age has little 
or no association with NART performance [184]. The greatest age-related differences were observed 
for HVLT (verbal episodic memory). Episodic memory deficits have been reported to be associated with 
strongest and most persistent risk of cognitive decline [129,172] and are the most common and earliest 
complaints. These findings are consistent with previous work, here presented in terms of poorer 
performance observed in multiple domains across age [71,81,195] and stability observed in crystallized 
intelligence, or knowledge that is learned and acquired over years which has shown to be more 
resistant to the effect of age.[163,164,196] 
Men were significantly more likely to be poor performers compared to women for HVLT, PW-Accuracy 
(attention), prospective memory and in NART.  The sex differences were greatest for HVLT.  In contrast, 
there was no significant sex difference for SF-EMSE (global function).  Differences in men and women 
have been shown across various domains, [197] and these findings were consistent with other studies. 
[198] Dementia can be considered as the extreme of poor cognitive performance. Though the overall 
prevalence of dementia is reported as higher in women, [199] this could be explained by a higher 
proportion of older women in the general population.  Findings from large population-based studies 
report no sex differences in the rates of dementia up to high age [200–202] with higher rates only 
observed in women compared to men in the oldest old. [202] The higher prevalence of dementia 
observed in women may be due to the fact that age is the strongest risk factor for dementia and 
women make up the majority of the older population due to their increased life expectancy relative to 
men. No significant differences between men and women were observed for VST (processing speed), 
although previous studies have found men to perform better. [203] This could be partly explained in 
the composition of the test, which relies on the accurate recognition of a triangle shape as well as 
speed. Hence accuracy (performed better by women) and reaction time or processing speed 
(performed better by men), when combined, result in men and women shown to be performing 
similarly.  
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As shown previously, [126] education and social class were independently associated with cognitive 
performance. This was observed across all the domains even when adjusting for age and the other 
covariates. Although associations were strengthened when assigning social class to women using their 
own social class, we found no qualitative differences in associations from this and the ‘conventional’ 
method and the prediction of poor performance in all the tests.  
When estimating the potential impact of education on the age-related likelihood of poor performance, 
this was noticeable for the SF-EMSE test for global cognition, where the risk of being in the poor 
performance group for those with an education up to ‘O’ and ’A’ level compared to no qualification 
was equivalent to being almost 10 years younger and at graduate level compared to no qualification, 
this difference was even greater, with the risk equivalent to being almost 20 years younger. 
We also found that the influence of education was stronger in younger age group (<65 years) than in 
≥65 year age group. Not having qualifications in those <65 years was associated with greater risk of 
being in the poor performance group compared to people aged 65 and over.  Plausible explanations 
for this difference include the likelihood that other factors such as co morbidities common in older 
people could have a greater influence on cognitive performance in older people.  
NART, as would be expected, showed the greatest association with education, however when 
controlling for the NART, associations were substantially attenuated but still observed for the SF-EMSE 
and FTMS for the levels of education examined. The change of direction of the association observed 
for SF-EMSE and sex after adjusting for NART may be because men performed worse than women on 
the NART and this was observed in the change in association on adjusting for NART. 
Education was associated with a lowered risk of poor performance for HVLT at graduate level but not at 
‘O’ and ‘A’ level in the fully adjusted model. Associations were no longer present for PW-Accuracy and 
little for prospective memory. Education and Intelligence (of which NART is a proxy measure), even though 
known closely related variables, are not perfectly correlated, and cannot be substituted for each other. 
[194] These findings support this and indicate that whatever NART assesses, whether it is a surrogate for 
prior ability including childhood intelligence or a composite indicator of education; adjusting for NART has 
a material influence on the independent association of social class and education on cognitive 
performance measures. Though NART does not completely remove association in all the tests here, it is 
an important exposure to consider and reasonable to adjust for when analysing cognitive function. 
Another noteworthy point is that tests put forward as measuring similar domains, such as FTMS and 
HVLT; both measures of episodic memory (one verbal and one non-verbal), showed quite different 
relationships, particularly for sex, with men showing greater likelihood of poor performance for HVLT 
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than the FTMS. One possible explanation is that tasks requiring verbal and semantic knowledge are 
considered to be more cognitively demanding, requiring greater self-initiation and encoding than non-
verbal tasks such as the FTMS of the CANTAB-PAL. [81,204] This observation, as well as that seen for 
processing speed, highlights the complex nature for assessing cognitive function, because different 
abilities do not work in isolation. As for others, [72] the EPIC-Norfolk tests showed no clear pattern  of 
the underlying cognitive domains being assessed. Each test actually assesses more than the one ability 
(as shown in Figure 2.2, Chapter 2) and to execute a task successfully, abilities work in conjunction and 
not independently of each other. While the score focuses on the performance of a single ‘main’ ability, 
it actually reflects a range of other abilities that are being utilised. 
There are a number of strengths to this study. The data are collected from a single large population with 
individuals being assessed under the same conditions. This reduces the variation in methodology seen in 
other studies that have combined data from various sources. We also examined ability separately across 
a wider range covering six domains including a test for global function and not restricted to a few 
domains, just episodic memory or simply global cognitive function as in many studies. Furthermore, we 
assessed differences in performance at individual test level rather than as aggregated test scores which 
allowed us to observe differences even in those tests intending to measure the same ability. 
A limitation of this investigation is that it was not possible to test for other risk factors for poor 
performance in particular comorbidities, all which influence cognitive performance. The main focus of 
this paper was on differences across assessment tools. This study is cross-sectional, and reflects a more 
‘healthy profile’ as it consists of survivors and those who attend the health examination and get tested.  
Summary of Chapter 
 
 Education and social class were independently associated with cognitive performance 
across all domains even after adjusting for age and the other covariates. 
 
 Older age was found to be associated with poor performance in all of the cognitive tests 
(abilities), except with the NART score (crystallised cognition). 
 
 Sex differences were observed for some tests. 
 
 The risk of poor global cognitive function for those with O/A level qualifications compared 
to those with no qualifications was equivalent to being almost 9.9 years younger and those 
educated to graduate level was equivalent to 19.6 years younger. 
 
 The Influence of education varied by age group. Not having qualifications in those <65 years 
was associated with greater risk of being in the poor performance group compared to 


























The work presented in this Chapter has been published: 
Hayat, S. A., Luben, R Wareham, N, Khaw K-T and Brayne C (2020). Cross-sectional and prospective relationship between 
occupational and leisure time inactivity and cognitive function in an ageing population. The European Prospective 





The current evidence for higher physical activity and better cognitive function and lower risk of 
dementia is strong but not conclusive. More robust evidence is needed to inform public health policy 
and practice. This chapter provides further insight to discrepancies observed across studies, reporting 
on habitual inactivity including that during work.  As part of this investigation, I examined cross-
sectional and prospective relationships of physical inactivity during leisure and occupation time, 
measured at two time points, with cognitive performance using a validated physical activity index in 
the 8585 EPIC-Norfolk participants with cognition data from EPIC-Norfolk. Associations were examined 
using multinomial logistic regression adjusting for socio-demographic and health variables as well total 
habitual physical activity.  
Inactivity during work was inversely associated with poor cognitive performance (bottom tenth 
percentile of a composite cognition score), Odds Ratio (OR) = 0.68 (95% Confidence Interval (CI) 054, 
0.86) P=0.001. Results were similar cross-sectionally; OR = 0.65 (95% CI 0.45, 0.93) P=0.02. Manual 
workers had increased risk of poor performance compared to those with an occupation classified as 
inactive. Inactivity during leisure time was associated with increased risk of poor performance in the 
cross-sectional analyses only.  
Associations between physical inactivity and cognitive function differ depending on whether activity is 
measured during work or leisure.  Findings from this cohort, which represents a wide socio-economic 
range, suggest that the relationship between inactivity and cognition is strongly confounded by 
education, social class and occupation.  Physical activity during leisure may be protective for poor 
cognition, but work related physical activity is not protective. This suggests the need to have a greater 
understanding of the mechanisms and confounding underlying these paradoxical findings.   
5.2 Introduction 
Physical inactivity and sedentary behaviour (independent of physical activity), have been reported to 
be risk factors for major health conditions, [111] including cognitive impairment. [112] The available 
evidence for future public health strategies on how to best manage or prevent cognitive decline, 
impairment and dementia has shown physical activity to be predominantly, but not consistently, 
beneficial, with mixed evidence from observational studies. [113,205,206]  The reasons for these 
discrepancies are unclear, [11] but may be partly due to the heterogeneity and limitations in the 
methodologies across studies.  This includes differences in follow up time, [207] low power with 




way the exposure (physical activity) and the outcome (cognition) are measured and defined across 
studies. 
Most studies have focused on moderate and severe cognitive impairment including dementia with far 
less on the relationship of physical activity and milder cognitive dysfunction. Cross-sectional studies 
with short follow-up times, cannot distinguish causal effects from reverse causation, and confounding 
is an issue highlighted as a limitation in observational studies. [206,207] Experimental studies 
examining the influence structured physical activity on enhancing cognitive function have also been 
inconsistent. [211] Studies cited in the literature have differed in methodology, but have 
predominantly used leisure time activity, [113,207] with few examining work-based physical activity. 
[205,206] Although leisure time activity has been associated with better cognition, [208] work-related 
physical activity has shown no relationship, [205] or even the contrary, with lower socio-economic 
groups and manual occupations with higher physical activity showing greater risk of dementia and 
cognitive impairment. [206,212]  To advise on public health strategies for maintaining cognition in later 
life for all in society, we need a better understanding of discrepancies in the existing evidence base.  
This chapter sets out to examine the cross-sectional and prospective relationship between physical 
inactivity and cognitive performance (both in terms of poor and high performance), in older men and 
women from a wide range of socio-economic background and education.  Findings are presented on 
habitual inactivity including work and leisure time, using a simple pragmatic validated physical activity 
scale.  
5.3 Methods 
5.3.1 Participants and measurements  
An overview of the EPIC-Norfolk 3HC methods have been described in Chapter 2.  Specific methods for 
the work presented in this chapter are given here.   
5.3.2 Assessment of cognition 
For this analysis, the EPIC-Norfolk cognition battery, as described in Chapter 2. However, in this 
investigation, two separate outcome measures were available at the time of this chapter for the Visual 
Sensitivity Test (VST), a test for processing speed. These were VST-simple and VST-complex and are 
analysed here as separate measures. As a result, here, we report on eight separate cognitive measures 





5.3.3 Assessment of Physical Activity 
Total (habitual) physical activity was assessed as described in Chapter 2 using the two questions as 
described in Appendix 2. A four-category physical activity index was derived based on the level of 
activity during occupation and leisure time (Appendix 3).  
5.3.4 Covariates 
Education (the highest level attained) and social class were derived from the baseline questionnaire 
and analysed as described in Chapter 2. Briefly, education was categorised into three groups (i) No 
qualification (not completing school to age 16), (ii) Completing school to age 16 or 18 years (‘O’ or ‘A’ 
level) and (iii) educated to graduate level (a degree or equivalent) or above.  Social class was analysed 
as separate categories for the univariate analysis, but then subsequently as the dichotomous variable 
‘‘non-manual’’ and ‘‘manual’’.  Self-report of smoking status and alcohol intake (units/week) were 
obtained from questionnaires from baseline and close to the time of cognitive testing (3HC). Alcohol 
units were categorised into three groups: 0 Units, 1-14 Units and more than 14 Units. Age (at baseline) 
was categorised into 5-year age bands.  
5.4 Analysis 
Descriptive analysis of cognitive scores by physical activity category revealed a non-linear relationship. 
Associations were therefore again examined using approximate percentile cut-offs rather than the 
continuous cognition score.  For this chapter, participants were classified into three groups based on 
their scores, creating a 3-level categorical variable for each of the eight cognitive measures individually. 
The lowest level (1) corresponded to poor performance, as described in Chapter 2using the 10th 
percentile of the population distribution. The highest level (3) corresponded to high performance 
(defined as obtaining a score greater than a cut-off point corresponding to approximately the 90th 
percentile of the population distribution). The remaining consisted of those within the 11th-89th 
percentile, the standard level (2).  For prospective memory, those failing were assigned to the poor 
performance group and those succeeding, to the standard level. In this investigation, we also included 
the composite score, representing general cognition underlying all the cognitive functions assessed.  A 
3-level categorical variable was created for EPIC-COGComp for poor, high and standard group level as 
for the cognitive measures individually as described in Appendix 5.  
The physical activity index was examined in three different ways. Firstly, the four point index was use 
to examine the characteristics of the population across the four categories of physical activity both at 




index into ‘inactive’ and ‘active’. Finally, we additionally examined the association using the 
dichotomised index for occupation and leisure time components separately.  
Associations between cognition (poor and high performance) and physical inactivity at the time of 
cognitive testing at 3HC (cross-sectional), and at baseline (prospective), were examined using 
multinomial logistic regression. Figure 5.1 is a timeline of the study, presenting the two time points used 
in the analyses. Associations were assessed adjusting for age at time of cognitive testing (per 5 years) 
and sex (models 1), adding education and social class (models 2), extending the models to include 
prevalent disease (models 3), and finally, adjusting further for total habitual activity (Models 4) in the 
separate work and leisure analyses. Education, social class, physical activity, smoking and prevalent 
disease were all treated as categorical variables in the analysis and age per 5 years entered as continuous.  
We also examined possible interaction with education and work-related activity and stratified by 
education group before calculating adjusted odd ratios for work and leisure. Sensitivity analyses were 
conducted (i) by assigning participants with missing data to the poor performance group and (ii) by 
grouping participants in approximate quartiles (rather three levels) of cognition scores. 
5.5 Results 
From baseline to time of cognitive testing (3HC), the mean follow-up time was 12.6 years (SD=2.0). There 
were 8585 participants with cognitive measures, resulting in 8501 participants in the cross-sectional and 
8585 in the prospective analyses respectively.  There were slightly fewer in the cross-sectional analyses due 
to some missing physical activity data. Those invited for the 3HC (N=18, 382) but did not attend, were more 
likely to be older, with higher self-reported heart attack, stroke and diabetes prevalence. Non-attenders 
were also more likely to have no qualifications and be in the lower socio-economic groups (Table 5.1). 
Tables 5.2 and 5.3 show the characteristics (unadjusted) of the participants by habitual physical activity 
category for men and women at baseline and the 3HC respectively. At baseline, for men, a greater 
proportion of the moderately inactive and inactive were educated to graduate level and were from 
higher socio-economic groups. They were also more current smokers compared to those in the other 
levels of activity. For women, the inactive groups had fewer individuals in the higher educated and socio-
economic groups, although as with men, more current smokers. Inactive individuals (for both men and 
women) were more likely to be older with men reporting higher rates of diabetes and women having 
higher rates of depression. At 3HC (Table 5.3), majority of individuals reported to be retired from their 
main occupation and were more likely to be inactive. Inactive men and women had higher rates of heart 
attack and stroke and more were non-drinkers and current smokers. There were no clear differences 




































































































































































































































































































































































































































Table 5.1: Characteristics of individuals by those invited, attended 3HC with a cognitive test measure compared 
to those who either did not attend 3HC (including the pilot) or had no cognitive test measure. 
 
 Total Invited (N=18,382)  
 







Characteristics at Baseline    
Mean (SD)    
 Age 55.7 (7.8) 58.9 (9.3) <0.001 
    
Frequencies, % (N)    
% men 44.7 (3841) 42.0 (4117) <0.001 
Level of education    
No Qualification 26.2 (2251) 45.1 (4414) 
<0.001 O or A level 56.1 (4521) 46.2 (4521) 
Graduate Level or above 17.6 (1513) 8.7 (856) 
Social Class    
Professional 8.8 (748) 4.9 (468) 
<0.001 
Managerial 41.1 (3498) 30.1 (2867) 
Skilled Non-Manual 16.0 (1364) 17.1 (1635) 
Skilled Manual 20.6 (1748) 26.8 (2555) 
Semi-Skilled 11.2 (950) 16.3 (1550) 
Non-Skilled 2.3 (197) 4.8 (459) 
    
Alcohol (Units/week)    
0 8.9(763) 15.5 (2263) 
<0.001 ≤ 14 Units 75.2 (6426) 71.6 (6912) 
> 14 Units 15.8 (1353) 12.8 (1239) 
Smoking Status    
Never 52.2 (4463) 45.0(4365) 
<0.001 Former 38.9 (3329) 41.0 (3971) 
Current 8.9 (760) 14.0 (1361) 
Co-morbidities    
Heart attack 1.5 (128) 2.6 (251) <0.001 
Stroke 0.6 (50) 1.0 (99) 0.001 
Cancer 4.4 (374) 4.4 (426) 1.00 
Diabetes 1.0 (85) 2.2 (218) <0.001 
Depression 14.6 (1250) 14.3 (1398) 0.6 
    
P- Value Using Anova or chi sq 







Table 5.2: Baseline (1993–1997) characteristics of the 8585 EPIC-Norfolk men and women with cognitive 
data collected at 3HC (2006–2011, including data from pilot 2004–2006) by level of physical activity. 
 Level of Activity as reported at Baseline by Men  







Baseline N=3841 N=880 N=1001 N=973 N=987  
       
Mean (SD)       
 Age 56.4 (7.9) 58.1 (8.0) 56.3 (8.0) 56.1 (7.7) 55.1 (7.5) <0.001 
Frequencies, % (N)       
Level of education       
No Qualification 22.1 (847) 22.9 (201) 19.2 (192) 19.9 (194) 26.3 (260) 
<0.001 O or A level 57.8 (2221) 59.5 (523) 52.5 (526) 60.4 (588) 59.2 (584) 
Graduate level  20.1 (772) 17.6 (155) 28.3 (283) 19.6 (191) 14.5 (143) 
Social Class       
Professional  9.5 (364) 11.1 (97) 14.6 (145) 7.7 (74) 4.9 (48) 
<0.001 
Managerial 42.7 (1629) 47.0 (411) 47.6 (473) 42.3 (408) 34.4 (337) 
Skilled Non-Manual 12.2 (466) 16.2 (142) 15.8 (157) 9.9 (96) 7.2 (71) 
Skilled Manual 22.7 (865) 14.4 (126) 13.1 (130) 27.4 (264) 35.2 (345) 
Semi-Skilled 11.0 (418) 9.8 (86) 7.8 (78) 10.8 (104) 15.3 (150) 
Non-Skilled 1.9 (72) 1.5 (13) 1.1 (11) 2.0 (19) 3.0 (29) 
Co-morbidities       
Heart attack 2.6 (101) 3.6 (32) 2.4 (24) 2.6 (25) 2.0 (20) 0.2 
Stroke 0.7 (27) 0.8 (7) 0.9 (9) 0.9 (9) 0.2 (2) 0.2 
Cancer 2.8 (106) 2.5 (22) 2.6 (26) 3.9 (38) 2.0 (20) 0.07 
Diabetes 1.4 (54) 2.3 (20) 1.4 (14) 1.8 (18) 0.2 (2) 0.001 
Depression 8.6 (329) 9.2 (81) 9.5 (95) 8.0 (78) 7.6 (75) 0.4 
Alcohol       
 
0.2 
(Units/week)      
0 5.9 (227) 5.7 (50) 5.0 (50) 6.7 (65) 6.3 (62) 
≤ 14 Units 68.3 (2614) 71.1 (619) 67.4 (672) 68.3 (663) 66.9 (660) 
> 14 Units 25.7 (984) 23.2 (202) 27.6 (275) 25.0 (243) 26.8 (264) 
Smoking Status       
Never 41.4 (1586) 36.9 (324) 44.6 (445) 41.0 (397) 42.6 (420) 
0.04 Former 49.6 (19.1) 53.0 (465) 47.4 (473) 49.5 (480) 49.0 (483) 
Current 8.9 (342) 10.0 (88) 8.0 (80) 9.5 (92) 8.3 (82) 
Mean Cognitive Test Score at 3HC (SD)     
SF-EMSE 32.5 (3.3) 32.2 (3.7)   32.9 (2.8) 32.6 (3.4) 32.3 (3.4) <0.001 
HVLT  23.9 (5.6) 23.6 (5.8) 24.2 (5.7) 23.9 (5.6) 23.7 (5.4) 0.1 
PAL- FTMS  15.4 (4.3) 15.3 (4.3) 15.4 (4.5) 15.6 (4.2) 15.2 (4.3) 0.3 
PW-Accuracy  12.3 (5.6) 12.3 (6.0) 12.7 (5.9) 12.4 (6.1) 12.0 (6.3) 0.08 
VST-simpleⱡ 657.7 (161.6) 658.8 (175.2) 656.4 (161.9) 654.9 (151.1) 661.0 (158.8) 0.9 
VST-Complexⱡ 2227.5 (422.9) 2267.8 (499.4) 2235.5 (440.4) 2200.7 (375.4) 2210.1 (369.2) 0.01 
Short-NART ⱡ 17.9 (10.3) 16.4 (10.0) 16.2 (9.8) 18.6 (10.3) 20.3 (10.5) <0.001 
Comp. Score 7.7 (1.8) 7.7 (1.8) 7.8 (1.8) 7.7 (1.8) 7.4 (1.8) 0.001 





Table 5.2: Continued… 



















Mean (SD)       
 Age 55.1 (7.7) 56.9 (8.2) 55.4 (7.9) 54.4 (7.4) 53.8 (7.1) <0.001 
Frequencies, % (N)       
Level of education       
No Qualification 29.6 (1404) 31.5 (307) 28.2 (445) 29.4 (362) 30.2 (290) 
<0.001 O or A level 54.8 (2598) 56.8 (554) 55.5 (876) 51.5 (634)  55.6 (534) 
Graduate Level or above 15.6 (741) 11.7 (114) 16.2 (256) 19.0 (234) 14.3 (137) 
Social Class       
Professional 8.2 (384) 5.6 (54) 9.0 (141) 9.2 (112) 8.1 (77) 
<0.001 
Managerial 39.8 (1869) 35.5 (342) 41.1 (642) 41.93 (511) 39.5 (374) 
Skilled Non-Manual 19.1 (898) 23.5 (226) 20.4 (319) 17.3 (211) 15.0 (142) 
Skilled Manual 18.8 (883) 21.2(204) 17.7 (277) 17.0 (207) 20.6 (195) 
Semi-Skilled 11.3 (532) 11.0 (106) 10.1 (158) 11.6 (141) 13.4 (127) 
Non-Skilled 2.7 (125) 3.2 (31) 1.5 (24) 3.0 (37) 3.5 (33) 
Co-morbidities       
Heart attack 0.6 (27) 0.4 (4) 0.6 (9) 0.6 (7) 0.7 (7) 0.8 
Stroke 0.5 (23) 0.7 (7) 0.5 (8) 0.4 (5) 0.3 (3) 0.6 
Cancer 5.7 (268) 6.8 (66) 5.2 (82) 5.7 (70) 5.2 (50) 0.4 
Diabetes 0.7 (31) 0.5 (5) 0.9 (14) 0.4 (5) 0.7 (7) 0.4 
Depression 19.5 (921) 22.7 (221) 19.4 (305) 18.1 (222) 18.0 (173) 0.03 
Alcohol (Units/week)      
0.1 
0 11.4 (536) 13.6 (131) 10.2 (160) 10.4(128) 12.2 (117) 
≤ 14 Units 80.8 (3812) 78.9 (758) 82.0 (1288) 81.0 (993) 80.5 (773) 
> 14 Units 7.8 (369) 7.5 (72) 7.8 (122) 8.6 (105) 7.3 (70) 
Smoking Status       
Never 60.9 (2877) 58.0 (563) 60.4 (947) 63.2 (774) 61.9 (593) 
0.02 Former 30.2 (1428) 30.9 (300) 30.8 (483) 28.1 (344) 31.4 (301) 
Current 8.9 (418) 11.1 (108) 8.9 (139) 8.7 (107) 6.7 (64) 
Mean Cognitive Test Score at 3HC (SD)   
SF-EMSE 32.7 (3.0) 32.6 (3.1) 32.7 (3.1) 32.8 (2.8) 32.6 (3.0) 0.2 
HVLT  26.04 (5.5) 25.7 (5.9) 26.1 (5.6) 26.4 (5.3) 25.9 (5.3) 0.04 
PAL- FTMS  15.8 (4.2) 15.7 (4.2) 15.8 (4.3) 15.9 (4.2) 15.8 (4.2) 0.6 
PW-Accuracy  13.8 (5.9) 13.4 (6.3) 14.0 (5.8) 14.0 (5.9) 13.8 (5.8) 0.08 
**VST-simple ⱡ 668.7 (169.9) 690.3 (212.0) 662.1 (155.7) 663.3 (148.5) 664.6 (168.5) 0.001 
**VST-Complex ⱡ 2172.3 (432.5) 2205.4 (481.4) 2163.7 (455.5) 2173.3 (403.1) 2151.3 (371.2) 0.07 
Short-NART ⱡ 16.6 (9.5) 16.8 (9.7) 16.1 (9.2) 16.4 (9.4) 17.6 (9.6) 0.001 
Composite score 8.1 (1.8) 8.0 (2.0) 8.2 (1.8) 8.1 (1.8) 8.0 (1.7) 0.3 
Pros. Mem % failed (N) 15.9 (738) 16.1 (154) 15.6 (241) 15.5 (187) 16.5 (156) 0.9 
Abbreviations: A, Advanced level, HVLT, Hopkins Verbal Learning Test; N, Number; NART, National Adult Reading Test O, 
Ordinary; PAL-FTMS, Paired Associates Learning, First Trial Memory Score; Pros. Mem, Prospective Memory; SD, standard 
deviation; SF-EMSE, Short Form Extended mental state exam; VST, Visual Sensitivity Test. 




Table 5.3: Characteristics of EPIC-Norfolk men (N=3786*) and women (N=4680*) at time of cognitive 
testing (3HC Phase, 2006-2011, including data from pilot 2004–2006) by level of physical activity. 
  Men  








 N=3841* N=1410 N=952 N=712 N=712  
Mean (SD)       
 Age 69.4(8.1)   72.0 (7.9) 69.2 (7.9) 67.4 (7.8) 66.4 (7.3) 0.01 
Frequencies, % 
(N)       
Retired from main 
occupation 75.9 (2842) 81.7 (701) 77.1 (749) 76.5 (727) 69.0 (665) <0.001 
Co-morbidities       
Heart attack 5.2 (198) 7.1 (100) 4.1 (39) 4.2 (30) 3.5 (25) <0.001 
Stroke 3.0 (116) 4.7 (66) 2.2 (21) 2.1 (15) 1.5 (11) <0.001 
Cancer 7.2 (276) 7.5 (106) 7.8 (74) 6.7 (48) 6.2 (44) 0.6 
Diabetes 3.9 (151) 5.2 (74) 3.0 (29) 4.1 (29) 2.4(17) 0.01 
Depression 14.0 (536) 13.1 (185) 15.9 (151) 14.5 (103) 12.4(88) 0.2 
Alcohol 
(Units/week)       
0 22.2 (824) 27.3 (375) 18.5 (173) 20.5 (144) 18.9 (132) 
<0.001 ≤ 14 Units 59.2 (2193) 55.6 (764) 62.6 (585) 60.6 (425) 59.9 (419) 
> 14 Units 18.6 (690) 17.0 (234) 18.8 (176) 18.8 (132) 21.2 (148) 
Current Smokers 




Test Score (SD)       
SF-EMSE 32.5 (3.3) 32.0 (3.7) 32.9 (3.0) 32.8 (2.9) 32.7 (2.8) <0.001 
HVLT  23.9 (5.6) 23.0 (5.8) 24.3 (5.6) 24.5 (5.4) 24.5 (5.1) <0.001 
PAL- FTMS  15.4 (4.3) 14.7 (4.4) 15.6 (4.3) 16.1 (4.1) 15.8 (4.1) <0.001 
PW-Accuracy  12.3 (6.1) 11.9 (6.0) 12.7 (6.2) 12.6 (6.2) 12.5 (6.2) 0.003 
**VST-simple ⱡ  657.7 (161.6) 667.9 (172.7) 660.7 (178.0) 645.6 (121.9) 646.9 (151.8) 0.01 
**VST-Complex ⱡ  2227.7 (422.9) 2267.2 (431.6) 2230.4 (462.7) 2192.3 (350.6) 2191.1 (414.3) <0.001 
Short-NART ⱡ 17.9 (10.3) 18.0 (10.4) 16.2 (10.1) 18.1 (10.0) 19.7 (10.5) <0.001 
Composite Score  7.7 (1.8) 7.3 (1.8) 7.9 (1.8) 7.8 (1.8) 7.8 (1.6) <0.001 
Pros. Mem % 






Table 5.3: Continued … 
  Women          




active Active P-Value 
 N=4744* N=1739 N=1509 N=792 N=640  
Mean (SD)       
 Age 68.1 (8.0) 70.8 (8.2) 67.2 (7.5) 66.0 (7.4) 65.3 (7.3) <0.001 
Frequencies, % (N)       
Retired from main 
occupation 78.8 (3549) 84.1 (788) 79.0 (1180) 76.8 (899) 75.7 (682) <0.001 
Co-morbidities       
Heart attack 2.0 (93) 3.1 (54) 1.8 (27) 0.8 (6) 0.9 (6) <0.001 
Stroke 1.4 (66) 2.1 (37) 1.3 (19) 0.9 (7) 0.5 (3) 0.01 
Cancer 11.1 (528) 12.5 (217) 10.7 (161) 9.1 (72) 10.6 (68) 0.07 
Diabetes 2.3 (109) 2.9 (50) 1.9 (29) 1.8 (14) 2.3 (15) 0.2 
Depression 28.0 (1328) 29.0 (504) 27.4 (414) 30.2 (239) 23.6 (151) 0.03 
Alcohol 
(Units/week)       
0 36.0 (1638) 43.1 (731) 31.7 (465) 30.4 (234) 33.3 (208) 
<0.001 ≤ 14 Units 58.5 (2664) 52.4 (889) 62.4 (914) 62.5 (481) 60.8 (380) 
> 14 Units 5.6 (253) 4.4 (75) 5.9 (86) 7.1 (55) 5.9 (37) 
Current  
Smokers % (n) 4.5 (212) 5.8 (100) 3.4 (51) 4.2 (33) 4.4 (28) 0.01 
Mean Cognitive 
Test Score (SD)       
SF-EMSE 32.7 (3.0) 32.2 (3.2) 33.0 (2.8) 33.0 (3.0) 32.8 (2.7) <0.001 
HVLT  26.0 (5.5) 25.0 (5.9) 26.7 (5.3) 26.6 (5.1) 26.8 (5.0) <0.001 
PAL- FTMS  15.8 (4.2) 15.3 (4.3) 16.1 (4.2) 16.1 (4.1) 16.1 (4.2) <0.001 
PW-Accuracy  13.8 (5.9) 13.0 (6.1) 14.5 (5.8) 14.3 (5.7) 14.2 (5.8) <0.001 
**VST-simpleⱡ 668.7 (169.9) 685.6 (189.4) 661.6 (172.0) 660.1 (152.5) 651.4 (122.3) <0.001 
**VST-Complexⱡ 2172.3 (432.5) 2208.1 (444.4) 2159.6 (469.6) 2136.1 (385.6) 2149.4 (361.4) 0.001 
NART ⱡ 16.6 (9.5) 17.2 (9.5) 15.7 (9.4) 16.2 (9.5) 17.5 (9.4) <0.001 
Composite Score  8.1 (1.8) 7.3 (1.8) 7.9 (1.8) 7.8 (1.8) 7.8 (1.6) <0.001 
Pros. Mem % failed 
(N) 15.6 (738) 19.3 (327) 12.5 (185) 16.0 (125) 14.5 (91) <0.001 
*Total does not match due to missing data  
Abbreviations: A, Advanced level, HVLT, Hopkins Verbal Learning Test; N, Number; NART, National Adult Reading Test O, 
Ordinary; PAL-FTMS, Paired Associates Learning, First Trial Memory Score; Pros. Mem, Prospective Memory SF-EMSE, Short 
Form Extended mental state exam; VST, Visual Sensitivity Test;  








Table 5.4 shows associations of habitual inactivity cross-sectionally and prospectively, across individual 
cognitive tests (assessing a range of domains) and the composite score. After controlling for age and 
sex, most attenuation occurred for the bottom 10th percentile, with some after adjusting for education 
and social class. Further adjustments for other co-variables, made little difference to the point 
estimates.  Apart from the NART, where education and social class strengthened the association with 
cognition, there was little change across the models for the top 10th percentile for the other tests. 
For most tests, there was little or no relationship between habitual inactivity and cognition. However, 
being inactive was positively associated with poor performance for VST-complex both in cross-
sectional and possibly also in the prospective analyses OR=1.20 (95% CI 1.02, 1.42 P=0.03); OR=1.20 
(95% CI 0.99, 1.44 P=0.06) respectively. Inactive participants were also less likely to perform poorly in 
the prospective analysis for the prospective memory task OR=0.79 (95% CI 0.69, 0.91 P=0.001).  
Physical inactivity increased the likelihood of high performance for the tests HVLT OR=1.23 (95% CI 
1.04, 1.47 P=0.02) and NART OR=1.37 (95% CI 1.14, 1.65 P=0.001), but only for the prospective 
analyses. For VST-Simple, those inactive at 3HC were less likely to be high performers. No associations 
were observed for poor performance. For the composite score, inactivity was associated with 
increased risk of poor performance cross-sectionally, and a possible decreased risk prospectively. For 
practicality, only the composite score was used to examine the relationship with work and leisure 
separately. Table 5.5 shows these associations in men and women with further adjustment for total 
habitual activity (Models 4).  
Leisure inactivity seemed to increase risk of poor performance, cross-sectionally OR=1.27 (95% CI 1.00, 
1.61 P=0.05). For high performance, no relationship was observed cross-sectionally, but a possible 
inverse relationship was observed for the prospective analyses. There seemed to be some indication 
of an increased risk with poor performance for inactivity in men cross-sectionally and decrease in being 



















































































































































































































































































































































































































































































   




















































































































   







































































































































   






















































































































   











































































































































   
   























































































































   
   












































































































































   




















































































































   























































































































































   
























































































































   

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In contrast to leisure time, inactivity during work was associated with lower risk of poor performance 
with little difference observed in the cross-sectional and prospective analyses. In relation to high 
performance, the relationship was stronger for men, with a possible increased likelihood of high 
performance observed for inactive working men, but not for inactive working women (Table 5.5).  
Figure 5.2 is a visual representation of the relationship between inactivity and cognitive performance 
for total habitual, as well as leisure and work time activity separately, at the two time points (men and 
women combined). Figure 5.3 shows that increased work related physical activity (as reported at 
baseline), was associated with increased risk of poor performance with manual workers having a 
greater risk of poor performance than those with physically inactive occupations; OR=2.70 (95%CI 1.76, 
4.16 P<0.001).   
No significant interaction was observed with education and work related activity either cross-
sectionally (bottom and top 10th percentile P=0.4 and P=0.9 respectively) or prospectively (bottom and 
top 10th P=0.6 and P=0.5 respectively).  However, those with no qualifications were less likely to be 
inactive at work and more likely to be inactive at leisure (Table 5.6).  
Table 5.6: Distribution of inactivity during leisure and work by education level (cross-sectional and 
prospective analysis). 
 Frequencies, % (N)  
  No Qualifications  Any Qualifications  P-Value 
Cross-sectional    
Inactive at work (N=1675) 25.7 (183) 48.3 (1492) <0.001 
Inactive at leisure (N=4098) 58.0 (1282) 45.0 (2816) <0.001 
Prospective    
Inactive at work at baseline (N=2742) 22.6 (372) 44.3 (2370) <0.001 
Inactive at leisure (N=3661) 50.6 (1138) 39.8 (2523) <0.001 
 
Due to the strong influence of education on cognition, data were stratified by education groups (‘No 
Qualifications’ and ‘With Qualifications’). Adjusted odd ratios in each group for both work and leisure 
are presented in Table 5.7. On stratification, results indicate that being inactive at work reduced risk 
of poor performance for both those with and without qualifications. Furthermore, those remaining in 
an inactive job at the time of cognitive testing increased their probability of being in the top tenth 
percentile OR= 1.29 (95%CI 1.02, 1.62 P=0.03).  The risk for poor performance increased for those 




In the first sensitivity analysis, imputing poor performance for missing data made little difference to 
the odds ratio (Table 5.8), suggesting that the missing data do not reduce the representativeness of 
the sample. The second analyses based on approximate quartiles of cognitive scores shows a threshold 
relationship with physical inactivity (Table 5.9). Using groups of approximate quartiles (Table 5.10), the 
associations for most of the tests, were similar to those observed in the main analyses (Table 5.4). 
There was little or no association between habitual inactivity and cognition. Changing the grouping 
made little difference on the overall findings. Given that this study is in apparently healthy older adults, 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5.9: Sensitivity Analysis II showing age and sex adjusted association by approximate quartile 
group 
 
    Model 1 
    OR (95% CI) P-Value 
 Freq, N    
Cross-sectional     
SF-EMSE 8368    
G1 2261 1.44 (1.21, 1.70) <0.001 
G2 2252 1.18 (1.00, 1.40) 0.05 
G3 2863 1.16 (0.99, 1.37) 0.07 
G4 992 1.00   
Prospective     
SF-EMSE 8483    
G1 2305 0.94 (0.78, 1.14) 0.6 
G2 2276 0.91 (0.76, 1.10) 0.3 
G3 2898 0.97 (0.81, 1.16) 0.7 
G4 1004 1.00   
Cross-sectional     
HVLT 8028    
G1 1998 1.35 (1.17, 1.56) <0.001 
G2 2482 1.21 (1.05, 1.38) 0.01 
G3 1621 1.09 (0.94, 1.26) 0.3 
G4 1927 1.00   
Prospective     
HVLT 8138    
G1 2036 0.91 (0.77, 1.07) 0.2 
G2 2514 0.87 (0.75, 1.01) 0.07 
G3 1640 0.88 (0.75, 1.04) 0.1 
G4 1948 1.00   
Cross-sectional     
FTMS 7352    
G1 2030 1.18 (1.00, 1.38) 0.05 
G2 2067 1.11 (0.95, 1.29) 0.2 
G3 1984 1.05 (0.90, 1.23) 0.6 
G4 1271 1.00   
Prospective     
FTMS 7461    
G1 2074 0.87 (0.72, 1.04) 0.1 
G2 2093 0.93 (0.83, 1.18) 0.9 
G3 2012 1.03 (0.87, 1.23) 0.7 
G4 1282 1.00   
Cross-sectional     
PW_Acc 8296    
G1 2071 1.05 (0.92, 1.21) 0.5 
G2 2198 1.02 (0.89, 1.17) 0.8 
G3 2131 1.02 (0.89, 1.17) 0.8 
G4 1896 1.00   
Prospective     
PW_Acc 8410    
G1 2105 0.92 (0.78, 1.08) 0.3 
G2 2229 1.01 (0.87, 1.18) 0.9 
G3 2154 1.05 (0.90, 1.22) 0.6 





Table 5.9: Continued… 
 
 
*See Appendix 5 below for details on how the composite score for the above approximate quartile group was 
created. 
  Model 1 
  OR (95% CI) P-Value 
  Freq, N       
Cross-sectional     
VST-Simple 7067    
G1 1765 1.20 (1.04, 1.39) 0.01 
G2 1768 1.09 (0.94, 1.26) 0.3 
G3 1776 1.13 (0.98, 1.30) 0.1 
G4 1758 1.00   
Prospective     
VST-Simple 7171    
G1 1790 1.14 (0.97, 1.34) 0.1 
G2 1795 0.99 (0.84, 1.16) 0.9 
G3 1795 1.04 (0.88, 1.22) 0.6 
G4 1791 1.00   
Cross-sectional     
VST-Complex 7067    
G1 1767 1.13 (0.98, 1.31) 0.1 
G2 1768 1.06 (0.92, 1.22) 0.5 
G3 1768 0.95 (0.83, 1.10) 0.5 
G4 1764 1.00   
Prospective     
VST-Complex 7171    
G1 1792 1.14 (0.97, 1.34) 0.1 
G2 1793 0.99 (0.84, 1.16) 0.9 
G3 1794 1.07 (0.91, 1.25) 0.4 
G4 1792 1.00   
Cross-sectional     
NART 8002    
G1 1803 1.10 (0.96, 1.26) 0.2 
G2 2183 1.24 (1.09, 1.41) 0.001 
G3 1973 1.10 (0.96, 1.26) 0.2 
G4 2043 1.00   
Prospective     
NART 8112    
G1 1835 0.77 (0.66, 1.90) 0.001 
G2 2219 0.82 (0.71, 0.95) 0.01 
G3 2005 0.86 (0.74, 0.99) 0.04 
G4 2053 1.00   
Cross-sectional     
Composite Score* 6061    
G1 1782 1.37 (1.17, 1.61) <0.001 
G2 1356 1.12 (0.94, 1.32) 0.2 
G3 1461 1.12 (0.95, 1.31) 0.2 
G4 1462 1.00   
Prospective     
Composite Score* 6152    
G1 1820 0.84 (0.70, 1.01) 0.07 
G2 1374 0.93 (0.77, 1.12) 0.4 
G3 1481 1.05 (0.88, 1.26) 0.6 




Table 5.10: Sensitivity Analysis III showing association between physical inactivity using groups of 
approximate quartiles 
Inactive*  Model 3 Model 4 
  OR (95% CI) P-Value OR (95% CI) P-Value 
Leisure Activity Only        
(ALL- men and women combined)       
Cross-sectional (N=6002)       
G1 (N=1758) 1.15 (0.98, 1.36) 0.09 1.08 (0.82, 1.41) 0.6 
G2 (N=1349) 1.07 (0.91, 1.26) 0.4 1.18 (0.91, 1.52) 0.2 
G3 (N=1442)) 1.06 (0.90, 1.23) 0.5 1.02 (0.79, 1.31) 0.9 
G4 (N=1453) 1.00   1.00   
Prospective (N=6057)       
G1 (N=1776) 1.07 (0.91, 1.27) 0.5 1.28 (1.04, 1.58) 0.02 
G2 (N=1363) 1.02 (0.87, 1.20) 0.8 1.10 (0.89, 1.36) 0.4 
G3 (N=1456) 1.09 (0.93, 1.27) 0.3 1.10 (0.89, 1.34) 0.4 
G4 (N=1462) 1.00   1.00   
Work Activity Only       
Cross-sectional (N=2756)       
G1 (N=590) 0.49 (0.38, 0.63) <0.001 0.45 (0.33, 0.63) <0.001 
G2 (N=588) 0.70 (0.55, 0.88) 0.002 0.71 (0.54, 0.94) 0.02 
G3 (N=716) 0.91 (0.74, 1.12) 0.4 0.86 (0.67, 1.09) 0.2 
G4 (N=862) 1.00   1.00   
Prospective (N=5020)       
G1 (N=1338) 0.57 (0.47, 0.69) <0.001 0.59 (0.47, 0.74) <0.001 
G2 (N=1091) 0.74 (0.62, 0.89) 0.001 0.74 (0.60, 0.91) 0.01 
G3 (N=1271) 0.94 (0.80, 1.11) 0.5 0.94 (0.77, 1.13) 0.5 







This analysis of cognition in a mid-life population derived cohort reveals a differential in association 
between cognition and inactivity during work and leisure.  Work related physical activity does not 
protect against poor cognitive performance. Those reporting an inactive occupation had a lower future 
risk of poor cognition and were more likely to have higher performance in cognitive tests in later life, 
a finding most obvious in men.  
One limitation of this study is of healthy volunteer bias and lower representation of the poor cognition 
group. Nevertheless, EPIC-Norfolk still includes a wide range of individuals in terms of social class, 
education, age and cognitive ability and both men and women as in the general population. [213] 
Another limitation is the inability to control for other early life indicators such as prior intelligence, 
early childhood factors, family social economic status and parental education, which are known 
determinants of cognitive function, [214] but were not available in this cohort.  
The use of a self-report measure of physical activity may be criticised as prone to recall biases, and not 
accurate as an objective measure. This index was derived based on self-reported classification of the 
level of certain leisure activities and the type of work participants typically did. We did not quantify 
the level of inactivity.  However this index has been validated and shown to predict cardiovascular 
disease and mortality.[215]  Its greatest advantage is its simplicity and usability in different settings.  
Finally, due to the nature of design of the study as an observational study, adjusting for the unequal 
distribution of the potential confounders is always limited and there may be residual confounding. 
The principal strength of this study is the in-depth exploration of particular types of physical activity 
and the relationship with cognitive function.  Differential associations between work and leisure time 
inactivity were observed. Varying distribution of these activities in populations, or as in this study, at 
different time points, may influence associations observed. This has not been explored previously. We 
also report differences across socio-demographic factors. Other cohorts have been limited in their 
breadth of sociodemographic factors, with either insufficient [206] or over-representation of more 
educated, ‘white collar’ or affluent individuals. [113,216] 
Physical inactivity during leisure time was more strongly associated with poor performance for men in 
the cross-sectional analysis and the inverse relationship between inactivity during work was stronger 
in women. However, in terms of high performance, occupational inactivity was stronger for men only. 
The reasons for this may well reflect the use of partner’s occupation for classifying women’s social 




physical activity patterns as her partner, although, this could be further evidence of confounding by 
social class.  
Unlike others studies, we observed little evidence of reverse causation. [113,205,206,208] The 
differential relationship between inactivity and cognitive function was only revealed by stratifying the 
components of the physical activity index into work and leisure time activity, something not done 
previously. Studies reporting reverse causation as a potential bias, have used moderate and severe 
cognitive impairment including dementia [113,205,206,208] as the outcome measure, with less 
interest in the milder cognitive dysfunction.  Cognitive impairment and dementia have a long 
prodromal period resulting in individuals having reduced physical activity, and more likely to be lost to 
follow up. 
These results are consistent with other studies, showing a positive relationship with poor cognition 
and leisure time inactivity [208,217,218] and work-related activity, [206] with increasing physical work 
of manual workers having a greater risk of poor performance.  We also found a physically inactive job 
(typically a desk job) reduces the risk of poor cognition irrespective of education. This may be because 
a desk job is likely to be more cognitively demanding than a manual occupation and strengthens the 
findings of confounding by education, occupation and social class. The observations for leisure activity 
also provide further evidence of confounding by differential leisure time pursuits according to 
education and social class.  
A number of issues have been addressed in response to reports calling for stronger evidence on 
physical activity for preventing cognitive decline, impairment and dementia. [11,219] Despite adjusting 
for a range of co-factors including education, social class and health, other studies have not been able 
to adequately address the issue of residual confounding. We conclude that the relationship between 
inactivity and cognition is complex and risk factors are not independent of each other. Though 
promoting physical activity can do no harm, policy makers must be transparent about the evidence 
and the limitations of confounding before embarking on any health promotion strategies so not to lose 
public support by giving mixed messages.  
Further studies are needed, in particular, on inequalities across socio-economic groups and the impact 
of lower education, poor quality work (shortage of beneficial physical and mental stimulation), 
particularly for manual labour, and the lack of opportunity and space to be physically active for leisure.  
All these are key drivers that provide fewer opportunities to build cognitive reserve to protect for 




discriminate between work and leisure, and be more specific on the nature of inactivity with good 
representation across socio-economic groups. 
 
 
Summary of Chapter 
 
 For most tests, there was little or no relationship between total (habitual) inactivity and 
cognition. 
 
 Leisure inactivity seemed to increase risk of poor performance, cross-sectionally (OR=1.27 
(95% CI 1.00, 1.61 P=0.05), but no association observed prospectively. 
 
 In contrast to leisure time, inactivity during work was associated with lower risk of poor 
performance (observed in both cross-sectional and prospective analyses). 
 
 Those with no qualifications were less likely to be inactive at work and more likely to be 
inactive at leisure. 
 
 Increased work related physical activity (as reported at baseline), was associated with 
increased risk of poor performance with manual workers having a greater risk of poor 
performance than those with physically inactive occupations; OR=2.70 (95%CI 1.76, 4.16 
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Despite several studies demonstrating an independent and inverse association between cognition and 
mortality, the nature of this association still remains unclear. In this chapter, associations of cognition 
and mortality were examined after accounting for sociodemographic, health and lifestyle factors, again 
exploring both the test and population characteristics that may influence this relationship. 
Participants with cognition data from 3HC were followed up until 2016 for mortality. The relationship 
between individual cognitive tests and the global cognition composite score (EPIC-COGComp) and 
mortality was examined as was whether the ability in predicting mortality differed by population 
characteristics. Risk of death was estimated using Cox proportional hazard regression models including 
sociodemographic, lifestyle and health variables, and self-reported comorbidities, as covariates in the 
models.  
Poor cognitive performance (bottom quartile of combined cognition score) was associated with higher 
risk of mortality, Hazard Ratio= 1.32 (95% Confidence Interval 1.09, 1.60); individual cognitive tests 
varied in their mortality associations and also performed differently in middle-age and older age 
groups. Poor cognitive performance is independently associated with higher mortality. This association 
is observed for global cognition and for specific cognitive abilities.  Associations varied depending on 
the cognitive test (and domain) as well as population characteristics, namely age and education.  
6.2 Introduction 
Studies have shown increased risk of mortality with dementia [134,220,221] and cognitive impairment. 
[39,119,120] However, in an ageing population, understanding the nature of this relationship across 
the continuum may provide insight into the different trajectories of decline. Poor cognitive function or 
mild impairment has also been shown to be independently associated with subsequent mortality, 
[121,130,181,222] both when measured globally and by specific cognitive domain. [121,131,223] It is 
important to investigate whether less severe cognitive dysfunction or poor cognition has a higher 
mortality risk, not only because it precedes cognitive impairment and dementia, [33–35] but also 
because it is likely to affect more individuals than those with impaired cognition and dementia as 
defined using accepted criteria. Studies examining association of milder cognitive difficulties with 
impending death have shown to be inconsistent. [39,119,224] 
Associations between cognition and mortality have been reported in late, [132,225] and at mid-life. 
Cross study comparisons are difficult due to differences in methodologies used. These include: 
inconsistencies in accounting for covariates that are associated with both cognitive function and 




individuals, [228–231] or clinical patients, [123] both of which are more likely to have co-existing 
morbidities. This has resulted in studies reporting different associations with mortality. 
[131,133,223,232] The earlier hypotheses of terminal cognitive effects being greater in middle age and 
younger old and diminishing in later life have been refuted [130] and shown to continue to exist into 
oldest age, studies examining these age related differences in community dwelling older individuals 
have been limited. 
The main aim of this chapter was to investigate how specific cognitive abilities differ in predicting 
mortality comparing this to a global cognition score after controlling for a range of known 
sociodemographic, health and lifestyle factors. We also examine the influence of the characteristics of 
the population tested on this relationship, namely age and education. 
6.3 Methods 
6.3.1 Participants and measurements  
An overview of the EPIC-Norfolk 3HC methods have been described in Chapter 2.  Specific methods for 
the work presented in this chapter are given here.   
6.3.2 Assessment of cognition 
For this analysis, the EPIC-Norfolk cognition battery, as described in Chapter 2. Again, as in Chapter 5, 
both the available outcome measures VST-simple and VST-complex were included in the analyses as 
separate measures.   
6.3.3 Covariates 
Covariates from both baseline and at time of cognitive testing were used. Weight from the 3HC was 
measured to the nearest 0.1kg (using digital scales, Tanita) and height was measured with a 
stadiometer (Chasmores, UK) to the nearest 0.1 cm to calculate body mass index (BMI: weight (in 
kilograms) divided by height (in meters squared)).  Education (the highest level attained) and social 
class were obtained from the baseline questionnaire. Education was categorised into three groups (i) 
No qualification (not completing school up to the age of 16), (ii) Completion of school up to the age of 
16 or up to the age of 18 and finally (iii) those obtaining an education to graduate level (those who 
obtained a degree or equivalent) or above.  Social class was dichotomised, into ‘non manual’ and 
‘manual’ class.  Self-report of smoking status (current, former or never smoker) and alcohol intake 




clinic appointment. Alcohol units were categorised into three groups: 0 Units, 1-14 Units and more 
than 14 Units. 
Physical activity index from the time of cognitive testing (at the 3HC) was used here as described in 
Chapter 2 and Appendices 2 and 3.  Age (at 3HC) was categorized into 5-year age bands. History of 
heart-attack, stroke, cancer, diabetes and depression were established using self-report of a range of 
conditions from health and life style follow up questionnaire from the nearest point of the 3HC. 
6.3.4 Mortality 
Participants were followed up from the date of the cognitive examination until the date of their death 
or end of 31 March 2016, an average of 7.1 years.  The cohort is linked to the NHS Central Register 
(NHS Digital) for health and the Office of National Statistics (UK) for death certification.  
6.3.5 Missing cognition data 
A number of sensitivity analyses were conducted to explore the effect of missing data. Hazard ratios 
were examined by assigning participants with missing data to either the poor performance or to the 
reference category. Hazard ratios also examined for individuals with data on all eight cognitive 
measures and the specified covariates (n = 5971) and compared to those with complete missing data 
of any of the eight cognitive measures as well as those not attending the health examination.   
6.4 Analysis 
Previously, poor performance was defined as obtaining a score less than a cut-off point corresponding 
to approximately the 10th percentile of the population distribution in each of the eight cognitive 
measures individually. Here, in order to have sufficient power for the analyses, the 25th percentile of 
the population distribution was used. Participants were classified into two groups based on the cut-off 
scores for each of the tests. For prospective memory, as with previous analyses, poor performance 
was defined as those failing the task.   
The composite score was created as detailed Appendix 5. For this chapter, EPIC-the composite score 
was created from the individual cognitive test and participants classified in two groups for the 
continuous composite score in the same way as the scores were for the individual test, based on groups 
of approximate quartiles.  Briefly, for each of the individual cognition tests, a score of ‘0’ or ‘1’ was 
assigned based on whether the individual was in the ‘poor performance’ or ‘good performance or 
reference’ group for each of the eight cognitive outcome measures individually. The composite score 




outcomes (range= 0-8). The approximate bottom quartile for the composite score, was used to define 
poor performance for ‘g’. 
Preliminary examination across groups of approximate quartiles (due to the non- parametric 
distribution) did not show a linear relationship with mortality for all the cognitive tests (Table 6.1). 
There seemed to be a more threshold response, with the lowest (approximate quartile) group having 
greater mortality than the other groups.    
The risk of death was estimated as a hazard ratio with 95 percent confidence interval (95%CI) for each 
of the cognitive tests in separate Cox proportional hazard regression models. The independent 
association of poor performance with mortality was assessed by first adjusting for age (per 5 years, 
treated as a continuous variable) and sex (models 1), then including education and social class (models 
2) and finally extending the models to include other health variables (smoking, BMI, physical activity) 
and comorbidities (models 3).  
Education, social class, physical activity and smoking were all treated as categorical variables in the 
analysis, as was co-morbidity (as present or not).  Low and high BMI have stronger association with 
mortality than the intermediate groups (Table 6.2), however initial exploratory analyses showed little 
difference in hazard ratio when BMI was entered as a categorical (as low, normal, overweight and 
obese groups) or as a continuous variable. Therefore, BMI was entered in the model as a continuous 
variable to improve sensitivity of the analysis. The cognitive score was entered as a dichotomised 
variable based on the description above (poor performance or not). Including alcohol did not change 
the associations observed and so to reduce degrees of freedom and to increase stability of the models, 





Table 6.1: Age and sex adjusted association with mortality across performance group (approximate 
quartile) for each cognitive test for participants taking part in EPIC-Norfolk, 2006-2011 (including Data 
from the Pilot Phase 2004–2006). 
 
  Deaths in each 
group 
Age and sex adjusted model 
 
Range of 
score or time 
Ɨ Freq, % (N) HR  (95% CI) P-Value 
SF-EMSE 
     
G1 (N=2305) 0-31 14.6 (337) 1.23 (0.92, 1.66) 0.2 
G2 (N= 2276) 32-33 9.6 (219) 1.03 (0.76, 1.39) 0.9 
G3 (N=2898) 34-35 7.6 (219) 1.02 (0.75, 1.37) 0.9 




   
HVLT 
     
G1 (N=2037) 0-22 15.1 (308) 1.22 (0.97, 1.53) 0.09 
G2 (N=2514) 23-26 9.7 (243) 1.11 (0.88, 1.39) 0.4 
G3 (N=1640) 27-29 6.0 (99) 0.80 (0.61, 1.05) 0.1 




   
FTMS 
     
G1 (N=2074) 0-13 14.3 (296) 1.08 (0.84, 1.41) 0.5 
G2 (N=2093) 14-16 9.2 (192) 0.94 (0.71, 1.22) 0.6 
G3 (N=2012) 17-18 7.4 (148) 0.90 (0.68, 1.19) 0.5 




   
PW-Accuracy 
     
G1 (N=2337) -31, 9 15.0 (351) 1.57 (1.24, 1.97) <0.001 
G2 (N=1872) 10-12 9.9 (185) 1.28 (1.00, 1.63) 0.05 
G3 (N=2144) 13-16 8.0 (172) 1.22 (0.95, 1.57) 0.1 










Table 6.1: Continued 
   Age and sex adjusted model 
 Range of score/time Ɨ Deaths in each 
group, % (N) 
HR  (95% CI) P-Value 
      
VST_Simple ( ms) 
     
G1 (N=1788) 694.11-4078.32  12.4 (222) 1.30 (1.03, 1.63) 0.03 
G2 (N=1786) 623.79-694.00  9.5 (169) 1.11 (0.87, 1.40) 0.4 
G3 (N=1783) 579.15-623.75  7.3 (131) 0.99 (0.77, 1.27) 0.9 




   
VST_Complex (ms) 
     
G1 (N=1786) 2387.29-11 825.88 13.8 (247) 1.30 (1.04, 1.63) 0.02 
G2 (N=1786) 2157.80-2387.16 8.3 (149) 1.06 (0.83, 1.35) 0.6 
G3 (N=1786) 1955.37-2157.64 7.1 (126) 0.99 (0.77, 1.28) 0.9 




   
Short-NART 
     
G1 (N=1835) 25-50 9.6 (176) 0.91 (0.74, 1.12) 0.4 
G2 (N=2219) 16-24 9.2 (205) 0.91 (0.75, 1.11) 0.3 
G3 (N=2005) 10-15 8.8 (177) 0.91 (0.74, 1.11) 0.3 
G4 (N=2053)* 0-9 9.3 (191) 1.00 
  
  p=0.8    
ƗP values by T test or Chi sq for proportion 
G1-G4 are approximate quartile, with G1 being the lowest approximate quartile and G4, the highest. *Reference group (G4) 
Abbreviations: CI, Confidence interval HVLT, Hopkins Verbal Learning Test, ms, milliseconds; : N, Number; PAL-FTMS, Paired 
Associated Learning, First Trial Memory Score; ; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy, SD, Standard 
deviation; SF-EMSE, Short Form Extended Mental State Exam; Sh-NART, Short National Adult Reading Test; VST, Visual 





Table 6.2: Distribution of deaths by body mass index (BMI) category 
 
In addition, the interaction terms 1/ age group (≤ 65 and those >65 years x each cognition test as the 
dichotomized variable) and 2/ education group (Qualifications and No Qualifications x each cognition 
test as the dichotomized variable) were included to examine if age or education group contributed to 
performance for each test. Due to the strong influence of age and education on both cognition and 
mortality, the data were also stratified into age and education groups and adjusted hazard ratios 
calculated in each group.  Stratification not only allows the examination of possible interaction, but 
examining the consistency of association in the different groups, permits the exploration of further 
potential confounding.  
Spearman’s rank correlation coefficients were calculated using the continuous score for each of the 
individual tests, to examine the strength of relationship between each of the tests (as shown previously 
in Chapter 3).  The final analysis (model 4) mutually adjusted for all eight cognitive measures (entered 
as dichotomised variables as described above).  Statistical analysis was performed using SPSS version 
23.0 (IBM Corp., Armonk, NY, USA), with the level of significance set at 0.05. 
6.5 Results 
After a maximum of 11.5 years of follow up (with an average of 7.1 years), there were 861 deaths in 
the 8623 participants taking part in EPIC-Norfolk 3HC.  There were 849 deaths observed in the 8585 
participants who had a cognitive tests measure (9.9% of the EPIC-Norfolk 3HC cohort). Figure 6.1 
summarises participation level at each phase and the selection of the analytical sample for this study. 
Table 6.3 shows the means and proportions of the variables included in this analysis by survival status. 
There were significant differences between the two groups for almost all the variables examined. 
Those who died, were older, more likely to be men, have no qualifications, be physically inactive, to 
  
Deaths Age and Sex adjusted  
 
Freq Freq, % (N) HR  (95% CI) P-Value 
>20-25 kg/m2 (Normal) 2854 8.8 (250) 1.00 
  
<=20 kg/m2 (Low) 216 15.7 (34) 2.17 (1.51, 3.11) <0.001 
>25-30 kg/m2 (Overweight) 3890 9.7 (379) 0.94 (0.80, 1.10) 0.4 
>30 kg/m2 (Obese) 1643 11.4 (187) 1.32 (1.09, 1.59) 0.004 
  
*P=0.001 




be non-drinkers, less likely to have been never smokers, and a higher proportion reported prevalent 
disease. Of the 8585 participants with cognitive data, 6128 participants had data for all the cognitive 
tests with 2457 having some of the test measures and 38 participants having none. These 38 
participants were not included in the main analysis. 
Compared to those with incomplete or no data, those having attempted all the tests were younger, 
had higher average scores for all the tests, reported less co-morbidity, were less likely to be physically 
inactive, have no qualifications and be non-drinkers (Table 6.4). The age and sex adjusted hazard ratios 
for mortality for those who attended the health check and those who were invited but did not attend 
were examined. Using the group who had attended 3HC and had data on all 8 tests as reference, the 
mortality risk were as follows: with data on 1-7 tests, HR=1.23 (95%CI 1.07, 1.41 P= 0.004); attended 
3HC, but with no cog data HR=1.71 (95%CI 0.96, 3.03 P= 0.07) and for those who were invited but did 
not attend 3HC, HR=2.33 (95%CI 2.11, 2.56 P= <0.001).  
Table 6.5 shows the results of the Cox proportional hazards analyses for all the tests separately and 
for the composite score. For the age and sex adjusted models, there was an increased risk of mortality 
in those obtaining a poor performance score as compared to those who did not for each of the 
cognitive tests apart from the Short-NART. Additional adjustment for education and social class made 
little difference to the hazard ratios, as did the additional adjustment for co-variates (smoking, body 
mass index, physical activity) and comorbidities (models 3). Although the magnitude of the association 
varied slightly across the different tests, the PW-Accuracy test showed the strongest association, and 





Figure 6.1 Selection of participants from EPIC-Norfolk 3HC (including the pilot phase) for all-cause 
mortality, followed up until March 2016. 
 
 Source: Hayat et al., EJE, 2018 [233] 
 
In the sensitivity analysis, imputing missing into the poor performance made little difference to the 
hazard ratios (with slightly strengthening associations for some), but attenuating considerably for most 
of the tests including the composite score when ‘missings’ were assigned to the reference category 
(Table 6.6).  Thus indicating that the ‘missings’ were likely to be in the poor performance group.  
Further sensitivity analyses, to compare those with measures on all eight tests, with those with seven 
tests or less, showed associations that were similar to those seen in the whole cohort analysis. 
Associations were statistically significant and stronger for participants with data on all eight tests, and 
considerably attenuated for those with data on seven tests or less. In the latter group, associations 
were observed for PW-Accuracy, VST complex and prospective memory, although not to significance.  




No significant interaction was observed with age group (≤65 vs >65 years) and any of the cognitive test 
(data not shown) and for education, only significant for HVLT (P=0.03) but none of the other tests. On 
stratification, there seem to be some age group differences, with significant and stronger associations 
observed for the composite score, HVLT, PW-Accuracy and VST-Complex (Table 6.8) in the middle-age 
group. Weaker and mostly significant associations observed for composite and for all the other tests, 
except short-NART in the older age group. Stratifying by education group, associations with mortality 
were observed in the ‘no qualifications’ sub group for all tests apart from HVLT and weak but not 
significant for NART.  Only weak (or no) association were observed in the ‘with qualifications’ sub group 
for all tests with strongest association observed for HVLT, PW-Accuracy and the composite score. 






Table 6.3: Characteristics by survival status of 8585 participants with cognitive measures in the Third 
Health Check Phase of the European Prospective Investigation of Cancer in Norfolk (EPIC-Norfolk 3HC) 
Study, 2006-2011 (including pilot data, 2004–2006). Participants followed up until 31 March 2016. 
 
P values by T test or Chi square for proportion 
Abbreviations: HVLT, Hopkins Verbal Learning Test, ms, milliseconds; : N, Number; PAL-FTMS, Paired Associated Learning, 
First Trial Memory Score; PW-Acc, PW-Accuracy, SD, Standard deviation; SF-EMSE, Short Form Extended Mental State 
Exam; Short-NART, Short National Adult Reading Test; VST, Visual Sensitivity Test. 
* Reference categories: With Qualifications; Non-manual and Active (respectively). 
  
 Dead Alive  






Age  75.6 (7.7) 67.9  (7.7) <0.001 
Body Mass Index (Kgs/M2) 27.1  (4.6) 26.8  (4.3) 0.8 





SF-EMSE 31.4  (4.1) 32.7  (3.0) <0.001 
HVLT  22.6  (6.3) 25.3  (5.5) <0.001 
PAL- FTMS  14.0  (4.8) 15.8  (4.2) <0.001 
PW-Accuracy  10.1  (6.4) 12.7  (6.0) <0.001 
VST-simple (Reaction Time, ms) 711.01  (211.3) 659.4  (160.7) <0.001 
VST-Complex (Reaction Time, ms) 2320.9  (520.9) 2184.3  (417.03) <0.001 
Short-NART  17.4  (10.2) 17.2  (9.8) 0.5 
Prospective Memory % failed (n) 30.3 (246) 17.5  (1330) <0.001 





Heart attack 9.9 (84) 2.7  (207) <0.001 
Stroke  5.7  (48) 1.7  (134) <0.001 
Cancer  15.8  (134) 8.7  (670) <0.001 
Diabetes  5.7  (48) 2.7  (212) <0.001 
Depression  11.5  (98) 8.3  (642) 0.001 
Sex, % men (n) 57.4  (487) 43.4  (3354) <0.001 
*Education, % No qualifications (n) 33.5 (284) 25. 4  (1967) <0.001 
*Social Class, % Manual (n) 31.0  (261) 34.4  (2634) 0.05 
*Physical Activity, %   Inactive (n) 56.8  (471) 35.1  (2678) <0.001 





Current 5.5  (36) 4.3 (334) 
<0.001 Former 56.0  (366) 45.1  (3527) 
Never 38.4  (251) 50.6  (3952) 





0 Units 34.1  (275) 29.3  (2187) 
0.01 1-14 Units/week 53.8  (343) 59.3  (4419) 




Table 6.4: Comparison of Characteristics of 6128 participants of the European Prospective 
Investigation of Cancer in Norfolk (EPIC-Norfolk) Study with all 8 cognitive measures and those with 
incomplete or no data. 
 All 8 tests (N=6128) 1-7 Tests (N=2457) 
No Cog Data 
(N=38) 
P-Value 
Mean (SD)        
Age  68.0  (7.7) 70.4  (8.6) 73.9  (9.4) <0.001 
Body Mass Index 
(Kgs/M2) 
26.8  (4.3) 26.9  (4.4) 27.4  (4.7) 0.5 
Cognitive Test  
Score 
       
SF-EMSE 32.9  (2.7) 32.0  (4.0) -  <0.001 
HVLT  25.3  (5.5) 24.4  (6.1) -  <0.001 
PAL- FTMS  15.8  (4.2) 14.9  (4.7) -  <0.001 
PW-Accuracy  12.6  (6.1) 11.9  (6.1) -  <0.001 
VST-Simple 660 .6  (147.6) 684.0  (251.4) -  <0.001 
VST-Complex 2186.8  (394.6) 2255.0  (592.7) -  <0.001 
Short-NART 17.2  (9.8) 17.4  (10.1) -  0.4 
Pros. Mem % 
failed (n) 
18.2  (1117) 20.2  (459) -  0.04 
Percent % (N)        
Sex, men  44.8  (2747) 44.5  (1094) 52.6  (20) 0.6 
*Education,            
No qualifications  
24.6 (1510) 30.2  (741) 47.4  (18) <0.001 
*Social Class,  
Manual 

















Co-morbidity        
Heart attack 3.0 (186) 4.3 (105) 5.3 (2) 0.01 
Stroke 1.8 (113) 2.8 (69) 7.9 (3) 0.001 
Cancer 9.1 (559) 10.0  (245) 10.5 (4) 0.5 
Diabetes  2.9  (179) 3.3  (81) 5.3  (2) 0.5 
Depression  21.8  (1336) 21.5  (528) 31.6  (12) 0.3 
Mortality, Dead   6.7  (410) 10.6  (261) 31.6  (12) <0.001 
Smoking, Current 4.4  (263) 4.4  (107) 5.7  (2) 0.9 
Alcohol Intake 
Units/week 
       
0  28.1  (1657) 34.0  (805) 36.4  (12) 
<0.001 1-14  60.5  (3566) 54.6  (1291) 57.6  (19) 
>14  11.4  (674) 11.4  (269) 6.1  (2) 
Hazard ratios (Age and Sex adjusted) 
8 Tests 1-7 Tests 0 Tests Non-Attenders 
HR   HR 95% CI HR 95% CI HR 95% CI 
1.00 (Ref) 1.23 (1.07. 1.41) 1.71 (0.96, 3.03) 2.33 (2.11, 2.56) 
  p= 0.004 p=0.07 p=<0.001 
P values by Anova, T test or Chi sq for proportion Reference categories: Any qualifications, Non-manual and Active 
Abbreviations: HVLT, Hopkins Verbal Learning Test, ms, milliseconds; : N, Number; PAL-FTMS, Paired Associated Learning, 
First Trial Memory Score; Pros. Mem, Prospective memory task; PW-Acc, PW-Accuracy, SD, Standard deviation;  SF-EMSE, 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   






























































































































































































































































































































































































































































































































































































































































































































































































































































































Table 6.7: Hazard ratios (95% CI), adjusted for age, sex, education and social class, smoking, body mass 
index (BMI), physical activity and prevalent disease by individual cognitive tests, for participants with 
all 8 cognitive measures and those with incomplete data (on 1-7 tests). 
  
Data with all 8 tests (n=5971) Data on 1-7 tests (N=Varies according to test)* 
  HR (95% CI) P-Value HR (95% CI) P-Value 
SF-EMSE       
Good 1.00      
Poor 1.31 (1.08, 1.58) 0.01 0.98 (0.76, 1.24) 0.8 
HVLT       
Good 1.00      
Poor 1.23 (1.02, 1.50) 0.04 1.06 (0.79, 1.41) 0.7 
PAL FTMS       
Good 1.00      
Poor 1.24 (1.03, 1.49) 0.02 1.01 (0.73, 1.35) 0.9 
PW-Acc       
Good 1.00      
Poor 1.37 (1.14, 1.65) 0.001 1.26 (098, 1.62) 0.07 
VST-Simple       
Good 1.00      
Poor 1.31 (1.08, 1.58) 0.01 0.85 (0.56, 1.29) 0.4 
VST-Complex       
Good 1.00      
Poor 1.29 (1.07, 1.56) 0.01 1.14 (0.76, 1.70) 0.5 
Short-NART        
Good 1.00      
Poor 1.01 (0.81, 1.26) 0.9 0.92 (0.63, 1.34) 0.7 
Pros. Mem      
Good 1.00      
Poor 1.31 (1.07, 1.59) 0.01 1.23 (0.94, 1.61) 0.1 
*N Varies according to test 
SF-EMSE N= 2302 





Pros. Mem= 2228 
Abbreviations: HVLT, Hopkins Verbal Learning Test, ms, milliseconds; : N, Number; PAL-FTMS, Paired Associated Learning, 
First Trial Memory Score; PW-Acc, PW-Accuracy, Pros. Mem; Prospective memory task; SD, Standard deviation; SF-EMSE, 





The data were also tested for reverse causality, which is to examine whether the associations observed 
were as a result of those with disease pathology (and being closer to death) also having lower 
cognition.  The analyses (model 3) were repeated for each of the tests individually and the composite 
score by excluding individuals who died within three years of follow-up after cognitive testing (N=229). 
At population level, the results of the reduced sample did not show evidence of reverse causality with 
hazard ratios barely changing. 
Exclusions of deaths within three years of the cognitive test and then stratifying the data by age group 
showed a different result from the original stratified analyses. The hazard ratios in the older-age group 
showed little change (Table 6.10).  However the same was not observed for the middle-age group with 
variations in their prediction of mortality across the different tests. The association for most of the 
tests were attenuated (and due to small number, were no longer significant). The greatest (and 
significant) increase in association for the middle-age group was observed for HVLT HR= 2.19 (95% CI 
1.20, 4.00). Association were also strengthened for prospective memory. The greatest differences 
observed across the two age-groups were also seen in HVLT and prospective memory (and remained, 
though to a lesser degree for composite score). The age group differences observed without exclusion 
of deaths, no longer remained for PW-Accuracy and VST-Complex. 
Correlations between the different cognitive tests were weak to modest, as discussed previously (Table 
3.5, Chapter 3) with the strongest between the HVLT (verbal episodic memory) and SF-EMSE (global 
cognition), r=0.48 and the weakest between the VST-Complex and Short-NART r= 0.06. Therefore, 
collinearity was not considered to be an issue when including all cognitive measures in the final model. 
The PW-Accuracy test remained the strongest independent predictor of mortality after mutually 





Table 6.8: Association of poor performance and mortality, stratified by age group (equal to or younger 
than 65 years and over 65 years) in the eight cognitive measures separately and the combined 
composite cognition score. 
 
Abbreviations: CI, Confidence interval; EPIC-COGComp , EPIC-Cognition composite score; HVLT, Hopkins Verbal Learning 
Test, N, Number included in the analysis; n, number of deaths, PAL-FTMS, Paired Associated Learning, First Trial Memory 
Score; ; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy, SF-EMSE, Short Form Extended Mental State Exam; Short-








Age ≤ 65 Years 
 
 
Age > 65 Years 
Test 
 
n/N HR (95% CI) 
 





SF-EMSE 95/3102 1.19 
 
(0.72, 1.97) 0.5 700/5171 1.17 (1.00, 1.37) 0.05 
         
HVLT 96/3048 1.74 
 
(1.05,2.87) 0.03 639/4896 1.15 (0.97, 1.36) 0.1 
         
PAL-FTMS 91/2843 1.15 
 
(0.68, 1.92) 0.6 594/4430 1.18 (1.00, 1.39) 0.05 
         
PW-Accuracy 95/3088 1.60 
 
(1.01, 2.54) 0.04 683/5117 1.29 (1.10, 1.50) 0.001 
         
VST-Simple 83/2683 1.11 
 
(0.64, 1.92) 0.7 530/4280 1.25 (1.05, 1.50) 0.01 
         
VST-Complex 83/2683 1.68 
 
(1.02, 2.75) 0.04 530/4280 1.23 (1.03, 1.47) 0.02 
         
Short- NART  90/3005 0.80 
 
(0.46, 1.39) 0.4 628/4902 0.99 (0.81, 1.22) 0.9 
         
Pros. Mem 95/3086 1.27 (0.70, 2.30) 0.4 689/5113 1.26 (1.07, 1.49) 0.01 
         
EPIC-
COGComp 




Table 6.9: Association of poor performance and mortality, stratified by education group (With 
Qualification and No Qualifications) in the eight cognitive measures separately and the combined 





No Qualifications P-Value 
Test 
 
n/N HR (95% CI) 
  
n/N HR 95% CI 
 
SF-EMSE 526/6117 1.12 (0.92, 1.36) 0.2 269/2156 1.25 (0.97, 1.60) 0.08 
HVLT 487/5896 1.33 (1.09, 1.62) 0.01 248/2048 0.99 (0.76, 1.28) 0.9 
       
PAL-FTMS 450/5422 1.06 (0.87, 1.30) 0.6 235/1851 1.43 (1.10, 1.86) 0.01 
PW-Accuracy 517/6079 1.31 (1.09, 1.57) 0.004 261/2126 1.41 (1.09, 1.81) 0.01 
VST-Simple 411/5205 1.15 (0.93, 1.43) 0.2 202/1758 1.37 (1.03, 1.83) 0.03 
VST-Complex 411/5205 1.12 (0.91, 1.39) 0.3 202/1758 1.61 (1.20, 2.15) 0.001 
Short- NART  480/5879 0.84 (0.63, 1.11) 0.2 238/2028 1.14 (0.87, 1.49) 0.3 
Prosp. Mem 521/6078 1.19 (0.97, 1.46) 0.1 263/2121 1.41 (1.09, 1.83) 0.01 
EPIC-COG 
Comp 
342/4508 1.27 (1.00, 1.60) 0.05 162/1463 1.46 (1.03, 2.07) 0.04 
 
Abbreviations: CI, Confidence interval; EPIC-COG Comp, EPIC-Cognition Composite score; HVLT, Hopkins Verbal Learning 
Test, N, Number included in the analysis; n, number of deaths, PAL-FTMS, Paired Associated Learning, First Trial Memory 
Score; ; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy, SF-EMSE, Short Form Extended Mental State Exam; Short-






Table 6.10: Association between poor performance and mortality for eight cognitive measures 
separately (Model 3) stratified by age group (≤65 vs > 65 years) after excluding 229 individuals who 
died within 3 years of cognitive testing. 
 
Age <=65 Years Age > 65 Years 
Test n/N HR (95% CI) P-Value n/N HR (95% CI) P-Value 
SF-EMSE 65/30722 0.89 
 
(0.47, 1.71) 0.5 521/4992 1.15 (0.96, 1.38) 0.1 
         
HVLT 65/3017 2.19 
 
(1.20, 4.00) 0.01 481/4992 1.22 (1.01, 1.48) 0.04 
         
PAL-FTMS 62/2814 1.05  
 
(0. 55, 2.01) 0.9 455/4291 1.27 (1.05, 1.53) 0.02 
         
PW-Accuracy 65/3058 1.29 
 
(0.72, 2.32) 0.4 509/ 4943 1.27 (1.06, 1.52) 0.01 
         
VST-Simple 52/2652 0.92 
 
(0.44, 1.91) 0.7 398/4148 1.30 (1.06, 1.60) 0.01 
         
VST-Complex 52/2652 1.30 
 
(0.66, 2.56) 0.5 398/4148 1.30 (1.06, 1.59) 0.01 
         
Short- NART  59/2974 0.87 
 
(0.45, 1.71) 0.7 465/4739 0.87 (0. 68, 1.11) 0.3 
         
Pros. Mem 65/3056 1.63 (0.84, 3.2) 0.2 512/4936 1.29 (1.07, 1.57) 0.01 
         
EPIC-COG Comp 46/2355 1.55 (0.76, 3.15) 0.2 331/3490 1.34 (1.07, 1.69) 0.02 
 
Abbreviations: CI, Confidence interval; EPIC-COG Comp, Composite score; HVLT, Hopkins Verbal Learning Test, N, Number 
included in the analysis; n, number of deaths, PAL-FTMS, Paired Associated Learning, First Trial Memory Score; ; Pros. Mem, 
Prospective memory; PW-Acc, PW-Accuracy, SF-EMSE, Short Form Extended Mental State Exam; Short-NART, Short 







Table 6.11: Poor performance as a predictor of mortality using the eight cognitive measures separately 
as measured in the EPIC-Norfolk 3HC after adjusting for all co-variates and mutually adjusting for all 
other cognitive measures (Model 4) 
 
N = 5971 
 (504 events) 
Test HR (95% CI) P-Value 
    
SF-EMSE 1.17 (0.95, 1.43) 0.1 
HVLT 1.07 (0.87, 1.32) 0.5 
PAL- FTMS 1.11 (0.91, 1.34) 0.3 
PW-Accuracy 1.27 (1.05, 1.54) 0.02 
VST-Simple 1.18 (0.97, 1.43) 0.1 
VST-Complex 1.19 (0.98, 1.44) 0.08 
Short-NART  0.90 (0.72, 1.13) 0.4 
Pros.  Mem. 1.18 (0.96, 1.45) 0.1 
    
    
Abbreviations: CI, Confidence interval; HVLT, Hopkins Verbal Learning Test, N, Number included in the analysis; n, number 
of deaths, PAL-FTMS, Paired Associated Learning, First Trial Memory Score; Pros. Mem, Prospective memory; PW-Acc, PW-
Accuracy, SF-EMSE, Short Form Extended Mental State Exam; NART, National Adult Reading Test; VST, Visual Sensitivity Test  
6.6 Discussion 
Key findings from this chapter show poor cognitive performance to be independently associated with 
higher mortality over an average of seven years of follow-up. Greater mortality was observed in the 
lowest (approximate quartile) group, showing the association to be a threshold effect similar to 
previous reports [168] rather than a gradient across the range of ability. Associations were not only 
observed for global cognitive function ( using the composite score), but also for the individual tests 
covering a number of abilities or domains [170]. These associations remained after adjusting for 
sociodemographic, a range of lifestyle and health variables, including prevalent disease. Associations 
were not observed for the Short-NART. This was expected as accumulated knowledge is known to be 
more stable than other cognitive abilities until later life. [69,71] 
This study confirms the robust relationship between cognition and mortality, [121,130–133] and that 
the ability to predict mortality not only exists for global cognition, but also across several cognitive 
domains. [121,131] This is to varying degrees, with some specific abilities to be more powerful 
predictors than others. Population characteristics, particularly age and education also influenced the 
relationship and the predictive value of each test. Cognitive impairment, even at mild levels increases 




[135] this study has shown this relationship extends beyond to include poor performance, even before 
any evidence of impairment.   
There are three possible explanations for the observed increased associations with mortality; (1)poor 
performance, which is on the trajectory of cognitive decline, is an early indicator of dementia, which 
reduces survival time (2) cognition is not related, but the association is confounded by disease 
pathology (reverse causality) which is having a negative impact on cognition and increasing mortality; 
(3) poor cognition is having an indirect impact by those with lower cognition unable to engage in 
appropriate lifestyle and health behaviours, such as healthy diet, being physically active and not 
smoking. Also having poorer health literacy which may hinder the recognition of signs and symptoms 
of disease, seek medical attention and follow prescribed medication regimes. It is unclear which of the 
three possibilities could be in operation, it could be either or all three.  
On initial analyses by age group, associations between cognitive test performance and survival were 
stronger in individuals who were in the middle-age group than those who were over 65 years.  
However, this may be an artefact of a recognised methodological issue. [130] The majority of the 
survivors in middle-age group are expected to survive many years beyond the census date, whereas 
survivors in the older age group (being chronologically closer to death, be frailer, have more co-
morbidities and disabilities) are more likely to die soon after the census date. Therefore, there are less 
differences between the cognitive scores of those who die shortly on either side of the census date in 
the older group, and the differences between deceased and survivors become more obscure.  This 
incomplete investigation of the effects of survival duration in studies is a known restriction of the 
survival analysis methods. [130]  
There was little evidence of reverse causality at population level in the EPIC-Norfolk cohort when 
excluding individuals who died within three years of the health examination. Excluding these 
individuals also removed the differences initially observed by age group, confirming that associations 
are not restricted to middle age, but continue into older age. [130] However, there was the 
strengthening of the hazard ratios for HVLT and prospective memory and mortality in the middle-age 
group, not seen in the older age group. This indicates that dysfunction of memory (both episodic and 
prospective) is far more detrimental in terms of survival in middle age than it is in later life.  These 
findings concur with those from the Whitehall Study that also showed memory to better predict risk 
of mortality in midlife. [234] 
The other observation to highlight is the variation in the VST measures across the age groups. This 




a reflection of overall frailty, slowing of simple responses and indicative of accelerated physical ageing 
in the older age group, and is not as sensitive to normal cognitive ageing and in situations of reasonable 
motor speed. The reduced differential between the age groups for PW-Accuracy and VST-Complex, 
after excluding those who died within 3 years indicate the greater significance of processing speed in 
proximity to death than to chronological age. These functions are known to be affected by physiologic 
functioning strongly predict mortality. [124] 
Investigations in mortality by cause are required to examine these results in more detail. To examine 
the question of the of different pathologies, is beyond the scope of this paper, as this requires 
information on cause specific mortalities across the different domains assessed by the EPIC-Norfolk 
Cognition Battery.  In the case of all-cause mortality, individual cognitive domains are generally 
comparable to the composite score though there are some individual variations. [226]  
With regards to education, being in the poor performance group (in general) had a greater 
disadvantage in terms of survival for the ‘no qualifications’ group than it did for the ‘with qualifications’ 
group. This was observed for the composite score and the individual tests (although not significant for 
SF-EMSE and NART). The association was not observed in the HVLT, a test of verbal episodic memory, 
that requires semantic knowledge. [151] Even though social class was adjusted for, it can be 
speculated, that education adds some advantage to survival that is beyond socio-economic status. 
These results are line with previous findings, [119] that better cognition does not give the survival 
advantage in circumstances of better socio-economic conditions as it does in lower socio-economic 
conditions. Having said that, the overall influence was seen in both education groups, providing further 
support of the independent relationship cognition and mortality.  
In the EPIC-Norfolk population with no overt symptoms of cognitive impairment, this work has shown 
that the relationship between cognition and mortality exists along the continuum to include poor 
cognitive performance and that this association is not restricted to the disease states of cognitive 
impairment and dementia. Although memory deficits are the most common precursors to dementia, 
prospective memory, processing speed and executive function have also been shown to be strong 
indicators of decline and mortality. [81,235] This study adds further evidence to the importance of 
these measures as predictors of mortality in this relatively high functioning population.  
Correlations between the cognitive tests were not high, suggesting that they measure different 
abilities. However, cognitive abilities do not work in isolation or independently of each other, with any 
given test making demands on a range of abilities. A single test cannot give a pure measure of a single 




being reported. Assessing cognition across domains provides detail to the size and nature of the 
relationship with mortality. 
A relatively large proportion of deaths in the middle age group occurred within 3 years. This may be a 
reflection of the health of the participants attending the health examination. The younger attendees 
attending the health examination, may have been available due to ill health stopping them from 
working or other activities, and older participants were the more able and fitter survivors able to 
attend the clinic. Both groups may therefore be slightly different from their peers in the general 
population. The mortality rate in the under 65 group was very small, and would need further numbers 
to see if the associations observed in this age group are robust.  
Having highlighted the limitation of the participants in EPIC-Norfolk as healthier individuals, the cohort 
still includes a wide age range from mid to later life, is representative of both men and women and 
covers a broad range of socio-economic and education levels. Conducting this study in this healthier 
population has the advantage of less confounding from co-morbidities, a limitation in other studies of 
older or from selected clinical groups.  These cognitive measures were part of a wider, comprehensive 
health examination (maximum length 3 hours). Those who were slower, less able and possibly less 
healthy individuals had less chance to complete all tests within the limited appointment time.  This is 
further strengthened as associations were observed in healthier individuals with data on all 8 
measures, but not in those completing fewer tests, also indicating that conducting this analysis in a 
less healthy cohort may not have shown similar associations. Various methods have been used to deal 
with the issue of confounding, including stratification, multi-variate adjustment and excluding people 
who died within three years of the cognitive test and found associations between cognition and 
mortality to remain. Nevertheless, residual confounding by other known and unknown risk factors may 
still be present. 
Inconsistencies across studies may also be due to the heterogeneity in methodologies, in terms of 
assessment tools and the sample population. If tests purporting to measure the same ability are 
tapping into different cognitive and sensory abilities, they cannot be measuring the exact same 
construct. Adding to this complexity is the variation in the rate of decline across the abilities, each with 
different influence on performance and subsequently on the outcome measured.  
One single test did not stand out as being the best predictor for mortality; however, we do not agree 
that individual cognitive domains are no better predictors than more general cognitive scores. [226] 
Using this argument for the sake of brevity is too simplistic. The test for general cognition (SF-EMSE), 




of all the tests of the battery, or even some of the other tests measuring fewer abilities. By combining 
all tests and presenting as a single standardised score and not considering the separate abilities (as 
some studies have done), may result in missing on vital information that may then hinder 
interpretation. 
These findings support the conclusion that cognitive function is independently associated with death. 
However, it is important to give due consideration to the characteristics of the sample population and 




Summary of Chapter 
 
 Poor cognitive performance was independently associated with higher mortality over an 
average of seven years of follow-up. 
 
 The relationship between poor cognition and mortality exists for global cognition and 
across separate abilities, with some specific abilities to be more powerful predictors than 
others. 
 
 Measuring cognitive domains separately gives more insight than a global measure. 
 
 Those with ‘no qualifications’ had a greater disadvantage in terms of survival. 
 
 Poor performance was associated with higher mortality across several domains and 
independently of common chronic diseases.  These associations varied not only in 
magnitude across domains but also differed between older and middle-aged 
participants. 
 
 Different cognitive tests tap into a range cognitive and sensory abilities to perform a 
given task. Therefore, psychometric properties of tests should be given due 
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The use of health records as a measure of dementia outcomes in medical research and for policy 
tracking has become an increasingly important resource for dementia ascertainment. Here we 
examine the variability in recording of dementia outcomes in different service settings. This chapter 
presents findings from EPIC-Norfolk linkage to medical records. Dementia diagnosis was ascertained 
from secondary care National Health Service (NHS) data sources.  Primary care records for a sub-set of 
the cohort were also reviewed. Characteristics of individuals with a dementia diagnoses from the 
different data sources were examined. Risk of receiving a dementia diagnosis were estimated using 
Cox proportional hazard models adjusting for socio-demographic variables. There were 2699 
participants receiving a dementia diagnosis in one or more of the data sources examined. There was 
limited concordance across the NHS-Digital data sources. Discrepancies were also observed with 
primary care records for a sub-set of the cohort and report on potential linkage-related selection bias.  
Using record linkage from diverse settings reveals differences in dementia diagnosis, suggesting that 
different people are identified via varying routes within the NHS. This Chapter presents potential 
linkage related selection biases in primary and secondary care data sources.  With the expansion of 
using routinely-collected health data, researchers should be aware and report on the limitations and 
challenges as well as associated biases of individual data sources. 
7.2 Introduction 
There has been an exponential increase in the secondary use of health records for research across the 
world in the last decade. [236] In the United Kingdom (UK), the potential value of using health care 
data led to the launch of the Farr Institute of Health Informatics in 2013, and its successor Health Data 
Research UK (HDR‐UK) in 2018, with the vision to improve population health, address health 
inequalities, and to drive efficient service provision. [237] Linkage to medical records has also been 
increasingly used to examine dementia causes and outcomes.  Researchers employ different methods 
to examine databases to ascertain dementia diagnoses. These include diagnostic and Quality and 
Outcomes Framework (QOF) codes, reviewing free text and searching for prescriptions for dementia 
defining drugs.[238] Whilst the availability of data provides opportunities for powerful and efficient 
research, it also presents some challenges and limitations, in particular, in relation to dementia-related 
outcomes.[238]   
In the UK, the National Health Service (NHS) holds data on all hospital admissions by condition. This 
potentially allows for ascertainment of dementia from routine data sources for cohort studies. To date, 




case ascertainment for epidemiological studies. [91,95,238] These data are coded using the 
International Classification of Diseases version 10 (ICD-10) which are mainly diagnostic codes.  
However, using these sources alone seriously underestimates the number of dementia cases as most 
dementia patients will not require hospitalisation for their dementia nor will they have dementia as a 
cause of death recorded on their death certificate. [95]  
General practitioners maintain primary care records, which include information, not only for 
diagnoses, but also for administrative purposes, including details of specialist referrals such as to 
memory clinics. Diagnosis of dementia is usually initiated in a primary care setting, based on patient 
symptoms or caregivers’ concerns, [239] therefore GP records, in theory, should be a more complete 
source for dementia case ascertainment.  The coding system used in primary care is different from the 
ICD system used in secondary care and death registration. This coding system uses Read Codes, and 
codes for dementia, in particular, are numerous, complex and prone to coding error and 
misclassification. [94] The use of multiple systems across different settings and unfamiliar codes adds 
to the confusion and lack of clarity. [94]  
There is no national system for collecting or sharing primary care data [240] and from the available 
literature, the linking of cohorts to GP data in the UK appears to be limited. [90,95,241]  Clinical Practice 
Research Datalink (CPRD) is a primary care database of anonymised medical records from general 
practitioners that is widely used in epidemiological research. However, CPRD has its limitations, including 
variability in the quality of data which are not primarily for the purpose of research and not accurately 
accounting for ‘missingness’ of data; [242] as only individuals attending their general practice are 
recorded.  Furthermore, CPRD is only available for a limited number of practices.    
Epidemiological studies depend on accurate, reliable and relevant information from data sources if 
they are to be useful for risk, natural history studies as well as estimates of prevalence and incidence 
of health conditions.  Whilst these opportunities for access to a wide range of data has hugely 
increased the potential of research of dementia – it also presents challenges and uncertainties in the 
strengths, limitations and the potential biases of these data sets. One main limitation is the impact of 
incomplete or inaccurate recording of dementia which can affect analysis and interpretation of results. 
[243] Researchers should be aware of the strengths and limitations of data sources used for research 
and the accuracy of results should be interpreted and reported subject to these caveats. [244] 
Dementia ascertainment is complex in primary and secondary care settings [94,96] as well on death 
certification,[245] with poor reporting underestimating dementia in the population. [246] There is 




applying different criteria for ascertainment. [91] Further adding to the complexity is the variations in 
dementia reporting across regions in UK. [91,93,248] As a result, data sources are prone to inconsistency, 
misclassification and influenced by change in dementia practice and policy, [248] such as those 
summarised in Box 7.1 below. Currently, no data source has been recognised as the ‘gold standard’. [238]  
A number of cohort studies have reported on use of electronic records for dementia outcomes. [90,95]  
These large quantitative studies may be limited in terms of generalisability.  If routine data are to be 
used to address measurement of dementia outcomes, it is of value to examine how these data sources 
behave in other populations. EPIC Norfolk provides an opportunity to test whether there are 
systematic differences and potential biases in such approaches.  
The aim of this investigation was to describe the procedures to gain further understanding of the 
accuracy of coding for dementia and dementia related outcomes across different data sources, namely 
HES, mortality data and the recently available mental health dataset. We examine whether there is a 
differential in estimating dementia across the different data sources. We provide novel insight into the 
mental health dataset and further compare secondary and primary records using GP records in a sub-
population of the EPIC-Norfolk cohort. 
Box 7.1: Increased awareness of dementia through changes policy for public and practitioners 
2006: Introduction of dementia to Quality of Framework (QOF) registers. QOF rewards GP 
Practices for the provision of quality care and helps to standardise improvements in the delivery 
of primary medical services. Participation in QOF is voluntary 
2009: The 2009 National Dementia Strategy was introduced to increase the public and 
professional awareness and understanding of dementia.  Also, the dementia prevalence indicator 
to the Quality Outcomes Framework was introduced in primary care  
2011: Changes to coding practice. For mortality coding, deaths previously coded with an 
underlying cause of unspecified cerebrovascular disease were reclassified as vascular dementia 
2012: The Dementia Challenge was launched in March 2012 by Prime Minister, David Cameron. 
This programme superseded the national strategy from 2009 – focus was on three main areas: 
bringing about improvements in health and care, creating dementia friendly communities and 
improving research 
2013:  The Dementia Commissioning for Quality and Innovation (CQUIN) was introduced (to 
encourage practitioners to identify those who potentially have dementia in a secondary care 
setting 
2014: Mortality coding revised - dementia coded as the underlying cause of death 
2015: Prime Minister launched his Challenge on Dementia 2020, which set out to build on the 





7.3.1 Participants and measurements  
All participants with baseline measure were included in this analysis as described in chapter 2 
7.3.2 Covariates 
Education (the highest level attained) and social class were obtained from the baseline questionnaire. 
Education was categorised into three groups (i) No qualification (not completing school up to the age 
of 16), (ii) Completion of school up to the age of 16 or up to the age of 18 and finally (iii) those obtaining 
an education to graduate level (those who obtained a degree or equivalent) or above.  Age at baseline 
and (where available), age at time of dementia diagnosis was used. 
Social class was classified according to the Registrar General’s occupation-based classification scheme 
into five main categories. [141]  Social class I consists of professionals, class II includes managerial and 
technical occupations, class III is subdivided into non-manual and manual skilled workers (III non-
manual and III manual), class IV consists of partly skilled workers, and class V comprises unskilled 
manual workers.  
7.3.3 Dementia ascertainment and diagnostic codes in hospital and death records  
Virtually complete follow-up for cohort for mortality and hospital admissions in EPIC-Norfolk has been 
established via linkage to routinely collected National Health Service (NHS) databases in England 
(Hospital Episode Statistics, HES) and for mortality data for all participants using their unique NHS 
number and date of birth.  Although mortality data are provided by the Office for National Statistics 
(ONS), data linkage to the EPIC-Norfolk cohort for NHS and mortality data was carried out by NHS 
Digital, a statutory body in England, permitted to receive identifiable patient data for linkage. Linked 
hospital records contain coded diagnostic information for all inpatient and day-case admissions. [89]  
We also obtained national mental healthcare data, which contain record-level data about individuals 
in contact with mental health services including memory clinics. There were three iterations of the 
mental health data covering different time periods. These were Mental Health Minimum Data Set 
(MHMDS), Mental Health and Learning Disabilities Data Set (MHLDDS) and the Mental Health Services 
Data Set (MHSDS). The MHMDS, MHLDDS and MHSDS incorporates mental health data (including 




Participants with incident dementia were defined as those free of dementia at the time of enrolment 
to the study, but identified with a dementia diagnosis subsequently. Individuals were followed from 
the date of consent, until the earliest date of a dementia diagnosis or date of death in or after 1996 
when formal follow up by health records began in EPIC-Norfolk.  Here, dementia from HES records, 
death certificate or the mental health data was defined as any of the diagnostic code as listed in Table 
7.1. For HES, mortality and the mental health data, ICD 10 codes were used. To maximise the outcome 
data, we focused on all-cause rather than cause-specific dementia. Cases were defined as ‘definite’ 
‘probable’ or ‘possible’ dementia, and only the ‘definite dementia’ cases were included in the analyses. 
The sub type of dementia was not analysed separately. Data were used from the NHS Digital (HES, 
mental health and mortality datasets) both individually and all three combined. Participants with no 
reports of death or dementia were censored on 31st December 2018. Figure 7.1 is a diagrammatic 
representation of selection of participants and record linkage in the EPIC-Norfolk cohort. 
7.3.4 Dementia case ascertainment through GP records 
For a sub-group of the EPIC-Norfolk cohort, we compared the NHS Digital datasets of secondary care 
to primary care data or GP records. The protocol was based on a ‘clean up’ exercise [94] that has been 
recommended by clinical commissioning groups to improve dementia diagnosis in practices. [249]  We 
employed Read codes (also included Table 7.1) which have been identified as being those most 
commonly used in making a dementia or dementia related diagnoses. [94] 
Case ascertainment from GP records was carried out in three phases. Firstly, twenty-six of the GP 
practices collaborating with EPIC-Norfolk were contacted to participate. Practices who agreed, were 
provided with a detailed protocol and a list of patients on their register who were also participants in 
the study.  Practice managers were provided with name, NHS numbers and date of birth under a secure 
password protected system to identify the correct individuals from their patient database. The practice 
ran searches to generate lists of patients (EPIC-Norfolk participants only) who may have dementia or 
dementia related condition, or have been prescribed dementia defining medication, Donepezil, 
Galantamine, Rivastigimine or Memantine.  
Due to the variability in coding systems and the use of Read codes across practices, [94] GP practices 
were asked to include any other dementia Read codes they routinely used.  Data were returned via 
the secure system. Practices were also asked to complete a simple questionnaire. The full protocol and 
sample questionnaire are available on request. Practices were advised to take advantage of this 
exercise by comparing results of the search against their Quality of Framework (QOF) [248] dementia 




In the second phase, cases identified from GP records were cross-checked with the NHS Digital data, 
and the level of agreement between the data sources was examined. Participants with a definite 
diagnosis in secondary care, but not indicated in the GP data were further reviewed in the third and 
final, case confirmation phase. Here, discrepant records were individually reviewed by the researchers 
(SAH and NJD). Figure 7.2 shows the timeline for recruitment of practices and data capture for 
dementia for the GP case ascertainment. Initial case ascertainment from GPs was conducted between 
2016-2017 and NHS Digital data were up to 31st March 2018, with case confirmation in GP records up 
to 20th December 2018. 
7.4 Analysis 
Definite dementia cases were defined as having one or more of the ICD-10, (or for the GP records) 
Read code, for dementia.  Age and sex-specific rates for all-cause dementia and mortality were 
calculated for the entire cohort. The number and proportion of participants with a diagnosis of 
dementia from the three NHS Digital data sources separately and combined were explored.  
Differences in socio-demographic characteristics (age at recruitment, sex, education and social class) 
of dementia cases across the three NHS Digital datasets were examined.   
Cox proportional-hazards models were used to compare the association of socio-demographic factors 
and risk of a dementia diagnosis across these data sources, with mutual adjustment all the co-variates. 





Table 7.1: ICD 10 and Read codes used in EPIC-Norfolk to search for ‘Definite’ dementia cases 
Read 
codes 
ctv3_codes Read Code Description  ICD 
Code  
ICD Description 
Eu00 Eu00 Dementia in 
Alzheimer's disease 
F00 Dementia in Alzheimer's disease 
    
 
G30 Alzheimer's disease 
Eu000   Dementia in 
Alzheimer’s disease 
with early onset 
F00.0 Dementia in Alzheimer's disease with early 
onset 
    
 
G30.0   
Eu001 X0030 Dementia in 
Alzheimer's disease 
with late onset 
F00.1 Dementia in Alzheimer disease with late onset  
      G30.1 
  XaIKC Alzheimer's disease 
with late onset 
    
Eu002 Eu002 Dementia in 
Alzheimer's disease, 
atypical or mixed type 
F00.2  Dementia in Alzheimer disease, atypical or 
mixed type  
      G30.8   Other Alzheimer's disease 
F110   Dementia in 
Alzheimer's disease, 
unspecified 
F00.9 Dementia in Alzheimer's disease, unspecified 
                                                                       
G30.9                                                                                         
Eu01 XE1Xs Vascular dementia F01 Vascular dementia 
      F01.0 Vascular dementia of acute onset 
Eu011  Xa0IH Multi-infarct dementia F01.1 Multi-infarct dementia 
Eu012 X003T Subcortical vascular 
dementia  
F01.2 Subcortical vascular dementia  
Eu01y Eu01y Other vascular 
dementia 
F01.8 Other vascular dementia 
Eu01z Eu01z Vascular dementia, 
unspecified 
F01.9 Vascular dementia, unspecified 
      F02 Dementia in other diseases classified elsewhere 
Eu020 X0034 Picks Disease 
(Read)/Frontotemporal 
dementia includes 
Picks Disease and 
progressive isolated 
aphasia(CTv3) 
F02.0 Dementia in Pick’s disease 
      F02.1 Dementia in Creutzfeldt-Jakob disease 
      F02.2 Dementia in Huntington's disease 
Eu023 Eu023 Dementia in 
Parkinson's disease 
F02.3 Dementia in Parkinson's disease 
      F02.8 Dementia in other specified diseases classified 





Table 7.1: Continued… 
Eu02y X0034 Dementia in other diseases specified 
elsewhere (Read)/Frontotemporal 
dementia includes Pick’s Disease and 
progressive isolated aphasia 
  
      G31.0 Frontotemporal dementia 
Eu025 X003A Lewy body dementia G31.8 Other specified degenerative diseases 
of nervous system    
Grey-matter degeneration [Alpers]  
Lewy body(ies)(dementia)(disease)  
Subacute necrotizing encephalopathy 
[Leigh]   
  XaKyY Lewy body dementia   
  
Eu02z XE1Z6 Unspecified dementia F03 Unspecified dementia  
      F05.1 Delirium superimposed on dementia 
  X002w Dementia     
  X00R2 Senile dementia     





Xa25J                                                                     Alcoholic dementia F10.7 Residual and late-onset psychotic 
disorder: Includes Alcoholic dementia 
NOS  
Chronic alcoholic brain syndrome  
Dementia and other milder forms of 




 Donepezil (Aricept®Aricept Evess®)    
 Galantamine (Reminyl®, Reminyl® XL)    
 Rivastigimine (Exelon)    













































































































































There were 2635 cases of dementia identified from the cohort of 25,639 individuals at the censor date 
of 31st December 2018 after 25.8 years of follow-up.  The youngest age of entry to the study at baseline 
was just below 40 and the oldest age of the participant at the censor date was 101 years. Out of the 
2298 individuals with data on age of diagnosis, the minimum age of diagnosis was 54 years and 
maximum was 99 years.  Figure 7.3 shows the relationship between age and number of dementia 
diagnosed. Table 7.2 shows the sex- and age-specific cumulative incidence of dementia and deaths in 
the cohort. Increasing age was associated with increasing rates of dementia and death.  This table 
reflects the higher mortality in men which results in higher absolute numbers and of dementia cases 
in women.  






Table 7.2: Age and sex specific proportions of dementia and death in EPIC-Norfolk from 1996 until 31st 
December 2018 using all 3 secondary care data sources provided by NHS Digital. 
Age Band at baseline Median age Freq (N) 
% with dementia 
(N) 
% Died (N) P-Value 
Men (N=11 607)   
  
 
<=59 Years 51.6 5915 3.2 (190) 17.4 (1028) 
<0.001 
60-64 Years 62.5 1848 12.3 (228) 46.7 (863) 
65-69 Years 67.5 1890 15.6 (294) 72.0 (1361) 
70-74 Years 72.5 1579 17.3 (273) 89.9(1420) 
>75 years 75.7 375 14.9 (56) 95.7 (359) 
Women (N=14032)      
<=59 Years 51.3 7656 3.1 (234) 11.9 (909) 
<0.001 
60-64 Years 62.6 2118 15.0 (318) 36.9 (782) 
65-69 Years 67.4 2103 23.2 (488) 55.4 (1166) 
70-74 Years 72.4 1766 27.5 (486) 80.4 (1419) 
>75 years 75.8 389 28.8 (112) 90.7 (353) 
ALL  (N=25 639)      
<=59 Years 51.5 13571 3.0 (412) 14.3 (1937) 
<0.001 
60-64 Years 62.6 3966 13.5 (536) 41.5 (1645) 
65-69 Years 67.5 3993 19.3 (769) 63.3(2527) 
70-74 Years 72.5 3345 22.8 (750) 84.7 (2839) 
>75 years 75.7 764 22.0 (168) 93.2 (712) 
NHS Digital Data Sources: Hospital Episode Statistics (HES), mortality and mental health datasets 





On comparing characteristics across the different data sources, there were no differences in terms of 
sex and socio-demographic profiles (Table 7.3), other than those from the mortality dataset were 
older. The majority of dementia cases were identified from HES, followed by mortality, with the least 
number identified from the mental health dataset.  The distribution of dementia cases across the three 
NHS Digital data sources is shown in Figure 7.4.  This figure shows very little overlap between all three 
datasets, with varying degree of overlap between across the different datasets. In terms of socio-
demographic factors predicting dementia, associations were similar across the three data sources 
(Table 7.3). Age was a stronger predictor in mortality dataset and weakest in the mental health data. 
Having qualifications had a lower risk of future dementia, as expected, this was observed for mortality 
and HES data but not for the mental health dataset, most likely due to the smaller numbers. 
The mental health datasets included recorded observations and mainly administrative data such as 
mental health reviews, care programmes and pathways that include contacts with mental health care 
professionals (both in hospitals and in outpatient clinics and the community) as well as diagnostics and 
treatment codes.  The service-level breakdown of the metal health data was not applicable here, as 
there was little additional diagnostic information.  The latest release, MHSDS (2017-2018) appeared to 
be the most complex dataset, covering mental healthcare more comprehensively and containing 





Table 7.3: Comparison of characteristics of 'definite dementia' cases identified from the three data 
sources separately and combined. 
  HES DATASET MH DATASET 
MORTALITY. 
DATASET 








dementia Definite dementia 
Definite 
dementia  
  N=2157 N=727 N=1276 N=2635  
Socio-demographic                   
Mean (SD)                  
Age at Baseline 66.9 (6.3) 64.1 (6.5) 67.9 (5.9) 66.7 (6.5) <0.001 
Age at Diagnosis 83.7 (6.5) 82.7 (6.8) 84.6 (6.4) 83.8 (6.5) <0.001 
Sex, % women (n) 59.8 (1290) 59.7 (434) 60.5 (772) 60.5 (1594) 0.9 
Education, % (n)                 
 
No qualifications 49.1 (1057) 45.3 (329) 50.4 (641) 48.4 (1274) 
0.5 O/ A level Standard 41.9 (903) 45.3 (329) 41.4 (527) 42.6 (1120) 
Graduate Level 9.0  (194) 9.4 (68) 8.2 (105) 9.0 (238) 
Social Class, % (n)                  
Professional  6.3  (132)  5.6 (42) 6.0 (74) 6.3 (162) 
0.7 
Managerial  33.6  (702) 32.0  (240) 34.0 (421) 33.9 (866) 
Skilled Non-Manual 20.5  (428) 21.1  (158) 21.7 (268) 20.5 (523) 
Skilled Manual  21.2  (442) 21.4  (160) 20.5 (253) 21.3 (544) 
Semi-Skilled 14.1  (295) 17.2  (129) 13.6 (168) 14.2 (362) 
Non-Skilled 4.2  (88) 2.7  (20) 4.3 (53) 3.8 (98) 
































































































































































































































































































































































































































































































































































































































































































Figure 7.4: Distribution of cases (N=2635) across the three main data sources from NHS Digital followed 














For the sub-study involving validation with GP records, out of the 26 practices that were contacted, 14 
agreed to participate, 6 declined and 6 gave no response. Of the 14 that agreed, 8 practices completed 
the questionnaire and 9 provided data. There were no criteria for selecting a practice for this 
validation, other than they were EPIC-Norfolk practices. There was a mix of rural and city practices, 
classified as urban or town and fringe areas, [250] although the majority of the practices ultimately 
submitting data were city-based. In this sub-population, 4.4% (209 cases) were dementia cases 
identified from HES, mental health data, mortality and the GP records compared to 10.1% cumulative 
incidence in the rest of the cohort.  
However, this sub-population of 4668 participants were younger, more likely to be women, and of 
higher education and social class when compared to the rest of the cohort (Table 7.5). Out of the 209 
cases, 57 were found in both secondary and primary care data and 87 were in primary care records 
only.  In this small study, almost all the practices reported to use Read codes and not free text and all 
reported their dementia cases to be confirmed through secondary referral. Five out of the eight 
practices reported on discrepancy with their QOF registers. The summarised responses to the 
questionnaire from GPs are given in Figure 7.5. Participants who were prescribed one of the four 
dementia drugs (N=57), also had a Read code of a definite dementia diagnosis.  There were no cases 
identified from drugs alone.   
 
166 
Table 7.5: Comparison of socio-demographic characteristics between sub-population (N=4668) and 
rest of EPIC-Norfolk cohort with baseline measures. 
 Cohort  GP Sub-cohort P-Value 
       
  N=21 537** N=4668   
Socio-demographic       
Mean (SD)      
Age at Baseline  59.8 (9.5) 56.1 (7.9) <0.001 
Age at dementia diagnosis  83.8 (6.5) 84.5 (6.6) 0.1 
Sex, % women (n) 54.3 (11 688) 57.1 (2344) 0.001 
Education, % (n)      
No qualifications 37.9 (8165) 31.4 (1289) 
<0.001 O/ A level Standard 49.8 (10 723) 52.5 (2154) 
Graduate Level 12.2 (2630) 16.0 (658) 
Social Class, % (n)      
Professional  6.7 (1401) 8.7 (353) 
<0.001 
Managerial 36.4 (7659) 37.1 (1497) 
Skilled Non-Manual 16.8 (3533) 15.0 (606) 
Skilled Manual 23.1 (4855) 22.7 (917) 
Semi-Skilled 13.6 (2854) 12.6 (507) 
Non-Skilled 3.5 (727) 3.9 (158) 




There were 65 participants who had a definite dementia diagnosis in the secondary care records, but 
not in their GP records. For the majority (51 cases), the reason for absence from GP systems was 
because the participant had died, and the dementia diagnoses had come from mortality records. Once 
a patient is deceased their information is removed from the GP system. For the remaining (N=14), 3 
participants had an MCI or probable dementia code, and for 10 participants, we were unable to confirm 
diagnosis. This could be because they had died recently, or had moved to another practice, in which 
case their records would no longer be available by the GP. One patient had no indication of any 
dementia or dementia related condition.  Another important point to highlight, that of the 57 cases 
that were in both the secondary and primary data sources, just over half were available from the initial 
GP data extract, with the other 27 missed by the practices. These were only obtained with further 
detailed review of individual records by the researchers. These cases would not have been included if 
the extra confirmation phase had not been a part of the study design. Distribution of dementia cases 
across primary and secondary care datasets are shown in Figure 7.6. 
Figure 7.6: Distribution of cases (N=209) identified from primary and secondary care in sub-population 









This study shows dementia is recorded across different data sources and although there is some 
concordance across these sources, this is limited. As a result, we have shown that using a single data 
source would underestimate dementia numbers and to use multiple sources is the best approach to 
maximize dementia ascertainment from routinely collected health records. [238] The most widely used 
data sources by studies are HES and mortality records, [91] each with limitations and both 
underestimate the burden of dementia. [96,238,251] Dementia is not always the primary cause of 
death and so may not be included on the death certificate, [251] and underreporting in hospital records 
is also a known problem. [252] In this relatively small study, we also show the limitations apply to GP 
records. Medication for dementia drugs provided no additional cases, even though this is another 
potential source. [238] For all sources to be useful for research, dementia diagnoses has to be 
documented accurately recorded which is not always the case and also varies across regions. [93] 
Medical records allow virtually complete follow-up, for research; [28] however, the limitations in terms 
of accuracy, completeness of dementia recording [91,92] and underestimation of cases are well 
recognised. As with other studies, [90,95,238] we also interpreted the absence of a dementia diagnosis 
code as absence of the dementia, although this may not necessarily be the case.  Even though using 
medical records is less sensitive to making a study diagnosis, specificity in all these data sources is likely 
to be high, as a clinical diagnosis, particularly in primary care records is usually made after referral to 
a specialist. [253] One major limitation of this study is that all the medical records for the entire cohort 
were not inspected, and so likely to have missed more, which would have reduced sensitivity. 
Furthermore, milder cases that have not been identified would have been missed.  Misclassification will 
have some impact on association, the level of importance of this will depend on the purpose of the study. 
Under-ascertainment is inevitable and should be taken into account when making prevalence 
estimations. 
Another limitation is that the competing risk of death was not accounted for, which will be high in this 
ageing population. Although the proportion of deaths by age in men and women were presented. 
Individuals are likely to die as a result of old age and other comorbidities before a diagnosis of 
dementia. In the Cox regression models, these individuals would have been censored and considered 
‘at risk’ when in fact they should not be. However, to account for the competing risk for death, death 
has to be a discrete event from dementia, and given that dementia from mortality records was 
included, this overlap does not allow for competing risk of death to be estimated here. 
Using simple socio-demographic factors to examine associations, including the most common and 
strongest risk factor, age, small differences were observed, across the main two data sources, with 
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some difference in the mental health dataset.  However, there is the potential for these differences to 
be greater due to missing data, particularly for more complex factors than those examined here. 
Therefore, associations with unrecorded dementia cases in a data source could yield different study 
results. Studies have highlighted regional variation in rates of diagnosis and reliability of existing data. 
[238] We have demonstrated that this heterogeneity exists even in a single geographical region.  
I have described the relatively newer mental health datasets from NHS Digital, which do not seem to 
be widely used as the other data sources and have not been described previously. These datasets are 
complex, with information on individuals (from referral to final discharge) who have been in contact 
with secondary mental health services. Each subsequent release of the mental health data was wider 
in scope than the previous version. The mental health dataset for the final year of follow-up (MHSDS) 
had the greatest number of dementia cases than all earlier iterations of this dataset from previous 
years. It is unclear as to why this sharp increase in diagnosis codes occurs. It may be as a result of 
change in the coding practice in mental health services, or the way these data are extracted to include 
diagnoses as well as service codes.  
The mental health dataset has huge potential to provide more accurate estimate of true dementia in the 
population in the UK.  As shown here, there are a number of potential pitfalls in dementia ascertainment. 
Not all individuals with dementia will have a hospital or death record, and despite the expectation, GP 
records are not a complete source for dementia. [94] However, the mental health dataset has the 
potential to provide additional cases, of those not only presenting to GPs and hospitals, but those 
individuals living in the broader community. This dataset will need further reviewing for future work. 
We were unable to examine primary care records via databases such as CPRD, as it is currently not possible 
to link to primary care in EPIC-Norfolk in this way. As we had to make direct contact with practices and 
rely on them to extract the data, we were restricted, for practical reasons, to link to a subset only. The 
protocol was time and labour intensive, although the main purpose of the sub-study was to provide some 
insight of the degree of agreement between primary and secondary records, which has been shown to be 
good in other large cohort studies. [90,95] However, in this study, we did not observe the same level of 
concordance, with a proportion of individuals in secondary care without a record in primary, even though 
the primary care records were scrutinised up to one year after follow up period in secondary care records. 
This discrepancy was mainly due to individuals who had died and GP live databases do not hold records 
on the deceased.  This protocol demonstrates how under-reporting by GP practices, may influence studies 
using databases such as CPRD to under estimate proportion of dementia cases. [254]   
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As with the UK Biobank study, [90] we also found significant proportion of dementia cases in primary 
care records, that were not in hospital or mortality records. In EPIC-Norfolk this figure was 42% 
compared to 52% in UK Biobank. The lower rate is reflective of the older age of the EPIC-Norfolk cohort. 
However, it also shows that even with an older cohort, there are still cases found in primary care, that 
would be otherwise missed if researchers are using HES and mortality data alone.    
The UK Biobank study was based on the Scottish arm of the study only and did not include other 
geographical areas covered by UK Biobank. Scotland has some of the best linkable health service 
datasets in the world, in part due to the adoption in the 1970s of a centrally maintained unique 
identifier allocated to all GP registered patients. Data quality is generally considered to be high and 
centralisation of data, both GP and secondary care, making the data more accessible to research.  This 
position is not currently shared by the other countries of UK, although may change in the near future 
with the establishment of HDRUK. [237] Another large cohort study, the Million Women Study, also 
found NHS hospital admission data to agree with primary care records, [95] however, this study only 
consisted of women, and also like UK Biobank, participants were younger.  
The study in the sub-population of the EPIC-Norfolk cohort has highlighted a number of key issues. The 
first is the potential level of ‘missingness’ as reported previously; [242] if we had relied on the initial data 
extract provided by the practices, we would have missed just under half the dementia cases. Even though 
the diagnosis was present in the records, the information was not provided by the practice. The second 
point to highlight is the bias introduced in the sub-population. It is clear from the characteristics and 
dementia rates, that this sub-population is different from the overall EPIC-Norfolk cohort. There were no 
specific criteria set in approaching practices; however, the practices that responded were mainly city 
practices, and the patient-base in these practices was younger, more educated and of higher social class.  
It is likely that the practices that responded were more proactive in taking part in research. As a result, 
introducing a selection bias.  This bias is clearly reflected in the dementia rates, which was 10% in the 
EPIC-Norfolk cohort overall, compared to 4% in the sub-set from the nine GP practices taking part. 
Databases such as CPRD are extremely powerful data sources, but are not representative of all 
practices in the UK based on geography and size, [242] and HES and mortality also rely on data that 
has been provided by practices. Errors in documenting or missing information can lead to biased results 
and so the data available for research should be used and interpreted with caution. 
Recently there have been changes to coding within primary care with the introduction of new codes 
SNOMED CT.[255] This new coding system to replace Read codes and eventually also be used in 
secondary care is meant to provide clarity and consistency across primary and secondary care. 
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However the implementation of this will take several years and the impact of this is yet unknown.  
There is also potential in the mental health data that includes other service related codes that could 
be utilised for further insight into the level of cognitive impairment in the community. There are a 
number of administrative codes that relate to low, moderate and severe cognitive impairment. This 
information could be used to supplement the diagnostic information and could be useful in 
ascertaining milder forms of impairment and dementia. This study could also be further strengthened 
by linking to primary care database such as CPRD,[242] to allow for more complete record linkage of 
the cohort. However, as shown in this study, it is not necessary that diagnoses within research 
databases are a true reflection of dementia cases known to the actual general practices. [238] 
Record linkage is a powerful tool to improve the accuracy and completeness of dementia 
ascertainment for public health research purposes. Currently there are inconsistencies in the 
methodologies and challenges in using these data that were not collected for the purpose of research. 
The results of this work suggest that in UK, record linkage with hospital admission, mortality and 
primary care data provide the ability to identify dementia cases for epidemiologic analyses of risk 
factors within a cohort.  However, the generalisability and reliability of these data for incidence and 
prevalence rates is more challenging due to variability in ascertainment and diagnostic criteria which 
may differ over time and in different populations. Researchers analysing linked datasets in most cased, 
will not have all the information necessary to assess the impact of error on their results. Researchers 
must be fully aware of the strengths and limitations of the data sources they use and be transparent 




Summary of Chapter 
 
 At the censor date of 31st December 2018 after 25.8 years of follow-up, there were 2635 
cases of dementia identified from the EPIC-Norfolk cohort recruited at baseline. 
 
 The age range of EPIC-Norfolk participants with a dementia diagnosis was 54-99 years. 
 
 Dementia is recorded in different data sources, concordance across these sources, is 
limited. 
 
 Using multiple sources is the best approach to maximize dementia ascertainment from 
routinely collected health records. 
 
 Small differences in socio-demographic factors were seen across the main two data 
sources, HES and mortality, with some difference in the mental health dataset. 
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Studies have shown impairment in multiple cognitive domains several years before a clinical diagnosis 
of dementia. This chapter examines the utility of the cognitive battery used in EPIC-Norfolk as well as a 
composite global score, to predict dementia, ascertained using health record linkage in 8581 of the 
participants individuals over 15 years follow-up (2004-2019). Risk of dementia was estimated using Cox 
proportional hazard models adjusting for sociodemographic, lifestyle and health variables, evaluating 
discriminative accuracy of the models by analysing receiver operating characteristic (ROC) curves. 
Poor cognition was predictive of incident dementia, even after adjustment for co-variates. Those with 
a poor performance score for global cognition (bottom 10%) were almost four times as likely to get a 
dementia diagnosis than those who performed well Hazard Ratio (HR)=3.51 (95%CI 2.61, 4.71 p<0.001).  
Associations were observed for specific as well as global cognitive abilities. The test for episodic (verbal) 
memory outperformed other tests and was comparable to global cognition scores.  Poor cognition in 
four or more tests was associated with 10-fold increased risk of developing dementia compared to those 
not performing poorly in any test HR=10.82 (95% CI 6.85, 17.10 p<0.001).  Cognitive measures 
strengthen prediction models of dementia (Area under the curve (AUC) = 0.85 (95%CI 0.82, 0.87 
p<0.001). 
This investigation provides further insight on poor cognition predicting future dementia. This 
association was observed for global cognition and specific abilities, particularly for verbal episodic 
memory. Deficits across multiple domains predict dementia over and above individual test scores.  
8.2 Introduction 
Dementia for most has a long prodromal period, whereby individuals who go onto develop dementia, 
exhibit cognitive deficits many years before any symptoms or receiving a clinical diagnosis. [77] Though 
difficult to discriminate dementia in its early stages from normal cognitive ageing, [74,256,257] there 
is evidence from large cohort studies that, in general, those who develop dementia after follow-up had 
exhibited poorer cognitive performance relative to those who did not develop dementia although this 
has not translated into accurate individual risk prediction. [81]  The risks exist both at a global and 
domain specific level, [174,258] including episodic memory, executive functioning, verbal ability, 
visuospatial skill, attention, and processing speed. [259,260] The predictive accuracy of dementia 




The purpose of this chapter is to examine the predictive utility of a range of cognitive tests (both global 
and domain specific) for dementia in a population of relatively healthy men and women prior to a 
clinical diagnosis. Also examined, is whether the extent of impairment across different cognitive tasks 
enhances the predictive power over and above the level of individual cognitive test performance alone. 
8.3 Methods 
8.3.1 Participants and measurements  
In this analysis, participants with cognitive measures taken at 3HC were included. Details of the 
methods of collecting the measures are described in Chapter 2. All cognitive measures of the individual 
tests and the composite score were used.  
8.3.2 Covariates 
Education (highest level attained) and social class were obtained from the baseline (1993-1997) 
questionnaire. Education was categorised into three groups (i) No qualification (not completing school up 
to the age of 16), (ii) Completion of school up to the age of 16 or up to the age of 18 and finally (iii) those 
obtaining an education to graduate level (those who obtained a degree or equivalent) or above.  Social 
class was dichotomised, into ‘non manual’ and ‘manual’ class.  Age was categorized into 5-year age bands.  
Other co-variates included in analysis (weight and height to calculate BMI, lung function, blood 
pressure, plasma vitamin C levels was estimated using a fluorometric assay. Self-report of smoking 
status (current, former or never smoker) and alcohol intake (Units/Week) were obtained from health 
and lifestyle questionnaire administered at the time of the clinic appointment. Alcohol units were 
categorised into 3 groups: 0 Units, 1-14 Units and more than 14 Units. Habitual physical activity was 
dichotomised into ‘physically inactive’ and ‘any physical activity’ Medical history of heart-attack, 
stroke, cancer, diabetes, hypertension, chronic obstructive pulmonary disease (COPD), depression; 
and memory and hearing problems, were established from health and life style follow up 
questionnaire.  Details for all co-variates are decribed in Chapter 2. 
8.3.3 Dementia ascertainment and diagnostic codes 
Almost complete follow-up for disease outcomes in EPIC-Norfolk has been established via linkage to 
routinely collected National Health Service (NHS) databases in England (Hospital Episode Statistics, 
HES) and mortality data for all participants using their unique NHS number and date of birth.  The 
linked hospital records contain coded diagnostic information for all inpatient and day-case admissions. 
[89] To maximise dementia ascertainment, the national mental healthcare data were also included.  
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Incident dementias were defined as those people without any formal record of dementia in medical records 
at the time of enrolment to the study, but identified with a dementia diagnosis through routine records 
subsequently. Participants were followed up from the date of consent at baseline until the first date of a 
dementia diagnosis, date of death or censoring with neither at 31st March 2019 Using the diagnostic codes 
for dementia as defined in Chapter 7, as any of the ICD-10 codes as listed in Table 7.1. We used cases with a 
definite clinical diagnosis from any cause. The sub types of dementia were not analysed separately.  
8.4 Analyses 
Associations were examined using approximate percentile cut-offs rather than the continuous 
cognitive score. Poor performance for this chapter was defined as obtaining a score less than a cut-off 
point corresponding to approximately the 10th percentile of the population distribution in each of the 
eight cognitive measures individually.  As described previously (and in Appendix 5), participants were 
classified into two groups based on the cut-off scores for each of the tests. For prospective memory, 
poor performance was defined as those failing the task.  The composite score was also included in the 
analysis. Participants were classified in two groups for the continuous composite score in the same 
way as the scores were for the individual tests described above. Details as decribed in Appendix 5. 
The risk of a ‘definite dementia’ diagnosis was estimated as a hazard ratio with 95 percent confidence 
interval (95%CI) for each of the cognitive tests in separate Cox proportional hazard regression models. 
Age (at time of cognitive testing), and multivariable-adjusted models were additionally constructed to 
estimate dementia risk. The models were as follows: 
Model 1: Socio-demographic factors (Age, per 5 years, sex, education and social class)  
Model 2: Socio-demographic and lifestyle (smoking, physical activity and alcohol)  
Model 3: Socioeconomic, lifestyle and biological factors (cholesterol, systolic blood pressure, body 
mass index (BMI), waist hip ratio (WHR), lung function, measured by forced expiratory volume in one 
second (FEV1) and plasma vitamin C) and prevalent disease.  
Education, Social class, physical activity and smoking were all treated as categorical variables in the 
analysis, as was co-morbidity (as present or not).  Exploratory analyses showed little difference in 
hazard ratio when BMI was entered as a categorical (as low, normal, overweight and obese groups) or 
as a continuous variable (data not shown), therefore, BMI was entered in the model as a continuous 
variable to improve sensitivity of the analysis. The cognitive score was entered as a dichotomised 
variable based on the description above (poor performance or not).  
 
177 
The distribution of participants with poor cognitive performance across the eight cognitive measures 
were categorised based on the number of tests with a poor performance score as follows: A/ 4-8 tests; 
B/ 2-3 tests; C/1 test D/ 0 tests (Reference category). Associations were examined with the number of 
tests included as a categorical variable in in the multivariate adjusted model (Model 3), and then 
additionally adjusted for each cognitive tests. 
The accuracy in predicting future dementia was examined by first generating predicted probabilities 
from multiple logistic regression. These were then used to plot a receiver operating characteristic curve 
to derive the area under the curve (AUC). The predictor variables included models examined by ROC 
were: 
A/ Age, sex and education (Basic model, as reported previously [28]) 
B/ Multi-variable adjusted model (including socioeconomic, lifestyle, biological factors and prevalent 
disease (Model 3) 
C/ Variables as in Model 3, further adjusted for composite score (using the dichotomous variable of 
the composite) 
D/ Variables as in Model 3, further adjusted for ‘number of tests with poor performance’ (using the 4-
level variable for number of tests, as described above). 
8.4.1 Missing data 
The impact of missing data was examined by assigning participants with missing data to 1/ the poor 
performance group and then 2/ to the reference group to examine the impact on hazard ratios. Hazard 
ratios were examined for individuals with data on all eight cognitive tests and the specified covariates 
(N=6151)  and compared to those with missing data of any of the eight cognitive measures as well as 




8.4.2 Sensitivity analyses 
For the sensitivity analyses, participants were first grouped into approximate quartiles of cognition 
scores (rather the tenth percentile as a cut-off), to investigate potential difference in association with 
change of the percentile defining poor function. In the second sensitivity analysis, participants who 
had died or were diagnosed with dementia in the first five years of follow-up, were excluded to test 
for potential reverse causation bias.   
8.5 Results 
Of the 8623 individuals who took part in the 3HC, 8585 had cognitive measures with a total of 537 with 
a dementia diagnosis (based on the ICD codes as in Table 7.1) after a maximum of 14.8 years of follow 
up (mean 9.6, median 9.8 years). Four of these participants were excluded from the analyses as they 
received their dementia diagnosis before cognitive assessment resulting in a total of 533 dementia 
cases in the final analytical sample of 8581 men and women who were aged 48-92 at the time of their 
cognitive assessment. Figure 8.1 summarises the participation level at each phase of the study from 
baseline and the selection of the analytical sample. The total number of incident dementia in EPIC-
Norfolk participants from the 25, 639 individuals who attended the baseline health check at the censor 
date was 3187. 
Table 8.1 shows the means and proportions of the variables included in this analysis by dementia 
status. Those with dementia, were more likely to be older, have no qualifications, more likely to be 
physically inactive, non-drinkers or smokers and have higher blood pressure. They were also more 
likely to have reported suffering from stroke, hypertension, diabetes, memory and hearing problems. 
Those with subsequent dementia scored lower on all the cognition tests at the 3HC, except the short-
NART. Of the 8581 participants with cognitive data, 6152 participants had data for all the cognitive 
tests with 2391 having some of the test measures and 38 participants having none. In the healthier 
cohort, over half the participants did not exhibit poor performance in any of the eight cognitive 
measures, 26.1% exhibited poor performance in one test; 17.1% in 2-3 tests and 4.8% in 4-8 tests 
(Figure 8.2). This figure is similar to Figure 4.1 (Chapter 4). This is repeated here as it includes the 
updated numbers across eight measures rather than the seven measures as used in the eariler 


















































































































Table 8.1: Characteristics by dementia status of 8581 participants with cognitive measures in the Third 
Health Check Phase of the European Prospective Investigation of Cancer in Norfolk Study, 2006-2011 
(including pilot data, 2004–2006). Participants followed up until 31 March 2019. 
  Definite dementia  No dementia   
  N=537 N=8048 P-Value 
Socio-demographic       
Mean (SD)      
Age  76.3 (6.2) 68.2 (7.9) <0.001 
Sex, % women (n) 50.3 (266) 55.6 (4476) 0.02 
Marital status, % married (n) 69.8 (353) 78.8 (6204) <0.001 
Education, % (n)      
No qualifications 34.0 (180) 25.7  (2068) 
<0.001 O/ A level Standard 51.0 (270) 56.5 (4548) 
Graduate Level 14.9 (79) 17.8  (1434) 
Social Class, % (n)      
Professional  7.8 (41) 8.9 (707) 0.5 
Managerial 41.7 (220) 41.1 (3278) 
 
Skilled Non-Manual 17.3 (91) 16.0 (1272) 
 
Skilled Manual 18.8 (99) 20.7 (1647) 
 
Semi-Skilled 12.7 (67) 11.1 (883) 
 
*Retired 76.3 (5904) 95.8 (483) <0.001 
Non-Skilled 1.7 (9) 2.3 (187) 
 
Lifestyle      
Physically Inactive, % (n) 46.2 (237) 36.6 (2909) <0.001 
Smoking Status, % (n)      
Current 3.3 (17) 4.4 (353) 
0.01 Former 52.6 (270) 45.5 (3620) 
Never 44.1 (226) 50.0 (3976) 
Alcohol Intake, % (n)      
0 Units 36.4 (180) 29.4 (2281) 
0.004 1-14 Units/week 54.1 (268) 59.1 (4586) 
>14 Units per week 9.5 (47) 11.5  (896) 
Take part in regular social activities 66.7 (171) 64.4 (2830) 0.3 
Biological/Physiological, mean 
(SD)      
Body Mass Index (Kgs/M2) 26.7 (4.2) 26.8 (4.3) 0.4 
Waist hip ratio 0.91  (0.08) 0.89 (0.08) 0.003 
Total cholesterol in mmol/L 5.1 (1.17) 5.4 (1.1) <0.001 
Systolic blood pressure, mmHg 138.5 (18.0) 136.0 (16.2) 0.001 
Plasma vitamin C in umol/L 60.5 (22.4) 63.2 (22.3) 0.02 
FEV (mL) 2.18 (0.7) 2.46 (0.7) <0.001 
Abbreviations: FEV, forced expiratory volume; umol/L, micromoles per litre;  mml/L, milliomoles per litre; mL, millilitres; 




Table 8.1: Continued… 
  Definite dementia  No dementia   
  N=533 N=8048 P-Value 
Prevalent disease      
Co-morbidity, self-report Yes% 
(n)      
Heart attack 4.0 (21) 3.4 (270) 0.5 
Hypertension 37.8 (200) 24.8 (2000) <0.001 
Stroke  4.5 (24) 2.0 (158) <0.001 
Cancer  10.2 (54) 9.3 (750) 0.5 
Diabetes  6.8 (36) 2.8 (224) <0.001 
Depression  18.9 (100) 21.9 (1762) 0.1 
COPD  9.3 (49) 8.1 (653) 0.4 
Memory problems 7.4 (39) 1.9 (152) <0.001 
Hearing problems  41.2 (218) 31.0 (2498) <0.001 
Cognitive Test Score, Mean (SD)      
SF-EMSE 29.8 (4.4) 32.8 (2.9) <0.001 
HVLT  20.0 (6.4) 25.4 (5.5) <0.001 
FTMS  12.7 (4.7) 15.8 (4.2) <0.001 
PW-Accuracy  9.7 (6.6) 13.4 (5.9) <0.001 
VST-simple 722.0 (224.6) 660.2 (161.4) <0.001 
VST-Complex 2378.0 (500.0) 2185.9 (421.7) <0.001 
Short-NART Error  17.4 (10.0) 17.2 (9.9) 0.7 
Success Frequency % (N)      
Prospective memory 82.8  (6537) 57.5 (289) <0.001 
P values by T test or Chi square for proportion 
Abbreviations: COPD, chronic obstructive pulmonary disease HVLT, Hopkins Verbal Learning Test, L, litre; umol, micromoles; 
mm, millimoles, ms, milliseconds; : N, Number; PAL-FTMS, Paired Associated Learning, First Trial Memory Score; ; Pros. 
Mem, Prospective memory; PW-Acc, PW-Accuracy, SD, Standard deviation; SF-EMSE, Short Form Extended Mental State 





Hazard ratios for dementia, adjusted for age (at the time of the invitation to the 3HC) per 5 years, sex, 
education and social class for those who attended the health check and those who were invited but 
did not attend (N=9605) were examined. Using the group who had attended 3HC and had data on all 
8 tests as reference, the dementia risk (adjusted for age, sex, education and social class) were as 
follows: with data on 5-7 tests, HR=1.12 (95%CI 0.93, 1.35 P= 0.2); 1-4 tests HR=1.38 (95%CI 0.95, 2.00 
P= 0.1); attended 3HC, but with no cognition data HR=2.35 (95%CI 1.21, 4.57 P= 0.01) and for those 
who were invited for the 3HC but did not attend HR=1.83 (95%CI 1.61, 2.08 P= <0.001). Data shown in 
Table 8.2.  




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 8.3 shows the results of the Cox proportional hazards analysis for all the tests separately and for 
the composite score. For the age and sex adjusted models, there was an increased risk of dementia in 
those obtaining a poor performance score as compared to those who did not for each of the cognitive 
tests apart from the Short-NART. Further adjustments for education and social class (Model 2) and 
then for co-variates; smoking, body mass index, physical activity and comorbidities (Model 3), made 
little difference to the hazard ratios. The magnitude of the association varied slightly across tests, with 
the association with the composite as the strongest. Of the individual tests, the HVLT, a test for verbal 
episodic memory was comparable to the association observed for global cognition. 
Imputing individuals with missing data into either the poor performance or reference group, slightly 
attenuated the hazard ratios (Table 8.4), but remained similar to those presented in the main table 
(Table 8.3). Missings added to the poor performance group showed greater attenuation of the hazard 
ratio, this is possibly because most of these individuals were unlikely to be poor performers.  The 
analyses based on quartiles of cognitive performance (Table 8.5) showed a threshold association, 
mainly for the bottom two quartiles for most tests. Therefore using the more stringent cut-off in this 
cohort of healthier and higher functioning individuals is appropriate. Repeating the multivariable 
analysis after excluding individuals who died or received a dementia diagnosis within five years of 
follow-up after cognitive testing (Number of dementia cases=426), resulted in slight attenuation of the 
hazard ratios (Table 8.6). Associations based on the level of dysfunction across the cognitive abilities, 
showed a steep linear increase in risk of dementia, as the numbers of abilities with poor performance 
increased (Table 8.7).  
Compared to those who did not have a poor performance score in any test, poor performance in one 
test doubled the risk of dementia, in 2-3 tests had a four-fold increase and those with poor 
performance in 4-8 tests (which was in just under 5% of the sample) had over a ten-fold increased risk 
of dementia, HR=10.82 (95%CI 6.85, 17.1 P=.001).  Those with poor cognition in 4-8 tests showed more 
variability across domains than those with poor cognition in fewer domains. Controlling for each of the 
cognitive test as well as the composite score made little difference to the associations, as shown 
diagrammatically in Figure 8.3 (with the data presented in Table 8.8), however, adjusting for HVLT 
(episodic memory) did attenuate the associate more than the other cognitive measures.  Those who 
with poor performance in 4-8 tests were more likely to be older, have no qualifications, have higher 
reporting rate of heart attack, hypertension, stroke, diabetes, memory and hearing problems. The 
mean score for all the cognition tests were substantially lower for this group, including a higher NART 
error score. (Table 8.9).  
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Table 8.4: Sensitivity analysis to examine the impact of missing data on association of poor 
performance with dementia for each cognition score separately and the composite score  
  
No Missing Values 
(Model 3) 
‘Missings’ assigned to ‘poor 
performance’ group (Model 3) 
Dementia N=362 
‘Missings’ assigned to 
‘reference’ group (Model 3), 
Dementia N=362 
Test HR 95% CI P-Value HR 95% CI P-Value HR 95% CI P-Value 
SF-EMSE           
Poor 3.16 (2.51, 3.98) <0.001 3.08 (2.46, 3.85) <0.001 3.08 (2.45, 3.86) <0.001 
Good 1.00   1.00   1.00   
HVLT           
Poor 3.12 (2.44, 4.00) <0.001 2.41 (1.92, 3.03) <0.001 2.92 (2.30, 3.71) <0.001 
Good 1.00   1.00   1.00   
FTMS           
Poor 2.11 (1.61, 2.78) <0.001 1.87 (1.50, 2.34) <0.001 1.85 (1.43, 2.39) <0.001 
Good 1.00   1.00   1.00   
PW-Acc           
Poor 1.78 (1.39, 2.28) <0.001 1.83 (1.45, 2.31) <0.001 1.72 (1.34, 2.20) <0.001 
Good 1.00   1.00   1.00   
VST- Simple                  
Poor 1.78 (1.33, 2.38) <0.001 1.37 (1.10, 1.71) <0.001 1.67 (1.26,2.21) <0.001 
Good 1.00   1.00   1.00   
VST-complex           
Poor 2.18 (1.65, 2.86) <0.001 1.58 (1.28, 1.97)  2.05 (1.58, 2.67) <0.001 
Good 1.00   1.00   1.00   
NART Errors           
Poor 1.07 (0.73, 1.56) 0.7 1.08 (0.82, 1.43) 0.6 1.00 (0.69, 1.45) 0.9 
Good 1.00   1.00   1.00   
Prospec. 
Memory           
Failure   2.36 (1.89, 2.95) <0.001 2.38 (1.92, 2.95) <0.001 2.22 (1.79, 2.76) <0.001 
Success  1.00   1.00   1.00   
Composite 
score          
Poor 3.51 (2.61, 4.71) <0.001 2.58  <0.001 2.95 (2.33,3.73) <0.001 
Good 1.00   1.00 (2.04, 3.26)     
 *Using Model 3 from the main analysis (adjusted for Socioeconomic, lifestyle and biological factors and prevalent disease).  
Hazard ratio for risk of dementia shown for (1) those with no missing values (2) missing values included as poor performers 
(3) missing values included in the reference (good) performers.  
Abbreviations: HVLT, Hopkins Verbal Learning Test, ms, milliseconds; : N, Number; PAL-FTMS, Paired Associated Learning, 
First Trial Memory Score; ; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy, SD, Standard deviation; SF-EMSE, Short 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 8.6: Sensitivity Analysis showing association with dementia after excluding individuals who died 
or were diagnosed with dementia within 5 years of cognitive testing (N=426 dementia cases). 
 
    
Excluding death and dementia cases 
within 5 years* 
Test, Frequency (N) 
Dementia 
(N) 
HR 95% CI P-Value 
SF-EMSE (7760) 288    
Poor  2.63 (2.02, 3.41) <0.001 
Good  1.00        
HVLT (7482) 277    
Poor  2.8 (2.14, 3.72) <0.001 
Good  1.00        
FTMS (6856) 240    
Poor  1.80 (1.32, 2.46) <0.001 
Good  1.00        
PW-Acc (7707) 283    
Poor  1.54 (1.16, 2.05) 0.002 
Good  1.00   
          
VST- Simple (6594) 236    
Poor  1.66 (1.18, 2.31) 0.003 
Good  1.00        
VST-complex (6594) 238    
Poor  1.61 (1.16, 2.24) 0.01 
Good  1.00        
NART Errors (7074) 273    
Poor  1.03 (0.68, 1.57) 0.9 
Good  1.00        
Prospective Memory  (7696) 283    
Failure (1574)  2.25 (1.76, 2.87) <0.001 
Success (6826)  1.00        
Composite score (5673) 189    
Poor  2.94 (2.11, 4.11) <0.001 
Good  1.00   





Table 8.7: Association between number of tests with a poor performance score and dementia, 
adjusting for all the co-variates (Model 3) and excluding those with dementia prior to attending the 




Model 3  
Number of tests where participants 




HR 95% CI P-Value 
 230    
0 (N=2365)  1.00   
1 (N=1184)  2.18 (1.45,3.27) <0.001 
2-3 (N=745)  4.30 (2.90, 6.39) <0.001 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 8.9: Comparison of characteristics of individuals in the poor performance group across the eight 
cognitive measure. 
  0 tests 1 test 2-3 tests 4-8 tests P-Value 
            
Socio-demographic       
Mean (SD)      
Age  65.9 (7.1) 68.8 (7.5) 71.4 (7.6) 74.5 (7.1) <0.001 
Sex, % women (N) 58.9 (1888) 54.7 (879) 47.1 (495) 46.4 (134) <0.001 
Education as reported at 
baseline % (N)      
No qualifications 15.2 (489) 28.1 (451) 40.6 (426) 52.8 (152) 
<0.001 O/ A level Standard 60.7 (1947) 56.4 (906) 51.2 (537) 43.8 (126) 
Graduate Level 24.0 (771) 15.5 (249) 8.2 (86) 3.5 (10) 
Prevalent disease   
 
  
Co-morbidity, self report 
Yes% (N)   
 
  
Heart attack 2.4 (77) 3.1 (49) 4.4 (46) 5.5 (16) 0.001 
Hypertension 24.2 (777) 23.0 (369) 28.5 (299) 29.1 (84) 0.003 
Stroke  1.3 (41) 1.8 (29) 2.4 (25) 7.3 (21) <0.001 
Cancer  8.7 (278) 8.9 (143) 11.0 (115) 8.7 (25) 0.2 
Diabetes  2.5 (81) 2.7 (44) 3.4 (36) 6.2 (18) 0.003 
Depression  22.6 (725) 21.9 (352) 18.9 (198) 22.1 (64) 0.1 
COPD  8.5 (273) 8.3 (134) 6.7 (70) 5.9 (17) 0.1 
self-report mem. Problem 0.9 (28) 1.6 (25) 3.7 (39) 12.1 (35) <0.001 
Hearing Problems  28.9 (928) 32.3 (518) 33.2 (349) 38.4 (111) 0.001 
Cognitive Test Score, Mean 
(SD)   
 
  
SF-EMSE 34.0 (1.7) 32.9 (2.2) 30.9 (2.8) 27.6 (3.2) <0.001 
HVLT  27.4 (4.2) 25.1 (4.9) 21.5 (5.4) 16.3 (5.3) <0.001 
PAL- FTMS  17.8 (3.2) 15.5 (3.9) 13.3 (4.3) 9.9 (4.4) <0.001 
PW-Accuracy  15.6 (4.7) 12.8 (5.7) 9.4 (6.3) 5.8 (6.1) <0.001 
VST-simple, reaction time 615.1 (66.3) 670.87 (141.8) 732.6 (196.3) 844.5 (294.2) <0.001 
VST-Complex, reaction time 2082.9 (269.8) 2223.9 (377.3) 2338.5 (488.1) 2600.0 (691.2) <0.001 
Short-NART Error  13.8 (7.4) 18.1 (9.8) 23.1 (10.6) 27.9 (10.9) <0.001 
Success Frequency % (N)      
Prospective memory 100 (3207) 72.5 (1165) 56.4 (592) 23.5 (68) <0.001 
Abbreviations: COPD, chronic obstructive pulmonary disease HVLT, Hopkins Verbal Learning Test, N, Number; PAL-FTMS, 
Paired Associated Learning, First Trial Memory Score; ; Pros. Mem, Prospective memory; PW-Acc, PW-Accuracy, SD, 
Standard deviation; SF-EMSE, Short Form Extended Mental State Exam; Short-NART, Short National Adult Reading Test; 





The ROC curves in Figure 8.4 show the accuracy of the models presented in this study. Age most 
powerful factor even under 5 year bands.  The AUC successively improved marginally from the basic 
model with addition of the covariates (Model 3), further with cognitive measure (shown here with the 
composite score); with the greatest predictive power of the final model which included ‘number of 
tests’.Multiple logistic regression was used to generate predicted probabilities for three models (1) 
adjusted for age, sex and education (2) the multivariate model with all co-variates (Model 3) excluding 
the cognitive test and (3) Model 3 plus cognitive performance for each of the tests and the composite 
score using both quartile and tenth percentile cut-offs. AUC values for these models for the individual 
tests (with the odds ratios from the multiple logistic regression used to generate the predicted 
probabilities) are presented in Tables 8.10 and 8.11 respectively. 
Figure 8.4: ROC curves for the prediction of incident dementia according to (1) age, sex, and education 
(2) with additionally adjusted for co-variates included in Model 3 (3) Model 3 + composite score (4) 




Table 8.10: Odds ratios (with 95%CI) of definite dementia diagnosis based on risk factors included (1) 
age, sex and education and (2) the fully adjusted and the multi-variate adjusted model (Model 3) as 
used in the cox regression as used in the main analysis. Also presenting AUC values as created from 
the predicted probabilities from multiple logistic regression. 
 
Risk factor OR 95% CI P-Value AUC 95%CI P-Value 
Minimally adjusted model N=8579    0.79 (0.77, 0.80) <0.001 
Age per 5 years 1.92 (1.81, 2.05) <0.001    
Sex (Men) 1.07 (0.89, 1.29) 0.5    
Education (No Qualifications) 1.11 (0.91, 1.35) 0.3    
Model 3 (Multi-variate model) N=8382    0.80 (0.78, 0.81) <0.001 
Age per 5 years 1.94 (1.80, 2.08) <0.001    
Sex (Men) 1.04 (0.86, 1.27) 0.7    
Education (No Qualifications) 1.12 (0.91, 1.38) 0.3    
Social class (Manual) 1.04 (0.84, 1.28) 0.7    
Smoking (current) 1.37 (0.83, 2.27) 0.2    
Physical activity (Inactive) 0.83 (0.69, 1.01) 0.07    
Co-morbidity, self-report Yes% (n)       
Heart attack 0.53 (0.32, 0.88) 0.01    
Hypertension 1.35 (1.11, 1.64) 0.003    
Stroke  1.41 (0.85, 2.33) 0.2    
Cancer  0.80 (0.58, 1.09) 0.2    
Diabetes  1.85 (1.24, 2.77) 0.002    
Depression  1.16 (0.91, 1.47) 0.2    
COPD  1.11 (0.80, 1.53) 0.6    
Memory problems 2.25 (1.52, 3.34) <0.001    
Hearing Problems  1.04 (0.86, 1.27) 0.7       
 
Abbreviations: COPD, chronic obstructive pulmonary disease; OR, Odds Ratio 
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Table 8.11: Odds ratios (with 95%CI) of dementia from the multiple logistic regression of the multi-
variate model (Model 3) with additional adjustment for the eight cognitive measure, composite score 
and number of tests. Both quartile and tenth percentile cut-offs shown with corresponding AUC values 
for each model.  
Test, Freq (N) HR 95% CI P-Value AUC 95%CI P-Value 
SF-EMSE (8285) 
   
   
Quartiles    0.82 (0.80, 0.84) <0.001 
Q1 (2231) 3.97 (2.41, 6.55) <0.001    
Q2 (2234) 1.93 (1.15, 3.22) 0.01    
Q3 (2835) 1.05 (0.62, 1.78) 0.9    
Q4 (985) 1.00      
10th PCTILE    0.82 (0.80, 0.83) <0.001 
Poor 3.14 (2.53, 3.89) <0.001    
Good 1.00      
HVLT (7951)       
Quartiles    0.82 (0.80, 0.84) <0.001 
Q1 (1977) 3.92 (2.68, 5.73) <0.001    
Q2 (2459) 1.66 (1.12, 2.46) 0.001    
Q3 (1612) 1.43 (0.93, 2.22) 0.1    
Q4 (1903) 1.00      
10th PCTILE    0.82 (0.80, 0.84) <0.001 
Poor 3.49 (2.78, 4.39) <0.001    
Good 1.00      
FTMS (7281)       
Quartiles    0.81 (0.79, 0.83) <0.001 
Q1 (2005) 3.07 (1.91, 4.92) <0.001    
Q2 (2053) 2.23 (1.38, 3.62) 0.001    
Q3 (1962) 1.81 (1.10, 2.98) 0.02    
Q4 (1261) 1.00      
10th PCTILE    0.81 (0.79, 0.83) <0.001 
Poor 1.98 (1.54, 2.54) <0.001    
Good 1.00      
PW-Acc (8215)       
Quartiles    0.81 (0.79, 0.82) <0.001 
Q1 (2040) 2.31 (1.65, 3.25) <0.001    
Q2 (2174) 1.55 (1.10, 2.21) 0.01    
Q3 (2120) 1.04 (0.71, 1.52) 0.8    
Q4 (1881) 1.00      
10th PCTILE    0.81 (0.79, 0.82) <0.001 
Poor 1.79 (1.42, 2.26) <0.001    






Table 8.11: continued…. 
   Based on Model 3       
  HR 95% CI P-Value AUC 95%CI P-Value 
VST- Simple (6997)       
Quartiles    0.80 (0.78, 0.82) <0.001 
Q1 (1738) 1.52 (1.11, 2.08) 0.01    
Q2 (1754) 1.04 (0.75, 1.46) 0.8    
Q3 (1756) 1.17 (0.83, 1.65) 0.4    
Q4 (1749) 1.00      
10th PCTILE    0.80 (0.79, 0.82) <0.001 
Poor 1.74 (1.32, 2.29) <0.001    
Good 1.00      
VST-complex (6997)       
Quartiles    0.80 (0.79, 0.82) <0.001 
Q1 (1740) 1.52 (1.12, 2.06) 0.01    
Q2 (1755) 1.03 (0.74, 1.44) 0.9    
Q3 (1751) 0.92 (0.65, 1.30) 0.6    
Q4 (1751) 1.00      
10th PCTILE    0.81 (0.79, 0.83) <0.001 
Poor 2.17 (1.67, 2.82) <0.001    
Good 1.00      
NART Errors (8109)       
Quartiles    0.80 (0.78, 0.82) <0.001 
Q1 (1782) 0.94 (0.68, 1.28) 0.7    
Q2 (2154) 0.84 (0.63, 1.12) 0.4    
Q3 (1956) 0.81 (0.61, 1.07) 0.1    
Q4 (2027) 1.00      
10th PCTILE    0.80 (0.78, 0.82) <0.001 
Poor 0.94 (0.68, 1.28) 0.7    
Good 1.00      
Composite score (6151)      
Quartiles    0.82 (0.80, 0.84) <0.001 
Q1 (1786) 4.01 (2.47, 6.53) <0.001    
Q2 (1336) 2.24 (1.34, 3.74) 0.002    
Q3 (1370) 1.70 (0.99, 2.91) 0.06    
Q4 (1509) 1.00      
10th PCTILE    0.83 (0.81, 0.85) <0.001 
Poor 3.64 (2.76, 4.80) <0.001    
Good 1.00      
Pros. Memory (8210)   0.81 (0.80, 0.83) <0.001 
Failure (1531) 2.37 (1.98, 2.84) <0.001    
Success (6679) 1.00      
Number of tests    0.84 (0.82, 0.86) <0.001 
4-8 (N=279) 8.79 (5.77, 13.39) <0.001    
2-3 (N=1011) 3.82 (2.70, 5.40) <0.001    
1 (N=1567) 2.04 (2.70, 5.40) <0.001    




This work presents findings on the value of a range of cognitive tests and their individual predicted risk 
of dementia in this cohort of individuals mid-late life. Dementia is associated with lower cognitive 
function many years before the recognised onset of the disease, [77,81] with preclinical disease on a 
continuum from completely asymptomatic individuals. [33] This chapter reports on eight simple 
cognitive tests that accurately predict an average of a decade before the onset of dementia. The more 
pervasive and greater the variability, the higher the risk of dementia. Presented here is additional 
evidence on the utility of a range of cognitive tests and the predicted risk of dementia in individuals 
free of dementia at the time of cognitive testing.  Impairment in multiple domains, independently 
predicted risk of dementia over and above performance score of individual tests or a composite score. 
Poor cognition in four or more tests is associated with a ten-fold increased risk of developing dementia 
compared to those not performing poorly in any test. The addition of cognition score (using just the 
composite score AUC=0.83), improved the multivariable adjusted model alone (AUC=0.81), and 
including the number of tests with impaired cognition, improved the model even further (AUC=0.85). 
These  findings are comparable to other studies of risk prediction models. [27,28]  
There are a number of limitations to this work. The first as discussed previously, is the issue of healthy 
volunteer bias. However, there is a wide representation  of individuals in terms of age, education, social 
class and both men and women as in the general population. [213]  As the focus of the 3HC was on 
aspects of ageing, it could be said that participants had concerns on their cognition. However, this 
seems unlikely as the majority of individuals scored well and the differences between the impaired 
group and the reference group were large. 
Those who did not attend this interview but had given permission to track medical records had 83% 
higher risk of dementia than those who attended and did all eight cognitive test (HR=1.83 (95%CI 1.61, 
2.08 P= <0.001)). The use of a self-report measure of many of the factors may also be criticised as 
prone to recall biases or not accurate as an objective measure. Conducting this study in this healthier 
population has the advantage of less confounding from co-morbidities. Although a wide range of 
factors were adjusted for, due to the nature of an observational study, residual confounding cannot 
be excluded.  
Using medical records allows a more complete follow-up, limiting attrition as a bias and is widely used 
method in epidemiological research. [28]  The downside of this is the dependence on medical records, 
prone to inconsistencies across time, with changes in policy and practice raising concerns over the 
accuracy and changing completeness of dementia recording. [91,92] Also, as highlighted previously in 
Chapter 7,  medical records are known to underestimate the number of individuals with dementia, as 
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not all individuals receive a formal diagnosis.  Nevertheless, even though less sensitive, medical record 
diagnosis is likely to be highly specific such that when an individual has a diagnosis or death 
certification with dementia recorded this is highly likely to be accurate. [92] 
Although adjudication may increase sensitivity, in a large cohort study, misclassification of relatively 
few positive cases as non-cases will have little impact on the overall association. Ascertainment was 
maximised by using a broad definition of ‘any definite dementia’ from a range of data sources. Any 
methodological changes (such as those for dementia mortality), are likely to have little impact on the 
overall rates for dementia.  Using ‘definite dementia’ as the outcome, is also a limitation, as it could 
be missing milder forms of cognitive dysfunction. There was minimal change in association when 
removing those with a dementia diagnosis or who had died within 5 years of cognitive testing. 
However, reverse causation cannot be ruled out due the long preclinical phase of dementia. [243] 
Further follow-up time is needed, although determining temporality for dementia will always be 
challenging.  Also, having a wide age range at baseline, it is possible to observe the different influence 
of factors and how their relationship varied with dementia as midlife or later life exposures.   
The cognition assessment in EPIC-Norfolk was a comprehensive battery covering a wide range of 
domains. These results are comparable to the predictive values reported in previous studies, [27] 
including those recently reported by UK Biobank. [28]  However, this study goes beyond the predictive 
accuracy of cognitive test score alone, and demonstrates the added value of including the level of 
impairment as measured across multiple domains.   
Substantial cognitive changes occur with healthy ageing. Previous studies have shown that there are 
milder or pre-symptomatic stages of dementia, not limited to memory. [80,82] This work confirms 
these findings in this larger cohort with a wider age range.  It is quite possible to misclassify milder 
symptoms or asymptomatic without memory concerns as normal cognitive aging.  These findings also 
clearly show the magnitude of the predictive accuracy of a wide range of cognitive tests from the same 
cohort, with some tests predicting better than others. In particular, this work shows that tests of 
processing speed are not as powerful as the other tests. These points are important to consider in 
future work. 
It is extremely important to disentangle confounding caused by methodological variation to 
understand who are at greatest risk. Here, the risk predicted was ten-fold greater in those with 
pervasive impairment, however the confidence intervals for this group were wide due to smaller size 
of this group. This gives some uncertainty of the true magnitude of the increased risk. Other cohort 
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studies examining dementia risk should consider impairment across multiple domains in their 
prediction models to examine the association within their settings. 
Even with a ten-fold increased risk of dementia in those with more pervasive impairments, the findings 
do not support future screening or use of predictive modelling for diagnostic use for dementia and 
agree with recommendations of the USPSTF. [261] Predictive modelling will always result in a 
considerable number of false positives and is very much a research tool at present. It does however, 
provide the necessary insight to factors that either increase or decrease risk of dementia. Detecting 
the earliest phases of impairment across cognitive domains, could inform the design of trials of 
preventive or modifying interventions [6] and identify target populations greatest at risk who can then 
also be included in such trials.  
 
 
Summary of Chapter 
 
 There were 537 participants with a dementia diagnosis in EPIC-Norfolk with a maximum 
of 14.8 years of follow up (median 9.8 years). 
 
 Poor cognition was predictive of incident dementia across all abilities, even after 
adjustment for co-variates. 
 
 Compared to those who did not have a poor performance score in any test, poor 
performance in one test doubled the risk of dementia. 
  
 Those with a poor performance score for global cognition (bottom 10%) were almost 
four times as likely to get a dementia diagnosis than those who performed well HR=3.51 
(95%CI 2.61, 4.71 p<0.001). 
 










9.1 Summary of findings 
This thesis explores the relationship of a number of non-modifiable and modifiable factors and 
cognition across a range of function and cognitive abilities. A major focus of this work was to get a 
better understanding and insight to heterogeneity in cognitive performance observed in older people 
and to identify what influences are important to consider when assessing cognitive function in an 
ageing population. This dissertation presents a number of key findings on cognitive function from EPIC-
Norfolk, a 25-year prospective cohort study that are presented in Box 9.1, adding to existing evidence 
from previous epidemiological studies on cognitive function and dementia. Heterogeneity in 
population characteristics, differences in methodologies and inadequate control of confounding are 
contributing to the inconsistencies observed across studies investigating relationship modifiable risk 
factors and cognitive impairment and dementia. It is important to disentangle confounding by 
methodological variation to have a clearer understanding of these associations. 
 
The European Prospective Investigation into Cancer in Norfolk is a prospective population study of  
25 639 men and women aged 40–79 years when recruited in 1993–1997 and followed up to the 
present.  The infrastructure of this study was used to examine the epidemiology of cognitive function 
in this middle aged and older general population. Most studies of cognitive function hitherto have 
been based in older populations, or in selected groups such as occupational cohorts.  In a 2006–2011 
at a follow up examination 8585 men and women from the cohort undertook a range of cognitive tests.  
Individuals were cognitively unimpaired at time of testing. The cohort has been followed up through 
record linkage with routine health records to ascertain dementia endpoints.  
 
In the first part of the thesis, I examine the descriptive epidemiology of cognitive function in this 
population to provide further insight into the relationship with various demographic and lifestyle 
factors. Cognitive function profiles are presented across a range of domains using previously validated 
assessment tools in this cohort of men and women in mid to later life. In general, cognition declines 
with age but there is a wide range of capability from poor to high performance across each age band, 
with some participants from the oldest age group outperforming their younger counterparts. I 
addressed a number of issues relating to the variability and heterogeneity of cognitive function 
observed in older people and provide further insight into the potential reasons for the inconsistencies 
reported in the current literature. In the second part of the thesis, I explore the prospective 




Box 9.1: Summary of key findings from this thesis 
Confirmation of previous findings  
 Variability, heterogeneity and dispersion exists for the range of cognitive domains assessed. 
There is a wide variation in cognitive performance in the EPIC-Norfolk cohort.  
 With fewer studies involving the healthy and cognitively unimpaired, this thesis adds to the 
understanding not only in terms of impairment, but across the spectrum, including that of 
high cognitive function. 
 This work addresses the question of what is important to measure when assessing cognitive 
function using a broad range of cognitive measures. 
 The EMSE is able to differentiate between individuals at the high end of the ability range in 
this general functioning population. Even a small number of additional items can extend the 
higher end of performance range. 
 Unlike for the MMSE, those in the highest performance group of the short-form EMSE were 
not in the poor performance group of the other tests, demonstrating the greater 
discriminative ability of the EMSE (even in the shortened form). 
 This thesis details the psychometric qualities and utility of a range of validated tests using, 
as a comparator, the widely used MMMSE test, known for its ceiling effects. Those with the 
highest possible MMSE score could potentially be in the poor performance group of another 
cognitive test. 
New findings (Methodological) 
 The short-NART equation for predicting the full NART score, is not as reliable in a more 
general population as it was in the elderly population it was originally tested on. 
 A recommendation from this investigation is to lower the cut-off even further so that there 
is no need to use the algorithm for the short-NART. 
Influence of socio-economic factors 
 The relationship of socio-demographic factors with performance varies according to the 
cognitive test. These differences are observed even across different tests purporting to test 
the same ability. 
 Education is strongly associated with cognitive function across all the abilities. However, this 
association varies considerably across abilities. Not having qualifications in those <65 years 
is associated with greater risk of being in the poor performance group. For the SF-EMSE, 
comparing those with an education up to ’O’ or ‘A’ level compared to those with no 
qualification, is equivalent to those almost 10 years younger and for those at graduate level, 




Box 9.1: continued 
Novel findings for physical activity  
 This thesis presents novel evidence on physical activity during work and leisure time from 
individuals across a wide range of socio-economic background and education, showing that 
this relationship is complex. 
 Inconsistencies in the literature on physical activity and cognitive function may be 
attributable to studies not addressing residual confounding by education adequately. 
 Physical inactivity during work is inversely associated with poor cognitive performance. 
Manual workers had almost three times increased risk of poor performance compared to 
those with an occupation classified as inactive. 
Insight to characterisation of dementia outcomes 
 Present differences of all-cause dementia incidence as ascertained across major data 
sources used in epidemiological research. There is a lack of consistency in dementia 
ascertainment from different routinely collected health records. 
 The work presents new insight into the more recent mental health services dataset. 
 This thesis highlights potential reasons for discrepancies across the different data sources. 
There is need to develop a more consensus approach to methods of data collection, coding 
and interpretation of routinely collected health data. 
Cognitive predictors of mortality and dementia 
 Poor cognition is independently associated with higher risk of all-cause mortality 
 The relationship with mortality varies across cognitive abilities. 
 Poor cognition has a greater disadvantage in terms of survival for those with no 
 qualifications. 
 Poor cognition predicts incident dementia.  This association was observed for those in the 
bottom 10% of the composite score HR=3.51 (95%CI 2.74, 4.48 p<0.001) as well as for the 
specific cognitive abilities. 
 Although associations vary across abilities, poor performance in the test for verbal episodic 
memory is particularly good in predicting dementia. Cognitive measures strengthen 
prediction models of dementia AUC = 0.83 (95%CI 0.81, 0.85 p<0.001). 
 Impairment in multiple domains, independently predicts risk of dementia over and above 
the performance score of individual tests or a composite score. 
 The more pervasive and greater the variability, the higher the risk of dementia. Poor 
cognition in four or more tests is associated with a ten-fold increased risk of developing 





9.2 Strengths and Limitations 
9.2.1. Strengths 
The setting of the EPIC-Norfolk has allowed the exploration of cognitive function from earlier stages of 
decline, a time-point of great interest in terms of identifying early indicators cognitive impairment and 
dementia. The large sample size, longer follow up, wider age range, large number of co-variates, 
characterisation of exposure and the detailed measure of cognition has identified the implications of 
confounding on associations that has not been clear in previous studies.  This clearly demonstrates 
that variation in methods for measuring and characterising the exposure will give different associations 
for addressing the same research question.  
The emphasis of EPIC-Norfolk has always been the development and use of better epidemiological 
assessment tools for diet, physical activity and now this has extended to include cognition. The other 
strengths include the large sample size, and the long follow up from baseline of over 25 years and up 
to 15 years from cognitive testing to time of time of follow-up for dementia outcomes. Although the 
cohort is not ethnically diverse, the population at baseline was similar to the national population 
samples studied in the Health Survey of England, in terms of anthropometry, serum lipids and blood 
pressure. [137] Furthermore, unlike other studies that are more restrictive in age, sex or based on 
specialised groups such as occupations cohorts that may not represent the general population, the 
EPIC-Norfolk cohort comprises both men and women, covers a broad range in age, education and 
social class.  
Even in this relatively well-functioning group that underwent cognitive testing, [138] there was a wide 
range of cognitive performance across all cognitive domains.  The use of an extensive battery was also 
an advantage allowing assessment across a broad range of abilities.  With the availability of 
longitudinal exposure and health outcome data from baseline to the present, this cohort provides the 
ideal opportunity to examine the trajectory of functioning in the general population and across a wide 
range of cognitive function, to allow examination of correlates of high as well as poor performance.  
9.2.2. Limitations 
The main limitation is healthy volunteer bias and attrition. Those who attended the 3HC were healthier 
and younger individuals, with older, frailer and cognitively impaired individuals more likely to be lost 
to follow-up. The less frail cognitively impaired will be less likely to attend, as discussed in Chapter 3, 
and this would result in selective truncation of individuals from the lower cognitive performance. 
However, despite this, there was still a broad range of ability observed across a wide age range. The 
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baseline characteristics available on the individuals from the first health examination allowed 
comparisons and some characterisation of those who did not attend the third health examination who 
had cognitive measures. Nevertheless, irrespective of whether individuals attended subsequent 
examinations, the whole cohort from baseline had complete follow-up using health record linkage. 
Although an extensive cognition battery was used to measure cognition, EPIC-Norfolk was not 
primarily a study of cognitive function at baseline, and the measures of cognition were incorporated 
at a subsequent examination.  However, the compliance rate for the cognitive measures was 
exceptionally high, where out of the 8623 individuals who attended the 3HC, 8585 had a cognitive test 
measure. The other limitation is that, although this study incorporates over 25 years of follow up, 
cognitive measures were not introduced until the third health examination phase, which took place 10 
years from baseline.  Furthermore, cognitive measures from only one time-point were used, so the 
work here is not presented in terms of decline in function, but as a level of performance compared to 
the rest of the population.  
Use of percentile scores rather than continuous score, which would be more statistically robust could 
also be criticised.  Methodology varies across studies which use different cut-offs to define cognitive 
performance. In this cohort, with no overt cognitive impairment, I have previously shown that the 
cognitive scores are not normally distributed, [170] and in the descriptive analysis of scores revealed 
a non-linear relationship which is why the associations were examined using approximate percentile 
cut-offs. Given that this study is in relatively healthy older adults, I chose in most of the analyses a 
more stringent cut-off (10th percentile), even though the more stringent cut-off will still include 
individuals who do not have cognitive impairment or dementia. Nevertheless, the bottom tenth 
percentile corresponds more closely to impairment and dementia prevalence rates which has been 
reported in the Dementia UK update report as 7.1% [262] based on findings from the MRC Cognitive 
Function and Ageing Study II. [263]  
9.2.3 Missing data 
On the whole, EPIC-Norfolk participants were very compliant, and there was little missing data, 
particularly for the cognition data where only 38 participants out of the 8623 who attended the 3HC 
phase had no cognitive measures. The characteristics of these 38 individuals are provided in the 
relevant chapters. Study samples in the analyses varied across the thesis due to information on co-
variates. Each chapter includes complete case analysis but also includes sensitivity analyses, to 
demonstrate clearly that ‘missingness’ was random and did not change associations. As mentioned 
above, the compliance for the cognition tests were good and there was complete follow-up through 
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medical health records for dementia and mortality outcomes. The issue of missing data in health 
records is well recognised, however, the impact of this potential bias is addressed in this thesis in 
Chapter 7. 
9.2.4 Multiple testing  
Multiple testing across different cognitive test means statistically significant association could be 
observed by chance. I did not do Bonferroni adjustments to estimate significant P values as assessment 
of associations rely on judgements in any case.  However, one of the main aims of this work was to 
examine and compare associations across different cognitive domains separately. To address this 
point, I also included a composite score representing global cognition (beyond that which is measured 
by the SF-EMSE test). There is the issue of multiple testing across different hypotheses and chance 
associations cannot be entirely ruled out as in any other study.   
9.2.5 Residual confounding, reverse causation and over-adjustment 
EPIC-Norfolk wide range of data available allowing control for a wide range of factors, but since 
adjustment can never be complete for many reasons including measurement of variables, residual 
confounding cannot be entirely ruled out.  This is particularly so for education which is a major 
potential confounder for other observed associations. Another limitation is the inability to control for 
other early life indicators such as family social economic status and parental education, which are 
established determinants of cognitive function, [214] but were not available in this cohort.  These 
factors are known to be associated with cognition as well as dementia and mortality. [222,264,265] 
To address the issue of reverse causation, sensitivity analyses were conducted, removing cases of 
those who had died or had a dementia diagnosis within 3-5 years. Despite this, reverse causation may 
still bias the observation as dementia has such a long preclinical phase. Conducting this study in this 
healthier population has the advantage of less confounding from co-morbidities. Although we adjusted 
for a much wider range of factors, confounding may still bias these results. Pre-existing health 
conditions were based on self-report, which are prone to recall bias 
Association with cognition is complex – pathways are not clear and so could have over-adjusted for 
some variables. Co-variates were added to models based on the literature. For cognition and dementia 
over-adjustment is less likely as shown in models, once adjusted for age and education, associations 
were not very different with further adjustments. All the models were shown in each chapter. 
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9.3 Interpretation of findings 
There is both the political and public will to invest in dementia research and gain a better 
understanding of mechanisms leading to disease. [266]  However, before we can investigate or advise 
on prevention strategies or for modifying the course of dementia, it is crucial to disentangle the 
existing evidence and gain insight into why to variations and inconsistencies are observed across 
studies.  There is no doubt that age is the biggest risk factor for dementia [36] and that is supported 
by this work. The additional contribution of other risk factors will be limited in relation to age, but they 
are still important. The evidence from observational studies on a range of factors that could contribute 
to delaying the onset and reducing the future number of people who have cognitive impairment and 
dementia [6,11,13] is supported by the work presented here.  
Despite the increase in dementia research, the evidence for most of these factors is still inconclusive 
and the reasons are not clear. [11,26] It is important to ascertain whether this is due real differences 
in the distribution of predisposing factors or due to differences in methodologies, including limitations 
in the way either the exposure or outcome is measured. [103]  These inconsistencies make it difficult 
to compare findings across studies.  In this thesis, I have used the data collected in the EPIC-Norfolk 
cohort, to try and to explore and provide further explanation for the differences that have been 
reported in other studies. This involved examining the accuracy of study-specific methodology, 
characteristics of the population and setting as well as the exposure and outcome in terms of cognition 
and dementia.  
I have examined association of potentially modifiable factors such as education, social class and 
physical activity with cognition across the continuum from mild cognitive dysfunction through to the 
other end of the spectrum of a clinical diagnosis of dementia. Although education is a well-established 
protective factor for cognition, I have shown here, that the strength of this association varies according 
to the cognitive tests used. Higher level of education is known to be associated with better cognition 
and lower risk of dementia. It is also associated with a healthier lifestyle, which may well to be part of 
the explanation. Also presented in this thesis, is a novel perspective to an existing problem of 
confounding and I suggest more precise assessment methods that are able to discriminate between 
physical inactivity during work and leisure, and are more specific on the nature of inactivity for future 
studies.  Furthermore, education attainment, which is a complex construct, needs to be given further 
consideration that other studies may not be accurately accounting for. Inconsistencies in the literature 
may be attributable to studies not addressing residual confounding by education adequately. 
Dementia remains a clinical diagnosis, despite the increased knowledge in biomarkers and that 
dementia is a syndrome that occurs on a continuum with a long pre-clinical phase.  Diagnosis is usually 
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made using various recognised classification systems and research studies use one or more of these 
definitions to operationalise dementia as an outcome. Another methodological issue highlighted from 
the work of this thesis is the need for more accurate and consistent recording of dementia in health 
records. Rates of dementia will vary depending on the definition of dementia which is based on coding 
and disease classification. Inconsistency across systems result in inaccuracies and incomplete 
dementia recording in health care records, [91,92] which are a major source of case ascertainment for 
epidemiological studies examining relationship of different risk and protective factors of dementia. 
[91,96] It is necessary to be aware of the shortcomings of these data sources when studies report on 
their findings. [238]  This work highlights methodological limitations that may contribute to the 
variability and dementia ascertainment across different settings.  It is paramount to have robust 
methods to provide the reliable and consistent evidence that is required to better inform future health 
policies.  
9.4 In context of other work 
There are many high quality prospective cohort studies that are investigating different aspects to 
enhance our understanding of ageing, cognitive impairment and dementia. [88,123,126,128,129] Each 
with strengths and limitations, adding to the difficulties to compare across studies.  Some of these 
studies were specifically set up to study cognition, [88] but many added cognitive measures later in 
the course of the study. The availability of a range of risk factors, have allowed detailed exploration of 
a range of factors from mid to later life and their association with cognition and dementia. 
[90,95,119,126,128] 
EPIC-Norfolk is such a study where cognitive measures were introduced at a later stage and cannot be 
considered to be representative of the older population of UK.  The EPIC-Norfolk cohort is deeply 
characterised with a wide range of both phenotypic and genetic data of which only selected factors 
were used as exposure and as co-variates. This presents a rich resource of a wide range of factors from 
mid to later life that can be used to compare with other studies similar in nature examining cognition. 
The fact that EPIC-Norfolk participants did not have any overt cognitive impairment at the time of 
cognitive testing, also offers excellent opportunity in providing a wider window to assess the earlier 
indicators of cognitive dysfunction, often missed by cohorts of older individuals in later life.  
9.5 Public Health Implications 
Prevention or delaying dementia onset is a public health priority. [266] Given the scale of the numbers 
of individuals, even a modest delay in the onset of dementia could have a major impact on public 
health, with significant cost savings and considerable benefits to the health and wellbeing of 
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individuals.  There is no shortage of evidence for recommendations on future public health strategies 
on how to best manage or prevent cognitive decline, impairment and dementia. The evidence is said 
repeatedly to be strong but inconclusive. [11] The aim of this thesis was to try and examine the reasons 
for theses inconsistencies. The relationship between risk factors and cognition is complex, not only in 
how these factors interact and cluster together, but also how these risk factors vary over time. This 
may be a reason why it has not been possible to translate the available evidence into proper prevention 
or intervention strategies.   
Developing and strengthening public health strategies that would enable the delay in onset of 
dementia is vitally important and with no doubt, will bring huge benefits for an ageing society. 
Targeting modifiable factors such as lifestyle, health and social-economic factors is a sensible 
approach.  However, care needs to be taken as to how this health message is promoted. Findings for 
the differential relationship between inactivity at work and leisure and cognition, demonstrates this 
point.  The conclusion from these analyses was that although promoting physical activity can do no 
harm, we must be aware of the limitations of confounding before embarking on any health promotion 
strategies so not to lose public support by giving mixed messages. 
Cognitive tests used in EPIC-Norfolk predicted future dementia up to a decade before the onset as 
defined clinically.  The aim would not be to use such models as a screening tool to identify individuals 
with dementia, however detecting the earliest phases of impairment across cognitive domains, could 
inform the design of trials of preventive or modifying interventions [6] and identify target populations 
greatest at risk who can then also be included in such trials. 
9.6. Implications for future work 
As highlighted by the Lancet report, [6] there is a growing interest in modifiable risk factors in the 
prevention or delay of dementia.  One key finding from this work on physical activity could be extended 
to include objective measure of physical activity that were available from the time of cognitive testing. 
These data current need further validation using the physical activity questionnaire.  However, using 
objective measures of physical activity would provide a more accurate measure of inactivity to examine 
associations in further detail. We could also examine sedentary behaviour, which is different from 
inactivity.  
It would also be useful to examine the other main modifiable risk factors of dementia, diabetes, midlife 
hypertension, midlife obesity and depression that have been highlighted in the Lancet report.  Of 
particular interest is depression, which has also shown to be associated with increased risk for 
dementia, [115] although longer prospective investigations does not show the same relationship. [116]  
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EPIC-Norfolk has detailed measures of emotional health, work strain, social support and personal 
dispositions. These data will provide further insight to this relationship over a period of twenty-five 
years. Some dementia risk factors linked to health disparities or social inequalities, which have not 
been examined in this thesis, but could be an extension to this work. Due to time constraints, I was 
unable to explore the relationship with social networks and mental activity in detail. It would be 
possible to examine the above factors with social and leisure activities to add to existing evidence for 
a better understanding of the influence of such activities to wellbeing and better cognitive function in 
later life. [64] 
The other area of work which will be of particular interest is the exploration of the new mental health 
data that were used in this thesis have had very limited use by other studies. There is a need for a 
deeper understanding of these data to be able to exploit the databases to maximise the information 
from these sources. The mental health data offer the potential to ascertain dementia cases not only 
from GPs, hospital and death records, but those individuals living in the broader community diagnosed 
by memory clinics. As the field of dementia research increases use of routinely collected health 
records, it is important for experts across disciplines, including clinicians, data curators and researchers 
to work together to develop methods for consistent and accurate data capture with less subjective 
input and influence by practice and policy changes.  With additional follow-up time, there will be more 
individuals in EPIC-Norfolk with dementia and dementia related syndromes that can be examined in 
detail with, other factors. This work led to the incorporation of childhood factors in the most recent 
health check, which will be available in the future.  
Despite the expansion in dementia research, establishing causal relationship between risk factors and 
outcomes is still a major challenge. Randomised controlled trials (RCTs) are the gold standard in 
evidence generation but are unlikely to be as effective in testing interventions or causal factors for 
dementia related syndromes. This is because of the complex and multifaceted nature of cognitive 
impairment and dementia, and the insidious onset of these conditions.  Furthermore, the biggest risk 
factor, age, comes with frailty, reduced functional health and co-morbidities, all adding to the 
complexity, that cannot be teased out by RCTs that are designed to test single-intervention at a time.  
Although the focus of research has turned heavily to data and linkage to health records, my thoughts 
resulting from this work is that this resource must be addressed with caution and although will be a 
great asset to dementia research, it should only supplement the evidence-base. Despite the 
shortcomings of observational studies that have been highlighted such as confounding and biases, I 
believe longitudinal population-based cohort studies have much to contribute to future dementia 
research.  The UK has many excellent cohort studies with vast amount of data, biological samples and 
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expertise gathered over many years. With future development on potential biomarkers, stored 
samples can be used to analyse potential early indicators of decline.  Only in these large cohorts with 
long follow-up time can the more complex interactions of potential risk factors and their temporal 
relationship with cognitive impairment and dementia be examined. A more collaborative approach 
across these cohorts is needed. We need to gain further insight into the characteristics of the cognitive 
tests and harmonise their measures to allow better understanding across their different populations, 
and a clearer overall picture. It is not sufficient to merely report associations, but important to try to 
elucidate what could be the underlying mechanisms that are involved and how this could translate to 








Dissertation at a glance 
 
What is already known on this topic? 
There is an increasing interest in the potential role of modifiable factors in preventing or 
delaying the onset of dementia. Despite the extensive research in this area, the available 
evidence is mixed and inconclusive and further research is needed. 
 
Reasons for discrepancies across studies are unclear but may be partly due to variability in 
methodologies and inconsistencies making it difficult to interpret and compare findings. It is 
crucial to disentangle the existing evidence and gain insight to variation observed across 
studies and investigate whether this is due real differences in the distribution of predisposing 
factors or due to differences in methodologies. 
 
What this study adds. 
This dissertation presents a number of key findings on cognitive function from EPIC-Norfolk, a 
25-year prospective cohort study. 
 
Though age, sex, education and social class were all independently associated with cognitive 
performance across all abilities, the magnitude of these associations differed across the 
different cognitive tests. 
 
The varying relationships seen across different tests may help explain discrepancies in results 
reported in the current literature and provides insights into influences on cognitive 
performance in later life. 
 
Measuring cognitive domains separately gives more insight than a global measure. Different 
cognitive tests tap into a range cognitive and sensory abilities to perform a given task. 
Therefore, psychometric properties of tests should be given due consideration when 
interpreting results. 
 
To our knowledge, this prospective study is the first to investigate habitual physical inactivity 
during leisure and work time (combined and separately) from individuals from a wide range of 
socio-economic background and education. Those with an inactive job had a lower risk of poor 
cognition. Manual workers had almost three times increased risk of poor performance 
compared to those with an occupation classified as inactive. 
 
With up to 15 years of follow-up,  poor performance exhibited across a wider range of cognitive 
abilities is shown to increase the risk of dementia.  These results suggest that a more variable 











Literature Review Search Strategy (overall :  
Search (((((((((((cognitive function) OR cognit*) OR cognition) OR cognitive abilities) OR cognitive 
abilities)) AND (((variation) OR variability) OR differences)) AND (((((age) OR aging population) OR 
ageing population) OR older adults) OR age related))) AND ((((abilities) OR domains) OR global 
function) OR specific))) AND ((((((((((((((mortality) OR death) OR health) OR function) OR cognitive 
impairment) OR dementia) OR cardiovascualr) OR CVD) OR cancer) OR depression) OR obesity) OR 
bmi) OR diabetes) OR chronic disease) identified 4727 citations. Limiting the search to articles 
published in English, based on human research and restricting the age group to ‘middle aged’ and 
Aged ‘45 years +’ reducing the number to 2308 citations, and further limiting to when including 





Work and Leisure time components of the EPIC Physical activity questions from which total physical 
activity score derived  
1. We would like to know the type and amount of physical activity involved in your work. 
Please tick what best corresponds to your present activities from the following four 
possibilities: 
Sedentary occupation - You spend most of your time sitting (such as in an office)  
Standing occupation - You spend most of your time standing or walking. However, your work 
does not require intense physical efforts (e.g. shop assistant, hairdresser, guard, etc.) 
Physical work - This involves some physical effort including handling of heavy objects and use of 
tools (e.g. plumber, cleaner, nurse, sports instructor, electrician, carpenter, etc.) 
Heavy manual work -  This involves very vigorous physical activity including handling of very 
heavy objects (e.g. docker, miner, bricklayer, construction worker, etc.) 
2. In a typical week during the past 12 months, how many hours did you spend on each of the 
following activities? (Put ‘0’ if none) Cycling, including cycling to work and during leisure 
time  
In summer             _______       hours per week 
In winter                _______       hours per week 
Other physical exercise such as keep fit, aerobics, swimming, jogging  
In summer             _______       hours per week 
In winter                _______       hours per week 
 
Hours per day of recreational activity computed from [(mean of summer and winter hours per week 





The four levels of the index are as follows: 
(1) Inactive (a sedentary job and no recreational activity) 
(2) Moderately inactive (a sedentary job with, 0.5 h recreational activity per day or standing job 
with no recreational activity) 
(3) Moderately active (sedentary job with 0.5–1 h recreational activity per day, or standing job 
with, 0.5 h recreational activity per day, or physical job with no recreational activity) 
(4) Active (sedentary job with 1h recreational activity per day, or standing job with 1h recreational 





EPIC-Cognition (EPIC-COG) Battery Scores and Data Cleaning  
The scoring (and where necessary, details on the criteria) applied to each item on the components of 
EPIC- Cognition Battery (EPIC-COG) are given here.  All the raw data collected have been kept in the 
original form. Data entered by the nurse was captured immediately on an electronic Case Report form 
(eCRF).  Pen and paper tests were recorded directly on a paper copy of the CRF identified with the 
participant’s unique study number. This information has been included as supplementary material and 
published. [170] 
Any changes made to data (as part of the data cleaning process) were made at the analysis library level 
with any assumptions and subsequent actions (i.e. what changes were made, who made the change, 
why and how that change was made) clearly documented.  Reasons for refusal were recorded to 
differentiate those participants who refused or failed to complete as a result of a technical fault or ran 
out of time, from those who refused because they expressed anxiety or difficulty with the task.  Those 
who refused prior to starting a test or those who said no to a test component were assigned as missing 
data. 
1/ Short Form- Mini Mental State Exam (SF-MMSE) 
These 11 items make up the SF-MMSE, giving a possible maximum score of 15 and are part of the wider 
Short Form Extended Mental State Exam (SF-EMSE), administered as the first test of the EPIC-COG 
battery. 
Scoring Criteria: Participants completing and or attempting any part of the SF-MMSE were included in 
the analysis, scoring ‘0’ on the sections not completed. Incomplete data would also include the added 
codes (as described above for reasons for refusal) indicating specific reason for the incomplete data. 
A derived full MMSE Score can be obtained by using the following simple algorithm: SF-MMSE Score 
+14 (giving a possible maximum score of 29). This work has been published. [149]  
Domain: Language  
Max Possible Score = 2  
     Correct    Incorrect        
Pencil………………   |_1_|          |_0 |                 
Wristwatch………...   |_1_|         |_0_|                  
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Domain: Registration  
Max Possible Score = 3  Named   Not named on  
    on first try first try 
Apple…………………………………………|_1_|    |_0_|       
Table………………………………………… |_1_|   |_0_|       
Penny…………………………………………|_1_|   |_0_|     
Domain:  Retrospective Memory   
Max Possible Score = 3 
    Recalled Not Recalled            
Apple………………………………… |_1_|      |_0_|                     
Table…………………………………  |_1_|      |_0_|        
Penny………………………………… |_1_|      |_0_|   
Serial Sevens 
Domain: Attention (Calculation) 
Max Possible Score = 5 
Scoring criteria specific to this item: The main section containing missing data for the SF-MMSE is for 
the Serial Sevens.  For this specific item, if a participant gave at least one answer (correctly or 
incorrectly) then all other scores were marked as 1 or 0 (non-missing). If there was an answer followed 
by a refusal then again all subsequent scores were also marked as 1 or 0 (non-missing). The nurse 
would indicate specific reason for an incomplete Serial 7 score.  
Correct    Incorrect   
1st answer is correct |_1_|   1st answer is incorrect   |_0_|   
2nd answer is correct|_1_| 2nd answer is incorrect   |_0_|     
3rd answer is correct |_1_| 3rd answer is incorrect   |_0_|     
4th answer is correct |_1_| 4th answer is incorrect   |_0_|  





Max Possible Score = 1 
Data entry Code: Correct  |_1_| Incorrect   |_0__|  Inapplicable  |___|      Refused   |___|   
 
Scoring criteria specific to this item: Spelling, grammar, punctuation and capitalisation were not 
important.   
The sentence had to have a subject (real or implied), a verb (showing an action or state of being) and 
had to convey a meaning that made sense.  Imperative sentences, where the subject was implied, such 
as ‘Help’ or ‘Go away’ were considered to be acceptable.  For consistency and accuracy in scoring, 
although the subject could be real or implied, but the verb could NOT be missing nor could it be implied 
for the sentence to be correct.  Further details (and examples) for clarifying these criteria were 
included in the protocol. 
In summary, to score a point, the sentence: 
 must make sense  
 be complete and not fragmented 
 include a subject (real or implied), and it should be quite clear as to who/what the subject is 
that the participant was referring to 
 include a verb, and the verb had to be clearly stated and not be implied 
Verification: All sentences were reviewed first by a member of the clinic team, then by a member of 
the research team based in Cambridge (who were not involved in the data collection) and checked 
against the above criteria. If there was a disagreement on whether a sentence was correct or not, the 




Praxis -Copying 2 inter-locking pentagons  
Domain: Visuo-spatial 
Max Possible Score = 1 
The participant was asked to copy a picture of a pentagon onto the paper copy of the CRF under the 
original drawing. The drawing was done freehand. If the drawing was not attempted (and there was 
no reason given for refusal), it was marked as incorrect.  
Correct  |_1_|Incorrect   |_0_|  
 
Scoring Criteria specific to this item: The two figures had to have both five sides and intersect to give 
a four sided figure in the middle. Both shapes did not have to be exactly the same, but needed to be 
relatively similar in shape and size to one another and all 10 angles needed to be relatively preserved 
The lines drawn by the participant had to be solid and although they did not have to completely join, 
most of them should have done so. Furthermore, all the lines had to be straight and not curved, tremor 
and rotation of the figures could be ignored. 
If the participant did more than one drawing, they were asked to cross out the figure they did NOT 
want to use. If this step was missed and there were two drawings, only the best drawing was scored 
at the final verification step. 
 2/ Additional Items forming the Extended Mental State Examination (EMSE) 
The remaining 15 item of the EMSE add a further possible score of 22 to the SF-MMSE score of 15 
(Maximum score =37). The majority of the analyses in this thesis use the complete SF-EMSE score. The 
SF-MMSE score was used in a limited number of analyses as a validated and recognised standard, to 
compare the other components of the EPIC Cognition battery.  
Scoring Criteria: As with the first 11 items, participants completing and or attempting any part of the 
SF-EMSE were included in the analysis, scoring ‘0’ on the sections not completed. Incomplete data 
would also include the added codes on refusal) indicating specific reason for the incomplete data such 





Extension on Expression/Naming 
Domain: Language   
Max Possible Score = 2 
Correct            Incorrect         
(1) Keys……………….  |_1_|         |_0_|                
(2) Envelope…………. |_1_|         |_0_|                
Animals named in 1 minute 
Domain: Verbal Fluency 
Max Possible Score = 5 
Scoring Criteria specific to this item: Nurses entered the numbers of animals named in one minute 
(this raw score is available from the dataset).  Any duplications were corrected by the clinic staff (at 
the first checking stage) The raw score was then converted to a derived score ranging from 0-5 as in 
the original EMSE test used in CFAS (derived scores for numbers of animals named as shown in Table 
A4.1table below) 

























Extension on Recall  
Domain: Retrospective Memory  
Possible Score = 4 
     Recalled  Not recalled  
(3) Pencil…………………   |_1_|      |_0_|       
(4) Wristwatch…………….   |_1_|       |_0_|      
(5) Keys……………………   |_1_|                    |_0_|      
(6) Envelope………………   |_1_|       |_0_|    
 
(7) Extension on Language (Writing address to dictation) 
Address on Envelope   
Domain: Language 
Max Possible Score = 2  
 
Scoring Criteria specific to this item: Every envelope submitted was checked at the clinic and then 
again by a member of the research team at Cambridge. Criterion was whether the letter would reach 
the right person and destination (spelling and neatness were not important). If it would, and the letter 
was addressed in the standard format (address at the front, middle of envelope), then it was marked 
as correct (score of 2 points). If the letter had all the information written correctly, and therefore, in a 
real scenario, the letter would reach destination, but the address was not written in a standard way 
(all on one line, address written at the back etc.), then that was ‘poor but acceptable’ and given a score 
of 1. If it did not have the correct information, or was missing (and other items of the EMSE were not 
missing), then that was scored as Incorrect (Score of 0). 
Correct: |_2_|   Poor but acceptable: |_1_|  Incorrect |_0_| 
 
Abstract and Concrete Thinking 
Naming like objects       
Domain: Executive function 
 Possible Score = 4 
 
Scoring Criteria specific to this item: All responses were checked for by the Cambridge research team 
and entered into the database and analysed on the basis of frequencies of the different responses 
given by participants. An answer was considered to be ‘Abstract’ , if the answer was the most specific 
category that both items fell into. If the answer was where the category was too broad, or described 
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characteristics that answer was ‘Concrete’ and an ‘Incorrect’ answer was anything that was not stating 
the category, no answer given or where participant highlighted the differences between the two items. 
A final judgement was made (and when necessary agreed by consensus) on all responses entered on 
the eCRF. 
For the Apple/Banana Similarity Item, there was only one correct ‘Abstract’ answer and this was ‘fruit’.  
Examples of responses scored as ‘Concrete’ (describing characteristics, or category too broad) included 
’food’, ‘eat them both’ or ‘grow on trees’, ‘has peel’ or ‘skins’ or ‘healthy food’. Examples of incorrect 
response include’ They are not the same or not similar, ‘pear’, ‘long and round’ 
The abstract answer for the Boat/Car similarity item was a little more complicated and responses from 
the cohort varied considerably.  Abstract responses included ‘modes of travel’ ‘or ‘conveyance’, ‘you 
travel/ ride in them both. Concrete answers included responses such as ‘mechanical’, ‘both have 
engines’, ‘both carry passengers/people’ or ‘used for leisure’ and incorrect responses included ‘one on 
water/sea, other on land’, ‘road and river’ ‘sailing and motoring’.   
 
(8) Apple and banana  
Abstract Answer (Fruit)                  |_2_|           
Concrete Answer (Food, grow, have peel)           |_1_|    
Incorrect                   |_0_|                   
(9) Boat and car 
Abstract Answer (Both vehicles/ modes of transport |_2_| 
Concrete Answer (Have seats/motorized)         |_1_| 
Incorrect             |_0_| 
 
Recall of name and Address 
Domain: Retrospective memory 
Max Possible Score = 5       
Recalled Not recalled  
(10) John……………………………     |_1_|        |_0_|       
(11) Brown…………………………    |_1_|        |_0_|       
(12) 42………………………………     |_1_|      |_0_|       
(13) West Street…………………….   |_1_|           |_0_|     
(14) Bedford……………………….     |_1_|       |_0_|   
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3/ Letter cancellation Task 
Attention, visual search and Mental Speed 
Max possible Score = 72 
Scoring Criteria:  The following three variables are the raw data calculated and recorded by the nurse: 
1/Target letters (PW)- number of target letters (P’s and W’s) correctly identified (target_pw) 
2/ Line stopped – the line that the participant stopped on after 1 minute (pw-line) 
3/ Column stopped – the column that the participant stopped on (pw_col) 
From the data above, the following derived variables that are used in the analysis can be calculated 
1/PW Accuracy — No. of PW correctly identified minus targets missed (pw_acc) up to the point 
reached 
2/ PW Speed = No. of cells covered/No. of cells on the “pw” worksheet i.e.960 
The outcome variable PW Accuracy has been used for this test in this thesis 
 
4/ Hopkins Verbal Learning Test 
Maximum possible is 36. 
 
Scoring criteria: The words were checked on the eCRF as the participant correctly recalled each word. 
The software program automatically tallied the number of checks for each trial and the nurse manually 
entered the score.  Those boxes not checked indicated that the participants had not recalled that word 
in that particular trial. The tally and the score had to be present for each trial and had to match to 
verify that the score was correctly entered by the nurse.  If a participant did not attempt (or refused) 
the entire test, then a comment had to be entered to identify those participants who didn’t do the test 
(missing data) as compared to those who scored 0 on a trial.  
If Trial 1 had a score for ‘Total’ and there was no score for Trial 2/3 (nor a comment or refusal), then 
after checking the paper record, that data was considered to be incomplete (and so assigned as missing 
data)  
If Trial 1 had no score entered but had a score for Trial 2 and 3, then after checking the paper records, 




5/ CANTAB Paired Associates Learning (CANTAB-PAL) Test. 
The CANTAB-PAL data was recorded and stored automatically under the participant study identifier. 
The data includes a number of outcome measures, such as PAL total errors; PAL total errors (adjusted); 
PAL First trial memory score, PAL Stages completed; PAL Stages completed on first trial all available in 
the analysis library.  Also recorded was whether the participant refused this test completely and/or if 
the test had been aborted and if so, at what stage of the test. All this data is available for analysis. In 
this thesis, the PAL First trial memory score (the number of patterns correctly located after the first 
trial) was the outcome measure used for this test. The First trial memory score indicates immediate 
ability to store visual information. 
 6/ Visual Sensitivity Test (VST) 
This electronic data was automatically collected and stored in files with the participant’s unique study 
identifier as the participant completed the test. The visual sensitivity data includes a number of 
measures, although the outcome measure used for analysis is reaction time (measured in 
milliseconds). There were a large number of measures per participant (approximately 70), and the final 
reaction time used for analysis was the average value of all these measures.  The two main derived 
outcome measures used were VST-simple and VST complex as described in Chapter 2. 
Data cleaning was done in a number of stages. Firstly, software program checked and excluded any 
participants whose visual sensitivity was not in its correct form or whose study identifier was not 
recognised.  Secondly, the largest time value was identified for each person.  Then using the remaining 
(all except the largest time) measures, a mean and standard deviation was defined.  Any record where 
the largest time value was greater than the mean plus 8 standard deviations was excluded (this was to 
remove any extreme outliers from the data from individual participant’s repeat measures).  The 
average reaction time was then calculated from the remaining measures and this value was used as 
the final reaction time for the analysis library. 
7/ National Adult Reading Test (NART) 
Maximum possible (Error Score) is 50. 
The NART Test Manual, second edition (Nelson, 1982) provides a pronunciation guide to assist with 
scoring. A more detailed pronunciation guide was developed in-house, highlighting variations that 
were acceptable (taking the regional Norfolk accent into account) and by also providing the ‘common 
incorrect’ answers which were presented by the EPIC-Norfolk cohort. This was also to assist those 
administering the test to discriminate what was correct and what – even though quite commonly used, 
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clearly incorrect. The detailed guide is given below.  Those administering tests were also provided with 
a sound recording of the words so that they could refresh their memories whenever necessary, and 
were given ongoing training throughout the year. 
Recordings (stored as mp3 files) of the test were made so that scores could be checked after the 
participant had completed the appointment if it was required. Any difficulty with reading, visual or 
hearing impairment or understanding of the instructions, were noted on the eCRF and if necessary the 
test was aborted. If the data was incomplete, as in words missing from recordings (and no explanation 
for this noted on the eCRF) and the equation from the SHORT-NART protocol could not be applied, 
then this data was assigned as missing data.  
Scoring Criteria: Each correctly pronounced word was given a score of 1. Incorrectly pronounced. 
When the participant reached the half way mark, the nurse could then decide if the test was to be 
continued or not depending on the score achieved in the first half. If a participant pronounced a word 
correctly and then ‘corrected themselves’ with an incorrect pronunciation, they were asked to choose 
a final answer.  Scores were based on the final answer given. In summary, the error score (50 minus 
the total number correct) remained as was if the participants NART error score was between 0-11.  For 
participants scoring between 12 and 20, a conversion (as shown in Table A4.2) was used to compute 
the Full NART Error Score. Participants scoring 21 or more were allowed to continue with full NART 
and the error score calculated as shown below. This is described in detail elsewhere. [163] 
Table A4.2: Conversion table for the Short NART error score 
Short NART correct score Conversion to Full NART error score 










21+ As in full NART (50 minus correct) 




8/ Prospective Memory  
Max Possible Score = 2 
Scoring Criteria: To obtain the highest score of 2, the participant had to carry out both actions without 
being prompted by the nurse.  If there was any variation, or the nurse was uncertain of a particular 
response, then this information was included in the eCRF. The research team at Cambridge then made 
the final judgment on the score.  If the participant carried out an extra action (i.e. put the pen in the 
envelope, wrote full name, or wrote something extra such as the date), they still scored the maximum 
2 points. Where there was some variation, a judgment was made if they would receive the points, for 
example, the participant put a cross at the back, or initialled inside before sealing, or initialled front of 
the envelope – in these particular situations, the participant still scored 2. 
Where there was missing data, the nurse was able to specify reasons (Unable or Refused) for this 
specific item. 
Possible Scores were as follows: 
Seal/Initial envelope…   
Seals and writes own name without prompt  |_2_|   
   One action without prompt, one with           |_1_| 
   One action without prompt only                 |_1_|  
   One action only (with prompt)             |_0_|   























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Creating the cognition composite score from the EPIC-Norfolk Cognition Battery (EPIC-COGComp) 
Method 
A composite score (EPIC-COGComp) representing all the abilities covered in the EPIC-Norfolk Cognition 
Battery was included in some of the analyses in this dissertation.  For each of the individual cognition 
test (as listed in Table A5.1, with the predominant abilities assessed by each test), a composite score 
that was then either split into three (Chapter 5) or two groups (Chapters 6 and 8), based on the cut-off 
point corresponding to a percentile of the population distribution in each of the eight cognitive 
outcome measures individually. Participants were allocated to a group based on their individual score 
as described below: 
In Chapter 5, EPIC-COGComp was created as a 3-category variable using the bottom tenth percentile 
as a cut-off Participants were classified as follows: 
Poor Performance: Participants were classified to this group if they obtained a score less than a cut-
off point corresponding to approximately the 10th percentile of the population distribution. Poor 
performance was assigned a score of 0. 
High Performance: Participants were classified to this group if they obtained a score above a cut-off 
point corresponding to approximately the 90th percentile of the population distribution. High 
performance was assigned a score of 2 
Standard Performance: All remaining participants not within the bottom or top tenth percentile 
groups were classified to this group. Standard performance was assigned a score of 1 
For prospective memory, where participants, as previously, those failing the task were classified to the poor 
performance group and assigned a score of ‘0’ and those who were successful were assigned a score of ‘1’. 
The EPIC-COGComp composite score was calculated as a sum of the score based on the performance 
group for all eight cognition test outcomes. However, as this composite was categorised into 3 groups 
and included high performance, the score range was 0-15). The lowest score was 0, (being in the poor 
performance group for all 8 cognitive test outcomes (only 4 participants in the cohort had a score of 
0). The highest score in the cohort was 14, with no participant attaining the top score of 15 (that is, 
being in the high performance group for all 8 cognitive test outcomes).   
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A three–level categorical variable of the EPIC-COGComp score was then created from the continuous 
score using the bottom 10th percentile (obtaining a score of 6 or below), top 10th percentile (obtaining 
a score of 10 or above) and those with scores between 7-9 in the standard performance group.  
In Chapter 6, EPIC-COGComp was created as a 2-category variable, this time the cut-off was using the 
(approximate) 25th percentile as a cut-off.  Participants were classified as follows: 
Poor Performance: Participants were classified to this group if they obtained a score less than a cut-
off point corresponding to approximately the 25th percentile of the population distribution. Poor 
performance was assigned a score of ‘0’ 
Good/Standard Performance: Participants were classified to this group if they obtained a score above 
a cut-off point greater than the 25th percentile of the population distribution. Good performance was 
assigned a score of 1.  
Prospective memory success or failure was treated as above.  
The EPIC-COGComp composite score was then calculated as a sum of the score based on the 
performance group for the eight cognition tests. For this analyses, the lowest possible score was 0 
(being in the poor performance group for all 8 cognitive test outcomes) and the highest was 8, (being 
in the standard performance group for all 8 cognitive test outcomes).   
The dichotomised variable of the EPIC-COGComp score was included in the analyses in the exact same 
way as the individual tests scores, with the approximate bottom quartile (or in this case, obtaining a 
score of 5 or below) defining poor performance for global cognition. 
In Chapter 8, EPIC-COGComp was using the 10th percentile as a cut-off to create a 2-category variable 
and the and the prospective memory success or failure was treated as previously. The EPIC-COGComp 
composite score was then calculated as a sum of the score based on the performance group for the 
eight cognition tests (range again, was 0-8).  
Missing Data 
As the EPIC-COGComp, composite score relies on a score for all eight cognitive tests, it was only 
possible to examine associations with mortality for those with a score on all 8 outcomes, reducing the 
analysis to only 6128 participants. To maximise use of the data, two variants of the composite score 
were created to include all the available cognitive measures. The first variant (EPIC-COGComp0) was 
generated by imputing a score of 0 (assigning individuals to the ‘poor performance group’) for any test 
with a missing value and the second variant (EPIC-COGComp1) was generated by imputing a score of 
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1 (assigning individuals to the ‘good performance or reference group’) for any test with a missing value. 
The range for both variants were also 0-8 or 0-15 for the two and three category composite score 
respectively. These variants were used in the sensitivity analyses as described in the relevant chapters. 
Table A5.1: List of the individual cognitive tests used in the EPIC-Norfolk 3HC  
 Name and outcome measure Predominant ability measured by test 
 
1 





Hopkins Verbal Learning Test (HVLT) 
 
Verbal episodic memory (Immediate total recall 
of three trials 
3 Cambridge Neuropsychological Test Automated 
Battery Paired Associates Learning Test  
Non-verbal episodic memory 
4 Letter Cancellation Task 
 
Attention 




Visual Sensitivity Test (VST) 
(1) VST-Simple 
(2) VST-Complex 
Simple and complex visual processing speed 
8 Shortened version of the National Adult Reading Test 
(Sh-NART) 
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